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Abstract 
 
The potential research on microfluidic devices for detection of biomolecules has recently 
intensified due to its application in point-of-care (POC) diagnostics for global health care. 
Early detection plays an imperative role to determine predisposition to disease (prevention) 
or the outcome of disease (monitoring and prognosis). There is a significant need for POC 
diagnostics devices as perceived from biohazard threats, the spread of infectious disease, 
home testing and monitoring. The POC diagnostics can provide a convenient and immediate 
response to a patient test sample. The POC diagnostics can be attained via use of 
transportable, portable, and handheld instruments such as blood glucometer, cholesterol 
meter etc. and test kits. It includes testing of blood or urine for pathogens, glucose, 
cholesterol, blood gas, coagulation, biomarkers, hemoglobin, pregnancy etc. Cheaper, 
smaller, faster, and smarter devices are the main merits of POC diagnostics for detection of 
various target analytes. A number of clinical biochemical studies such as blood gas, 
glucose/lactate/cholesterol, nucleic acid sequence analysis, proteins/peptides, combinatorial 
synthesis, toxicity monitoring, immunoassays, and forensic analysis are also focused areas 
for developing  microfluidic biochips.  
Recently, there is an increasing demand to integrate advanced biosensors into “Lab 
on a chip” systems by introducing microfluidics. Efforts are being made to increase the 
resolution, accuracy and miniaturization for detection of biomolecules along with 
microfluidic integrated unit for sample pre-processing. Due to their portability, faster 
response and flexibility of microfluidic devices, it has the potential to fulfill a number of un-
met needs for diagnostics. Microfluidic devices are known to offer important opportunities 
for modern research, especially for the clinical diagnosis due to their numerous advantages. 
It is a technology which manipulates minute volumes (from 10
-6
 to 10
-18
 litres) in micron-
size channels and containers, becoming so called “Labs on a Chip”. Current research for 
improving biological assays has yielded a wealth of techniques via miniaturization of 
existing methods and the development of novel analytical approaches. Presently, the 
microfluidic devices have become an interesting subject in many academic laboratories for 
chemical and biological analysis with new physical phenomena which are not accessible in 
macro-scopic labs. Microchannels, microvalves, micropumps etc. are few main components 
that control fluid flow through the microfluididic devices for POC applications. The POC 
biosensor consists of a transducer and a bioreceptor element which combines with a signal 
condition circuit. Some biosensors have been successfully commercialized for POC 
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application such as blood glucose biosensor. Blood, saliva, urine etc. are the common body 
fluids used for diagnostics and can be sampled directly from the organs. 
Microfluidic chips are also known as laboratory of microfluidic chips, which can be 
used for synthesis of materials, sample  preparation, reaction, separation, detection and cell 
culture and sorting. It offers various advantages such as very low reagent/sample 
consumption, and waste generation, fast reaction times, high reaction efficiency and a large 
surface to volume ratio. Miniaturization of these devices can increase throughput and allows 
multiplexing platform and massive parallelization for integration of several assays analyses. 
The ‘microfluidically’produced result from these the medical decision making devices can 
bring precision to the art of medical diagnostics. Therefore, microfluidics has received much 
more attention from the researchers in recent years.  
Nanomaterials are experiencing a rapid development in recent years due to their 
potential applications in the field of electronics, catalysis, ceramics, magnetic data storage, 
structural components, biomaterials and biosensors. Nanostructured metal oxides show 
increased surface-to-volume ratio, chemical activity, mechanical strength, electrocatalytic 
properties and enhanced diffusivity. Nanostructured materials involve the tailoring of 
materials at atomic level to attain unique properties, which can be suitably manipulated for 
desired applications. The nanostructured metal oxides such as titania (TiO2), silica (SiO2), 
iron oxide (Fe3O4), cerium oxide (CeO2), zinc oxide (ZnO), zirconia (ZrO2), nickel oxide 
(NiO) etc. are widely used to fabricate electrochemical biosensors. Utilization of these 
nanostructured materials has been found to enhance the biosensor sensitivity, selectivity, 
detection limit and reproducibility. In particular, the biofucntionalization of these materials 
could provide excellent electrocatalytic properties. In biosensor fabrication, the method of 
immobilization of desired biomolecules onto a biocompatible and electroactive electrode is 
generally the first and major concern. A successful nano-matrix can be an excellent 
candidate to immobilize or integrate biomolecules on transducer surface and efficiently 
maintain the functionality of the biomolecules. There are still challenges such as 
miniaturization, automation and integration of the nanostructured-based biosensors to 
microfluidics. Utilization of nanoparticles, nanotubes and nanowires in microfluidic 
assembly is currently of much interest for injection, separation, and detection. The small 
volumes and short reaction length may allow a sensitive detection. Their integration with a 
microfluidic platform through a combination of microfabrication and nanomaterial synthesis 
allows unique functionality to the device. Using these smart integrated microfluidic systems, 
many advances have been achieved for electrochemical and optical detection of 
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biomolecules such as antigens, enzymes, antibodies, DNA hybridization and 
oligonucleotides. Thus, nanostructured materials and the carbon composite can be used to 
enhance the biosensing signal. This thesis focuses on improving the detection limits, 
selectivity and sensitivity using nanomaterials in the most common detection techniques in 
microfluidics, i.e., electrochemistry, and electronic detection. 
Coronary artery disease is one of important issue that has been found to cause human 
deaths in all developed countries. Recently, the risks of high blood cholesterol levels have 
increased worldwide. The high blood cholesterol levels may lead to cardiovascular diseases 
including arteriosclerosis. The atherosclerosis is known to be a critical condition in which 
arteries becomes blocked due to the accumulation of cholesterol. Deposition of cholesterol 
on the walls of arteries can form plaques resulting in blockages and interruption of the blood 
circulation that can cause angina and myocardial infarction. Thromboembolism can occur 
due to the bursting of these plaques. Hence, cholesterol has become one of the important 
parameter for POC testing. Lipids are not soluble in water and allow sufficient transport of 
cholesterol and other lipids called lipoproteins. The four major categories of lipoprotein are 
known as chylomicron (CM), low density lipoprotein (LDL), very low-density lipoprotein 
(VLDL) and high density lipoprotein (HDL). There is a significant interest for POC 
diagnostics applications using Lab-on-a-chip, and microfluidic devices to detect desired 
target analytes or biomolecules such as free cholesterol, total cholesterol, low density 
lipoprotein etc. in human blood. 
Electrochemical detection technique has become an attractive technique for POC 
biosensor devices due to label-free detection and higher signal to noise ratio resulting in 
high sensitivity and excellent selectivity. Besides these, the electrochemical detection offers 
numerous advantages such as easy detection, low cost, low-power requirements, inherent 
miniaturization, portability, and high degree of compatibility with advanced 
micromachining technologies. These properties allow electrochemical detection enormously 
suitable to be integrated with miniaturized microfluidic systems. However, the sluggish 
heterogeneous electron transfer rates in electrochemical detection of some materials on 
transducer surface may lead to decreased sensitivity with time. This thesis shows some 
aspects on the fabrication of low cost nanostructured metal oxides like anatase-TiO2, NiO 
and chitosan-TiO2, carbon nanotubes-NiO composites based microfluidic devices for 
free/total cholesterol and LDL detection. The major role of nanostructures materials in these 
microfluidic devices are the immobilization or functionalization of enzymes and antibodies 
on its microfluidic transducer surface. The nanomaterials used as microfluidic electrodes 
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can overcome these problems because of their very high surface area may lead to higher 
stability and large amperometric currents. Several methods are available for the estimation 
of cholesterol, LDL etc. in clinical laboratories such as ultracentrifugation, nuclear magnetic 
resonance (NMR) spectroscopy, electrophoresis, chromatography, Friedewald method etc. 
These techniques are tedious, expensive, time consuming and have lesser reproducibility 
and hence are not desirable in clinical laboratories. Additionally, the accuracy/precision is 
the major limitation of these methods. In order to develop efficient detection strategies for 
cholesterol, LDL etc., the POC microfluidic biosensors are very attractive choice towards 
clinical health-care.  
Chapter 1 gives an overview of the importance of POC diagnostics with 
microfluidic-based biosensors for detection of biomolecules. First part of thesis gives an 
introduction to POC biosensors with its merits and demerits as reported in research 
literature. A historical background of microfluidic devices with its current research activities 
has been pictured. A brief description relating to the suitable materials used for microfluidic 
fabrication has been given. Particularly, utilization of nanostructured metal oxides and 
carbon materials for attachment of biomolecules and their integration with microfluidic 
assembly have been described. Besides this, efforts have been made to discuss the possible 
aspects for suitable detection strategies using microfluidic assembly to improve biosensor 
efficacy in terms of sensitivity, selectivity and stability compared to that of other methods. 
Electrochemical-based biosensors and their integration to microfluidic biochips for 
detection of various biomolecules such as cholesterol, LDL etc. have been described. The 
importance of cholesterol and LDL detection in human blood serum using microfluidic 
technique and their advantages and disadvantages has been explained. The motivation of the 
work relating to construction of the microfluidic system towards POC diagnostics has been 
highlighted. The first chapter concludes with an overview of the entire thesis. 
Chapter 2 deals with basic principles construction of microfluidic devices such as 
fluidic transports, scaling effect, diffusion, mixing etc. Various components and materials 
for microfluidic devices have been explained in this chapter. Besides this, the principle, 
characteristics and various types of biosensors have been demonstrated. A brief literature 
survey on biosensor has been presented. Significant features in design of biosensors 
construction have been explained. The electrochemical technique and various 
immobilization processes for microfluidic biosensor fabrication have been illustrated. In 
particular, the efforts have been made to focus on utilization of nanomaterials in POC 
biosensor with appropriate references to existing research literature. The importance and 
applications of synthesized nanostructured metal oxides such as TiO2, NiO and their 
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nanocomposites with chitosan and carbon nanotubes (CH-TiO2 and CNT-NiO) in 
microfluidic biosensors have been included in this chapter. The importance and prospects of 
cholesterol and lipid profile in human serum samples have also been explained. Salient 
features of enzyme, antibodies etc. used for fabrication of electrochemical cholesterol and 
LDL detection systems have been described. 
Chapter 3 gives a broad overview of various materials, fabrication and 
characterization techniques that has been adopted in this thesis for the development of 
microfluidic biosensors. In this chapter, attempts have been made to give details for 
fabrication of PDMS microchannels using various steps of soft lithography. The description 
of how patterned microelectrodes (indium tin oxide; ITO) can be fabricated using wet 
chemical etching and photolithography techniques has been given. An overview of the 
chemical synthesis of nanomaterials has also been included. The sol-gel synthesis of 
anatase-TiO2 and its composite with chitosan has been discussed. The co-precipitation 
synthesis of NiO, chemical vapor deposition of CNTs synthesis and its composite with 
carbon nanotubes are explained in this chapter. The synthesized nanoparticles, composites 
based electrodes or bioelectrodes have been characterized using various spectroscopic and 
microscopic techniques. Details of spectroscopic techniques such as UV-visible (UV-vis), 
X-ray diffraction (XRD), Fourier transform infrared (FT-IR), Raman, Zeta potential and X-
ray photoelectron are described. The principles of different microscopic techniques such as 
scanning electron microscopy (SEM), atomic force microscopy (AFM) and transmission 
electron microscopy (TEM) that are used to characterize the electrodes/bioelectrodes have 
described in this chapter. Electrochemical studies such as cyclic voltammetry, 
chronoamperometry, chronocoulometry and impedance spectroscopy techniques have been 
illustrated. Finally, efforts have been made to discuss the basics of chronoamperometric 
(CA), cyclic voltammetry (CV) and impedance spectroscopy (EIS) that were employed to 
characterize the developed microfluidic biosensor devices.  
Chapter 4 describes the experiments and results relating to the fabrication of 
nanostructured anatase-TiO2 based microfluidic platform for free cholesterol estimation. I 
have highlighted the role of anatase-TiO2 in the microfluidic system. The results of XRD, 
FT-IR, UV-Vis AFM and TEM of this integrated microfluidic system have been described. 
The electrochemistry of the fabricated microfluidic biochip has been observed using EIS 
and CV studies. The desired flow rate of cholesterol solution through the channel has been 
optimized by tuning flow rate with the help of a syringe pump. Finally, free cholesterol 
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concentration (0.64–10.3mM) has been estimated using electrochemical technique. This 
microfluidic system shows excellent sensitivity, reproducibility and selectivity.  
In order to improve the adsorption capability of biomolecules on microfluidic 
transducer surface, a better candidate, chitosan modified TiO2 nanoparticles has been 
utilized to monitor total cholesterol. The Brunauer–Emmett–Teller (BET) studies are used 
to quantify the specific surface area and pore size distribution of titania nanoparticles before 
and after chitosan incorporation. The bienzyme functionalized mesoporous anatase titania-
chitosan (antTiO2-CH) nanocomposite has been characterized using electron microscopy, 
UV-visible, FT-IR and XPS. The electrochemistry for effective electrochemical area, 
surface coverage, flow rate etc. has been investigated using CV, EIS and 
chronoamperometric techniques. Finally, esterified cholesterol has been detected using EIS 
spectroscopic technique. Results of the proposed nanocomposite (antTiO2-CH) based 
microfluidic biosensor have been described.  
Chapter 5 deals with studies relating to nickel oxide nanorods (NR-NiO) integrated 
with microfluidic device for total cholesterol detection. I have focused to describe the 
importance and role of nanostructured NiO to develop the microfluidic biosensor. Results 
relating to the confirmation of synthesized materials (NR-NiO) have been illustrated using 
various microscopic and spectroscopic techniques. The electrochemical characterization of 
the proposed microfluidic device has been carried out using CV and EIS. Finally, the total 
cholesterol concentration has been estimated using this proposed microfluidic device. 
Potential merits and demerits of this microfluidic biosensor have been explained. In 
conclusion, the nanostructured NiO has been found to be an interesting material for the 
integration with microfluidic system as well as biomolecules attachment. However, there are 
still considerable challenges to be addressed improving in the biosensing characteristics for 
cholesterol and LDL detection in microfluidic system. Thus, efforts have been made to form 
a composite material with carbon nanotubes and nanostructured NiO for fabrication of 
microfluidic biosensor, which is the topic of research for next chapter. 
Chapter 6 covers the step by step fabrication process of a novel microfluidic 
nanobiochip based on a composite comprising of nanostructured NiO and carbon nanotubes 
(CNTs), as well as the biochip’s use for total cholesterol estimation. This chapter contains 
the overview relating to the application of CNT and its nanocomposite with NiO for 
microfluidic biosensor development. The fabrication of the microfluidic biochip using CNT-
NiO nanocomposite has been demonstrated. The biochip is immobilized with a bienzyme, 
composed of cholesterol esterase and cholesterol oxidase, and integrated with PDMS 
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microchannels. Additionally, this chapter includes results of experiments on toxicity effect 
of these synthesized CNTs, NiO nanoparticles and CNT-NiO in A549 cell line and the 
characterization of the CNT-NiO nanocomposite using XRD, Raman and XPS. The 
morphological studies have been investigated using SEM and TEM techniques. The 
electrostatic interaction between NiO and CNTs has been conferment using Zeta potential 
measurement. The electrochemical properties of this proposed microfluidic biochip have 
been investigated using CV and EIS studies. The chronoamperometric response of the 
biochip has been measured as a function of the cholesterol oleate concentration. This 
Chapter also demonstrates an impedimetric-Lab on a chip (iLOC) immunosensor for the 
label-free detection of blood low density lipoprotein (LDL) using this synthesized CNT-NiO 
nanocomposite material. The studies relating to fabrication of a biosensing platform for 
LDL concentration detection have also been described. In order to measure electrode 
surface areas, diffusion coefficients and charges with respect to time and the mechanisms 
and rate constants for chemical reactions coupled to electron transfer reactions, the 
chronocoulogram (CC) have been carried out for various electrodes at same step potential. 
Electrochemical impedance properties of the proposed iLOC and potentials optimization for 
biosensing have been investigated. Finally, the impedimetric response for the iLOC as a 
function of LDL concentration has been carried out. This platform is also suitable to 
observation and studying the antibody-antigen interactions on this transducer surface.  
Chapter 7 summarizes the work reported in this thesis and highlight the major 
conclusions derived from various experimental reported in this thesis. A careful analyses of 
future prospects of this work towards a practical microfluidics-based POC sensor realization 
has been analysed. Detection of multi-analytes such as LDL, VLDL, HDL, cholesterol and 
triglyceride based on this microfluidic system is one of the potential challenges that can be 
realized with minor modifications. Future direction towards fabrication of electrode arrays 
and selective deposition of biofunctionalized nanomaterials could be easily feasible with 
recent advances in microfabrication technology. Advances in microfluidic technologies 
have provided an exciting opportunity to integrate photonics and microfluidic at micron-size 
scales to leverage the combined advantages resulting in a totally new area of research 
termed as optofluidics. New possibilities towards POC applications can be realized using a 
microscope in combination with optofluidic channels.  
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PDMS: Polydimethylsiloxane 
GC: Chromatographic  
IBM: International business machine 
MEMS: Microelectromechanical system 
BioMEMS: Biological microelectromechanical system 
PCR: Polymerase chain reaction 
RT-PCR: Real time- polymerase chain reaction  
cm: Centimetre 
µm: Micrometre 
mm: Millimetre 
nm: Nanometre 
IUPAC: International union of pure and applied chemistry 
SPR: Surface plasmon resonance  
SWCNT: Single walled carbon nanotube 
MWCNT: Multiwalled carbon nanotube 
CdSe: Cadmium selenide 
Au: Gold 
H2O2: Hydrogen peroxide 
SARS: Acute respiratory syndrome  
In2O3: Indium oxide 
CNT: Carbon nanotube 
fm: Femtomolar 
mm: Millimolar 
nm: Nanomolar 
A: Ampere 
nA: Nanoampere 
mA: Milliampere 
µA: Microampere 
mV: Millivoltage 
V: Voltage 
NP: Nanoparticles  
CH: Chitosan 
ZnO: Zinc oxide 
NMOx: Nanostructured metal oxides 
TiO2: Nanostructured titania  
Ant: Anatase 
NiO: Nickel oxide 
NR-NiO: Nickel oxide nanorods 
SiO2: Silica  
Fe3O4:  Iron oxide  
CeO2: Cerium oxide  
ZrO2: Zirconia  
Al2O3: Aluminum oxide 
CeO2: Cerium oxide 
xv 
 
MgO: Magnesium oxide  
Fe3O4: Iron oxide 
BaO: Barium oxide 
CuO: Copper oxide 
V2O5: Vanadium oxide 
CHD: Coronary heart disease  
CEs: Cholesterol esters  
PLs: Phospholipids  
TGs: Triglycerides 
ChEt: Cholesterol esterified 
ChOx: Cholesterol oxidase 
AAB: Anti-apolipoprotein B 100  
CM: Chylomicron 
LDL: Low density lipoprotein  
VLDL: Very low-density lipoprotein  
HDL: High density lipoprotein  
NCEP: National cholesterol education program 
ITO: Indium tin oxide 
XRD: X-ray diffraction 
FT-IR: Fourier transform infrared 
BET: Brunauer–Emmett–Teller 
UV-vis: Ultraviolet visible  
AFM: Atomic force microscopy 
TEM: Transmission electron microscopy 
XPS: X-ray photoelectron 
SEM: Scanning electron microscopy 
FE-SEM: Field emission- scanning electron microscopy  
CV: Cyclic voltammetry 
CA: Chronoamperometry 
EIS: Electrochemical impedance spectroscopy 
NMR: Nuclear magnetic resonance 
RIA: Radio immuno assay 
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  : Overpotential 
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1.1 Point-of-care diagnostics 
Point-of-care (POC) diagnostics is considered important in the clinical scenario of diseases as well as for 
treatment of patients. Early diagnostics plays an imperative role in determining pre-disposition to a 
disease (prevention) or the outcome of disease (monitoring and prognosis) [1-15]. POC devices are 
generally small, portable, handheld, faster and cost-effective devices. These devices can be used for 
bedside, near-patient, satellite or remote, and decentralized testing. POC devices provide a convenient and 
immediate response to the patients and clinical care team [1, 2]. By utilizing POC testing devices, results 
could be made available quickly to the clinical care team thereby facilitating immediate clinical decision 
and treatment device [4-6]. Numerous tests including blood glucose, blood gas concentration, 
coagulation, expression of cardiac markers, drugs of abuse, pregnancy, Hb, urine analysis and infected 
diseases etc. could be feasible with POC devices [1-15]. POC testing can be achieved via use of portable 
devices such as blood gluco/lactate meter, creatinine analyzer, C-reactive protein analyzer, pulse co-
oximeter, cholesterol meter etc. With the goal of getting, cheaper, smaller, faster, and smarter, the POC 
devices seems to be one of the most favoured technologies of the coming generation of the health care 
diagnostic devices [16]. 
Currently health care is an active field of intellectual engagement for emerging technologies. 
Various techniques are used towards the discovery, delivery of chemicals for diagnosis and treatment of 
human diseases [17]. The outbreak of new or re-emerging infectious diseases along with changing 
lifestyles has led to an urgent need towards the faster development of POC devices that could be used for 
effective therapeutic interventions [18]. It may be noted that even simple routine biochemical tests require 
well-trained technicians and expensive laboratory infrastructure with continuous supply of chemicals 
resulting in high costs. Such diagnostic challenges have necessitated the development of new technologies 
nearer to the patient sites and are termed as the POC diagnostics. POC diagnostics are commonly 
described as analytical testing platforms that can be used both in a clinical laboratory and in the vicinity 
of a patient via portable equipments [19]. Therefore, the entire clinical community is witnessing a 
paradigm shift from the conventional diagnostic devices to miniaturized and automated POC devices that 
can fulfill the increasing demand of medical sector including direct unprocessed specimen utilization and 
the minimum need of electronic or mechanical maintenance. The POC has the potential to provide rapid 
and accurate information on desired biochemical tests required by increasing population of patients in 
emergency rooms at reasonable costs [20]. An ideal diagnostic device should provide a suitable 
environment for interaction of a desired analyte present in a sample with the bio-recognition molecule 
(e.g., protein/ lipid/ nucleic acid/ whole cell) immobilized on to the sensor surface [5, 6]. Until recently, 
development of such devices was considered unachievable due to the extensive variability in biological 
4 
 
samples resulting in unreliable clinical data and the complexity of the electronics that are needed to 
support it.  
Compared to the core laboratory analysis, potential demand for POC devices have increased in 
the past two decades due to its several advantages [7]. The annual growth rate of POC (12 %) indicates 
that 40 % of laboratory tests are predicted to be conducted on POC devices within the next decade [18]. 
The POC test can be performed at an outpatient clinic or patient's home or even at a primary care 
provider’s office desk. POC testing can be accomplished in mobile transport vehicles such as ambulances, 
helicopters, fire engines, cruise ships and the space shuttles. The short therapeutic time offers improved 
patient outcome by reducing delays in waiting time for laboratory results and can prevent such 
bottlenecks [21]. Thus, POC devices would certainly result in improved physician efficacy by minimizing 
the turn-around time and better fitting within clinical workflow. The characteristics such as portability, 
rapid result, small sample volume, no sample processing, and ease of use have promoted the use of POC 
devices in patient health care [22].  
The applications of POC diagnostics have grown rapidly towards the medical health care [23]. A 
number of clinical biochemical studies such as blood gas, glucose/lactate/cholesterol, nucleic acid 
sequence analysis, proteins/peptides, combinatorial synthesis, toxicity monitoring, immunoassays, and 
forensic analysis are the focused areas for developing the micro total analysis systems (µTAS) or Lab-on-
a-chip (LOC) [24]. Detection of nucleotides and peptides of any cancer such as breast, prostate, oral, lung 
etc. is very important for early diagnostics. One of the most successful examples of POC testing device is 
the iSTAT device from Abbott Laboratories (Abbott Park, IL, USA). This iSTAT analyzer uses 
microfabricated electrodes coupled with an electrochemical detection unit that measures various 
electrolytes, blood gases, glucose, lactate and hematocrit [13]. In the last decade, extensive research has 
been taking place on POC devices using microfluidic, LOC, microarrays etc. technologies in the realm of 
enzymatic, DNA, proteomic and immunoassays analysis. The modern POC diagnostics devices utilize 
immunoassay technology via antigen-antibody binding. In addition, POC diagnostics devices are widely 
used to determine various specific protein biomarkers such as glycated hemoglobin, C-reactive protein, 
D-dimer, troponin I or T, prostate-specific antigen, human immunodeficiency virus, influenza, chlamydia, 
and hepatitis [6, 7]. A traditional urine test at home for diabetics and kidney-disease patients can be 
performed by POC devices. The home POC devices can measure the pregnancy hormone human 
chorionic gonadotropin for pregnancy test. An ideal POC diagnostic device uses a minute amount of 
unprocessed sample that is collected from the patient directly [25]. Efforts have been made to detect 
multiple biomarkers for accurate POC tests with high sensitivity and short turn-around time. These 
devices would be safer to use in a hospital, user friendly and easy to operate by non-technical experts. 
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Chong et al. have fabricated paper-based microfluidic POC diagnostic devices for drug 
metabolism monitoring [26]. Ahn et al. have demonstrated the disposable smart Lab on a chip (LOC) for 
POC clinical diagnostics [1]. Cheng et al. have reported the enhanced performance of a POC CD4+ T-cell 
counting microchip through monocyte depletion for HIV/AIDS diagnostics [3]. Gervais et al. have 
developed toward one-step POC immunodiagnostics using capillary-driven microfluidics and PDMS 
substrates [5]. Gubala et al. have reviewed the status and future prospects of POC diagnostics [7]. Myers 
et al. have reviewed the innovations in optical microfluidic technologies for POC diagnostics [11]. 
Sandhu et al. have described the synthesis and applications of magnetic nanoparticles for biorecognition 
and POC medical diagnostics [12]. Soper et al. have developed the POC biosensor systems for cancer 
diagnostics/prognostics [27]. Tüdos et al. have described the trends in miniaturized total analysis systems 
for POC testing in clinical chemistry [13]. Wang et al. have developed electrochemical biosensors 
towards POC cancer diagnostics [28]. Chin et al. have reported the POC diagnostic devices for health care 
[29]. Choi et al. have reviewed the microsystem toward point-of-care detection of nucleic acids and 
proteins [30]. However, there are many challenges yet to be addressed in ideal POC device with desired 
characteristics. Various challenges including miniaturization, all-peripheral instrumentation, faster 
implementation etc. needs more attention remain before these technology can be translated to be efficient 
POC devices.  
1.2 A historical snapshot of microfluidics devices 
Microfluidics is a new branch of science and technology in which significant progress has been made in 
the past two decades. The microfluidics has a long history from basic research to diagnostic products. 
This technique has revolutionized the chemical and biochemical analysis of biomolecules. A major 
milestone in microfluidics could soon lead to stand-alone, self-powered chips that can diagnose diseases 
within minutes [31]. An overview of the state-of-the-art microfluidic technology with time line is 
depicted in the Figure 1.1. Initially, researchers manipulated liquids at high precision using gas 
chromatography, high-pressure liquid chromatography, and capillary electrophoresis [32]. In 1950s, the 
biological fluids molecules are controlled precisely by utilizing inject printing technologies and are 
known as the first microfluidic device. In 1970s, IBM started to commercialize these printers. Terry et al. 
developed a silicon micromachined based gas chromatographic (GC) air analyzer at Stanford University 
[33]. In terms of fluid propulsion within microchannels with sub-millimetre cross sections, the year 1979 
set a milestone when a miniaturized GC was realized by Terry et al. on a Si wafer. In the 20
th
 century, 
many researchers have investigated the applications of MEMS (microelectromechanical system) in 
biology, chemistry and biomedical fields. The nineties witnessed the integration of bioanalytical and 
microelectronics disciplines which can be considered the birth of microfluidics. Manz et al. introduced the 
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concept of miniaturized total chemical analysis systems (µTAS) and developed the microfluidic high-
pressure liquid chromatography systems and microfluidic capillary electrophoresis in 1992 [34].  In 1996, 
George M. Whitesides introduced soft lithography using PDMS (polydimethylsiloxane) for fabrication of 
microfluidic devices. These researchers demonstrated that the utilization of polymers in microfluidics is 
easier, more flexible and less expensive than silicon or glass [35-37]. Whitesides et al. have reviewed the 
origin and future of microfluidic devices and fabricated a new platform for POC diagnostics, cellular and 
developmental biology [38]. In 2000, the efforts have been made to develop laboratories on a chip that 
integrates almost all diagnostic operations performed in a hospital on a single microfluidic chip. It has 
been observed that the majority of microfluidic devices are still fabricated using silicon or glass. These 
materials are known to be expensive and the process is time-consuming and requires access to specialized 
facilities. Thus, they are marginally useful in research requiring rapid evaluation of prototypes. 
 
 
Figure 1.1 Historical snapshot of microfluidics technology with time [15]. 
 
 
Microfluidics is currently one of the most promising technologies to meet the growing needs in 
healthcare for faster processing of samples, accurate and reliable results, parallelization and 
miniaturization [39]. It is an extremely attractive technology because of its ability to manipulate minute 
volumes of a fluid within given spatial dimensions and the ease of multiplexing and integration onto 
compact, portable devices for on-chip testing [40]. The fluid volumes of interest are typically measured in 
order of microlitres (10
−6
 L) to picoliters (10
−12
 L), and flow rates generally do not exceed more than a 
few microlitres per minute [41]. Various biological fluids such as blood serum, breast milk, sweat, 
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synovial fluid, tears, urine, saliva, sebum (skin oil) etc. are most commonly used in microfluidics, and can 
be precisely controlled and manipulated. Due to the small size and dimensions of the microfluidic 
systems, both energy and chemical consumption are drastically reduced. Due to laminar flow regime, it 
can perform liquid-liquid extraction, sample fractionation and immuno-affinity extraction between two 
parallel flows. Fluidic behaviour in laminar flow regime can be used for performing various sample pre-
treatments and process.  
The range of applications of microfluidics is rapidly growing in fields of biotechnology and 
healthcare for faster processing of given samples, to obtain accurate and reliable results [42]. Extensive 
research has been carried out in the last decade towards the development of microfluidics technology 
proposing exciting possibilities in the realm of glucose, urea and cholesterol assays analysis, 
deoxyribonucleic acid (DNA)/polymerase chain reaction (PCR) analysis, proteomic analysis involving 
proteins/peptide, immunoassays and toxicity monitoring and microarrays [43]. The developments in 
microfluidics have been very promising to people in industry as well as research that resulted in adoption 
of these platforms for clinical diagnostics [29]. The increased surface-to-volume ratio of microfluidic 
systems can be an advantage when working with immobilized materials such as enzymes, DNA and 
antibodies [44]. Furthermore, advances in microfluidics, arrays, and sensors promise to revolutionize the 
detection of pathogens in vivo and in vitro in the environment through the development of LOC devices 
[45]. In addition, a vast area for research in cell culture applications has recently evolved via exploiting its 
ability to mimic in vivo like conditions of cellular micro-environment [46]. Microfluidics can provide 
more realistic in vitro environments for small-scale biological species of interest. The applications of 
microfluidics towards various fields such as biochemical assays, cell/organ analysis, synthesis, 
digitization and PCR have been described. Working with such minute volumes of fluids, microfluidic 
devices can be used to achieve exceptional performance in terms of parameters such as sensitivity, speed, 
and spatial resolution [47]. Microfluidics-based sensor can be used to detect target analytes with 
sensitivity as good as one part per billion. For example, an ink-jet droplet generator can print an image 
with approximately one million discretely controlled droplets in an area of 1 cm
2
. However, still there is a 
strong need of such devices that rely on several qualitative and quantitative results including simple ‘yes’ 
and ‘no’ result. This will instantly remove the heavy burden on the conventional diagnostics methodology 
that hinders testing of thousands of samples within a given point of time. Moreover, a high-throughput 
system for handling a large number of samples must be instant and utilize very small chemical volumes to 
keep the cost of the device at an affordable level. The comparative length scales for several biological 
structures, as well as common micro-fabrication structures used in microfluidics devices as shown in 
Figure 1.2. 
8 
 
The recent trends to miniaturize, automate and parallelize assays address these issues directly 
while simultaneously increasing resolution and accuracy. There is an effort to miniaturize and integrate 
sample pre-processing with analyte detection. These microsystems integrate scaled-down laboratory 
functions and processes to a miniaturized chip format and are known as “Lab-on-a-chip” or bio-
microelectromechanical systems (bio-MEMS) [48]. There is an increasing demand to integrate multiple 
platforms into LOC systems by introducing microfluidics [49]. Thus, a Lab-on-a-chip is an analytical 
device which integrates several or one functions on a single device in microscale size. Usually, it is a 
microchip-based system that (similar to the micro total analytical system or μTAS) contains all liquid 
handling steps on the chip to perform the analysis [50]. The μTAS includes all the necessary steps to 
perform various analyses such as sampling, dilution, sample filtration, chemical reactions, separation and 
detection. However, all steps in the analytical procedure need not necessarily be integrated on the chip 
[50]. MEMS are made up of elements in the range of 1 to 100 µm in size and devices can be fabricated in 
very small size such as 20 µm-1.0 mm [51]. The MEMS devices are fabricated through the deposition of 
material layers, patterning by photolithography and etching to produce the required shapes [51]. These 
micro-systems are being employed in fields such as biology, microelectronics, physics, engineering and 
other related areas.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 The length scales of microfluidic device and biological based micro-fabrication. 
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The active microfluidic devices have been found to have many disadvantages such as high cost, 
difficulty in integration and complex fabrication/control circuitry [52]. Thus, the passive microfluidic 
devices based on valves, passive filters, mixers, extractors, membranes and passive actuators have 
recently been fabricated [52]. The passive microfluidic devices have no external power requirement for 
device operation and offers ease of integration, continuity in substrate material, rapid prototyping, low 
cost, and possibility of use without active control. With microscale fluid regulators such as pumps, valves, 
mixers etc. can be integrated with the LOC, the analytical performance of these platforms can be greatly 
enhanced. Advances in microfluidics and LOC technology have resulted in altogether exciting and 
promising approach to integrate optics and fluidics part at micron-size scales to leverage the combined 
advantages. All these studies can be brought to commercial reality by precisely controlling spatial and 
temporal factors such as cell–cell and cell–matrix interactions, oxygen and nutrients delivery, metabolites 
removal etc. [53]. Optofluidic elements that can manipulate light inside a microchannel level were also 
demonstrated [54]. Principles of optical microscopic imaging coupled with fluorescence tags and surface 
plasmon resonance-based detection were explored and demonstrated as effective biosensing platforms for 
detection and quantification of various biomolecules. Microfluidics systems were adapted for imaging 
intracellular events like cell division, migration etc. Microfluidic devices allow the generation on a single 
chip of a large number of crystallization conditions (temperature, pH, humidity etc.). Application of 
microfluidics spread to many other areas such as sugar testers, drug screening, microprocessor cooling, 
chemical microreactor and micro fuel cells. Table 1.1 summarizes different potential application of 
microfluidic devices. 
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Table 1.1 Area-wise applications of microfluidic devices [55] 
Area Applications 
Clinical Analysis Rapid analysis of blood and bodily fluids, point of care diagnostics, 
enzymatic analysis, electrochemical detection, cell counting and shorting etc. 
Miniaturized analytical system 
Genomics and proteomics 
Rapid, high density sequencing, DNA finger printing, combinational analysis, 
forensic analysis, gene expression analysis, integration with fluids with DNA 
arrays.  
Chemical/biological warfare 
defense 
Early detection and identification of pathogen and toxins, early diagnosis, 
triage etc.  
High throughput screening  Combinatorial synthesis and assaying for drugs and toxicological assays 
Environmental testing  In situ analysis of environmental contamination etc. 
Biomedical devices Devices for in vivo drug delivery, in vivo monitoring for diseases and 
conditions, single molecule detection etc. 
Sample separation Purification of biological analysis for further analysis 
Biomimetic analysis Development of machines that mimic biological functions 
Studies of chemical reaction Enzyme substrate 
Amplifications of nucleic 
acids/sequences  
PCR, RT-PCR etc. 
Flow of fluids Studies on diffusion through small channels, laminar flow studies etc. 
Small scale organic synthesis Combinatorial synthesis 
Bioimaging analysis Optofluidics application based on surface plasmon resonance coupled with 
fluorescence tags molecules, nanoparticulate imaging contrast agents for in 
vitro and in vivo biosensing devices 
 
Andersson et al. have described the cell sorting, trapping and sampling using microfluidic devices 
[56]. Sorger et al. demonstrated integrated microfluidic devices for rapid detection of protein biomarkers 
in patient samples [16]. Haeberle et al. have critically reviewed the microfluidic platforms for LOC 
applications [9]. Dinh et al. have developed a multifunctional biochip functionalized with nucleic acid and 
antibody receptors that are specific to gene fragments of Bacillus anthracis and Escherichia coli, 
respectively [57]. Dong et al. have fabricated a microfluidic array device for immunoassays analysis with 
screen printing technology [4]. Kovarik et al. have demonstrated the fabrication of μTAS, and its 
integration with other techniques such as optics, acoustics, biomimetics, electricity and magnetism [58]. 
The recent advances of microﬂuidic devices for drug discovery, target selection, pre-clinical tests, clinical 
trials, chemical synthesis, formulations studies and product management have been extensively reviewed 
by Kang et al. [59]. Weibel et al. have described the applications of microfluidics in chemical biology 
[60]. Hansen et al. have demonstrated the microfluidics in structural biology for smaller, faster and better 
performance [61]. Fiorini et al. have described the biotechnological applications of microfluidics for 
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potential development of health care devices [62]. Thus, adoptions of these microfluidic platforms in the 
development of POC diagnostics devices are promising to the researchers working in this area.  
The reasons for miniaturising analytical devices originate from two sources: economic benefits 
and increased analytical/technical performance of the analysis. However, both are interrelated; an 
improved analysis can have economic impact due to faster analysis, higher sample throughput and lower 
reagent consumption. The several advantages of downscaling analytical systems are listed below [62] 
 Higher sample throughput 
 Multiplexing 
 Automation 
 Integration  
 Portability 
 Manufacturing cost 
 Disposability 
 Lower energy consumption 
 Reduced chemical consumption 
 Laminar flow 
 Improved separation efficiency 
 Short diffusion paths 
 Increased surface-to-volume ratio 
 Faster heat dissipation 
Higher sample throughput may result in improved separation performance, multiplexing, and/or 
faster analysis due to short diffusion paths for analytes and reagents. Multiplexing can be achieved by 
construction of parallel analysis lines integrated on the same chip. In addition, chemical reactions can 
proceed faster because of improved thermal transport such as heat dissipation. Microchip with channel 
systems for multiple liquid-handling step, along with the MEMS-based detection systems can provide 
automated and compact devices. Both integration and automation are prerequisites for efficient portable 
analyzers.  
An ideal diagnostic device should provide a suitable environment for interaction of desired 
analyte present in a sample with the bio-recognition molecules that an immobilized on to the sensor 
surface [15]. An ideal microfluidic device can multiplex more than 100 analytes within 1 minute that may 
be a variety of proteins, enzymes, antibodies and nucleic acids. It can be used to detect a concentration as 
low as picomolar to femtomolar within a large dynamic range. It provides higher selectivity, excellent 
sensitivity, zero cross talk, false positives and there would be no cross contamination between samples 
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from different patients for simultaneous reading. These devices may be impervious to water and cannot be 
damaged easily. Due to utilization of transparent materials in microfluidic devices, fluids flow can be 
monitored optically resulting in new technologies based on optical read-out. In addition, these devices 
would have a longer battery life and can have a good shelf life at temperatures from -55°C to 55°C. The 
flow control, filtration/processing of the sample, antifouling surface, wettability, signal generation and 
receptor attachment are all highly dependent on the properties of materials used for the construction of 
microfluidic devices. The precise control of the materials is essential for the proper working a POC 
device.  
1.3 The state-of-the-art biosensors 
A biosensor is an analytical device consisting of a biological sensing element and a transducer that 
converts a biological response into a measurable signal, whose magnitude is proportional to the 
concentration of a specific chemical or set of chemicals [63]. Biosensors are used in our daily life, such as 
in health care diagnostics, food safety and environmental monitoring. Health care is one of the main areas 
where biosensors find a lot of applications, such as monitoring of glucose, cholesterol, urea, lactate, 
lipoproteins etc. in human blood serum, saliva or sweat [64].  
In 1962, Clark introduced an oxygen electrode at Cincinnati Children’s Hospital [65]. This is the 
first glucose enzyme-electrode that relied on a thin layer of glucose oxidase entrapped over an oxygen 
electrode via a semipermeable dialysis membrane. The term “biosensor” was introduced by Cammann in 
1977 [66]. The IUPAC definition of a biosensor, however, was introduced more recently as 1999 to 2001. 
Electrochemical detection has been employed to monitor the oxygen consumed by the enzyme-catalyzed 
reaction between glucose and glucose oxidase in presence of oxygen. A negative potential was applied to 
the platinum cathode for a reductive detection of the oxygen consumption. The method of detection is 
based on the decrease in oxygen concentration that is proportional to glucose concentration. The Clark’s 
technology was transferred to Yellow Spring Instrument Company, which launched the first dedicated 
glucose analyzer for diabetes mellitus in 1975. Table 1.2 gives the milestones and achievements relevant 
to biosensors [63]. This proposed oxygen-electrode is known as first generation of biosensor which is 
oxygen dependent. In the first generation biosensors, the normal product of the reaction diffuses to the 
transducer and causes the electrical response. The second generation biosensors involved the specific 
'mediators' between the reaction and the transducer in order to generate improved response. Thus, this 
generation of biosensor depends on mediator but does not depend on oxygen for biochemical reaction. In 
1980, the efforts have been focused on the development of mediator-based ‘second-generation’ 
biosensors by introducing the commercial strips for self-monitoring of blood glucose. In third generation 
biosensors, the reaction causes the response and does not involve any mediator diffusion [67]. In these 
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biosensors thus, the direct electron transfer (ET) between the biomolecules (enzyme, antibody, DNA etc.) 
and the electrode surface excluding any intermediate ET reactions with redox mediators. Wang et al. have 
described the advances in electrochemical glucose biosensors [68]. Pumera et al. have reviewed the 
electrochemical biosensors based on nanoscale materials as biomolecule tracers, including gold 
nanoparticles, quantum dots for DNA and protein multiplexing, novel nanobiolabels as apoferritin, 
liposomes and enzyme tag loaded carbon nanotubes [69]. Thus, the electrochemical detection plays an 
important role in development of biosensors because of the low cost, ease of use, portability, label-free 
operation, simplicity and higher signal to noise ratio. Details of biosensor with a brief literature survey, 
types of biosensors and methods of immobilization have been illustrated in the Chapter 2. 
Common methods of detection for electrochemical biosensors involve measurement of current, 
voltage, conductance, capacitance and impedance. Chornokur et al. have developed an impedance-based 
miniaturized biosensor for ultrasensitive and fast prostate-specific antigen detection [70]. Dubuisson et al. 
have reported a label-free DNA electrical detection platform using graphene [71]. An electrochemical 
biosensor for early detection of cervical cancer has been by demonstrated Chandra et al. [72]. Jie et al. 
have reported an electrochemiluminescence immunosensor based on CdSe nanocomposite for the 
detection LDL [73]. Singh et al. have reported the nanoparticle-enhanced sensitivity of a nanogap-
interdigitated electrode array impedimetric biosensor [74]. Researchers have explored various biosensor 
platforms for the detection of target analytes including cholesterol and LDL. There are many different 
ways to construct a biosensor. The choice of the transduction process and transducer material is critically 
dependant on fabrication of the sensing layer on the transducer surface. It is known that the biosensors are 
promising analytical tools applicable in different areas for clinical diagnosis and many other applications. 
The miniaturization, multiplexing and parallelization of the biosensor fabrication are the important issues 
for POC applications. Thus, the biosensor integrated microfluidic platforms for detection of desired 
analytes can play an important role in POC diagnostics.  
Electrochemical detection is being increasingly used for enzymatic analysis and hence is an 
attractive choice for microfluidics systems because of higher sensitivity arising due to higher signal-to-
noise ratio and improved ratio of faradaic-to-charging current [75]. The size of the electrode affects mass 
transport of the redox active species to and from the electrode surface and the bulk solution that may 
perhaps influence the electrochemical response [76]. Compared  to macro-sized conventional electrodes, 
micro-electrodes  offer  many  advantages including reduced charging  current,  high mass  transport 
which is  dominated  by  radial  diffusion,  immunity  to  ohmic  drop  and  small  RC  constant. The small 
electrode surface area of the electrode can significantly reduce the charging current due to smaller small 
double layer capacitance. The higher faradaic current compared to that of non-faradaic current of 
microelectrode provides enhanced detection limit. The microelectrodes can generate small amount of 
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currents resulting in a negligible ohmic drop of potential. Electrochemical impedance spectroscopic (EIS) 
method has recently received considerable attention for the detection of biomolecules towards the POC 
applications [77]. Impedance spectroscopy is the study of the resistive and capacitive behaviour of an 
electrode–electrolyte interface by means of electrochemical transportation of electrons in a given 
frequency domain [78]. The impedimetric method is known to be a non-destructive, sensitive and label-
free analytical detection technique that relates a bio-recognition event occurring at an electrode/electrolyte 
interface [78]. Besides this, EIS can be used to obtain information on biomolecular interactions, amount 
of adsorbed proteins, surface charge densities and the magnitude of adsorption coefficient [79]. The EIS 
uses a small perturbation (usually sinusoidal) which reduces the matrix interference and rapidly responds 
to the change caused due to binding of an analyte with the immobilized bio-recognition element on the 
transducer surface [77-79].  
 
Table 1.2 Milestones and achievements relevant to biosensors [63] 
Year Contributions  References  
1956 Leland C. Clark Jr. (1918 – 2005) presented his first paper about the oxygen electrode. In 
1962, Clark and Ann Lyons from the Cincinnati Children’s Hospital developed the first 
glucose enzyme electrode. 
[80, 65] 
1959 Rosalyn Sussman Yalow (born 1921) and Solomon Aaron Berson (1918 – 1972) 
developed the radioimmunoassay which allows the very sensitive determination of 
hormones such as insulin based on an antigen–antibody reaction. Today the RIA 
technology is surpassed by enzyme–linked immunosorbent assay because the colorimetric 
or fluorescent detection principles are favored over radioactive-based technologies. 
[81] 
1963 Garry A. Rechnitz together with S. Katz introduced one of the first papers in the field of 
biosensors with the direct potentiometric determination of urea after urease hydrolysis. At 
that time the term “biosensor” had not yet been coined. Thus, these types of devices were 
called enzyme electrodes or biocatalytic membrane electrodes. 
[82] 
1967 G.P. Hicks und S.J. Updike introduced the first practical enzyme electrode immobilizing 
the enzyme within a gel. In 1970, Bergveld introduced the ion selective field effect 
transistor. 
[83] 
1972 Betso et al. showed for the first time that direct electron transfer of cytochrome c could be 
realized at mercury electrodes. 
[84] 
1973 Ph. Racinee and W. Mindt (Hoffmann La Roche) developed a lactate electrode [71] 
1975 The first commercial biosensor was introduced for diabetes patients [68] 
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1976 First microbe - based biosensors [85] 
1980s 
 
Self - assembled monolayers start to receive considerable attention in the scientific 
community and are employed in biosensor research 
[86] 
1981 
 
Oxidation of NADH at graphite electrodes is described for the first time 
 
[87] 
1983 
 
First surface plasmon resonance immunosensor 
 
[88] 
1984 
 
First ferrocene - mediated amperometric glucose biosensor by Cass et al. 
 
[89] 
1988 
 
Adam Heller and Yinon Degani introduced the electrical connection (“ wiring ”) of redox 
centers of enzymes to electrodes through electron-conducting redox hydrogels 
 
[90] 
1988 
 
Direct ET by means of immobilized enzymes was introduced 
 
[91] 
1990 
 
Bartlett et al. introduce mediator - modified enzymes 
 
[92] 
1997 IUPAC introduced for the first time a definition for biosensors in analogy to the definition 
of chemosensors 
[93] 
2002 
 
Schuhmann et al. introduced the use of electrodeposition paints as immobilization 
matrices for biosensors. In 2007, an implanted glucose biosensor operated for five days. 
[94, 95] 
 
1.4 Integration of nanomaterials with microfluidics  
Nanomaterials with at least one of their dimensions ranging from 1 to 100 nm scale have been predicted 
to provide unique physical and chemical properties due to the quantum size effect, surface effect, surface-
to-volume ratio and macro-quantum tunnel effect. Different techniques can control the size of materials at 
the nanoscale dimensions. The nanosensors, nanoprobes and other nanosystems are revolutionizing the 
fields of POC biosensors to enable rapid analysis [96]. Metal nanoparticles such as gold, silver, nickel etc. 
are widely used in biosensor development. These nanomaterials provide the amplification of signal 
transduction in biosensor technologies thereby improving the characteristics of biosensors. They can be 
used to obtain the enhanced immobilization of biomolecules due to the ultrafine surface area. 
Nanomaterials exhibit good catalytic properties that are different from their bulk material properties due 
to their high surface area, and high edge concentration. In addition, the nanoparticles on the surfaces of 
electrodes can be used to improve electron transfer that improves the biosensor efficacy.  
Law et al. have reported the development of a nanoparticle-enhanced biosensor by integrating 
both the nanoparticles and immunoassay sensing technologies into a phase interrogation surface plasmon 
resonance (SPR) system for detecting antigen at a concentration as low as the femtomolar range [97]. 
Claussen et al. have developed an electrochemical H2O2 biosensor using single walled carbon nanotubes 
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(SWCNTs) networks decorated with Au-coated palladium nanocubes [98].  Wang et al. have reviewed 
nucleic acid conjugated nanomaterials for enhanced molecular recognition. A free-standing ﬂexible 
conductive reduced graphene oxide/naﬁon hybrid ﬁlms by a solution chemistry that utilizes self-assembly 
and directional convective-assembly towards the biosensor application has been reported Choi et al. [99]. 
Zamolo et al. have developed an ultrasensitive electrochemiluminescence-based sensor for the detection 
of palytoxin using CNTs [100]. Saddiqui et al. have developed the vertically aligned carbon nanoﬁber 
electrode arrays using electrochemical impedance spectroscopy [101]. Mahmoud et al. have developed a 
picomolar detection system of protease using peptide/single walled CNT/gold nanoparticle-modiﬁed 
electrode [102]. A label-free, electrical detection of the severe acute respiratory syndrome (SARS) virus 
N-protein with In2O3 nanowire biosensors utilizing antibody mimics as capture probes has been 
developed by Ishikawa et al. [103]. Luo et al. have fabricated a boron-doped diamond nanorod forest 
electrode and demonstrated their application in nonenzymatic amperometric glucose biosensing [104]. 
However, these materials need several steps of surface treatment for attachment of biomolecules.  
To use a biosensor at outside of the laboratory, it either has to be as simple or automated with 
regard to sample processing and reagent addition. Automation and miniaturization of analytical 
techniques, as well as the development of on-line and remote sensing devices can be achieved using 
microfluidic biosensor technology. Use of nanoparticles (NPs), nanotubes and nanowires in microfluidic 
assembly is currently of much interest in various fields such as biomedical, physics, chemistry etc. Their 
integration with a microfluidic platform through a combination of microfabrication and nanomaterial 
synthesis allow the unique functionality of the device. Using this smart integrated microfluidic system, 
many advances are achieved for electrochemical and optical detection of biomolecules such as antigen, 
enzymes, antibodies, DNA hybridization and oligonucleotides. Recently, this advanced technology has 
been explored in the field of biosensors and biochips. Nanostructured materials such as metal oxide 
nanoparticles, carbon, and polymeric materials, have been widely investigated to enhance the biosensing 
signal. Choi et al. have demonstrated the application of nanoparticles for the detection of biomolecules, 
their integration with nanopatterning and the microfluidic technologies for molecular diagnosis [105]. 
Most biological samples are known to have in a liquid medium, thus the biosensors can be combined with 
compelling fluid handling systems. Lee et al. have developed an integrated ZnO surface acoustic wave 
microfluidic for cancer diagnostics [106]. Other than biosensing applications, microfluidic could act as a 
novel route for the synthesis of controlled nanostructured materials.  
Nanostructured metal oxides (NMOx) have recently captured increased interest for the 
development of microfluidic biosensors. To fabricate an efficient microfuidic biosensor, it is critical to 
select an appropriate NMOx for immobilization of the desired biomolecules. Details and importance of 
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nanostructured titania (TiO2), nickel oxide (NiO) and their composites such as chitosan-TiO2 and CNT-
NiO have been described in the next Chapter.  
1.5 Importance of cholesterol  
Coronary heart disease (CHD) is one of the important issues that can cause the human death in all 
developed countries. CHD is a disease in which a waxy substance called plaque builds up inside the 
coronary arteries]. These arteries supply oxygen-rich blood to the heart muscle. The atherosclerosis is a 
known to be a critical condition in which arteries becomes blocked due to the accumulation of cholesterol 
[100]. Deposition of cholesterol inside walls of arteries can form plaques resulting in blockages and 
interruption of the blood circulation that can causes heart attack, angina and myocardial infarction. Over 
time, plaque can become harden or rupture. Hardened plaques narrow the coronary arteries and reduce the 
flow of oxygen-rich blood to the heart. In ruptured plaque, a blood clot can form on its surface resulting 
in a complete block of blood flow through a coronary artery. Thromboembolism is another condition that 
can occur due to the bursting of these plaques. If the flow of oxygen-rich blood to the heart muscle is 
reduced or blocked, angina or a heart attack can occur. Hence, the estimation of cholesterol in blood has 
become an important parameter for POC diagnostics.  
Cholesterol is a janus-faced molecule and is a waxy, fat like substance found in all animal 
products such as meats, eggs and dairy products [107]. It is useful in cell membranes and controls the 
membrane permeability and fluidity. It can produce sex hormones, and can form bile acids, which are 
necessary for the digestion of fats. Recently, the risks of high blood cholesterol levels are increased 
worldwide. The high blood cholesterol levels may lead to cardiovascular diseases including 
arteriosclerosis. In blood stream, the human body can make cholesterol in the liver and it can absorb 
cholesterol from the diet. It is an important component for the metabolism of fat soluble vitamins, 
including vitamins A, D, E, K and insulates nerve fibers. It is known that 70% of cholesterol exists in 
ester form and 30% as free form in a blood sample. The chemical formulas of (a) free cholesterol and (b) 
cholesterol ester have been shown in Figure 1.4. 
 
 
 
 
  
Figure 1.3 The chemical formula of (a) cholesterol (free), and (b) cholesteryl ester [108]. 
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Cholesterol [(3β)-cholest-5-en-3-ol; molecular formula: C27H46O, molecular mass: 386.6 g/mol] 
is a family of polycyclic compounds [Figure 1.3 (a)], it is known to be a sterol. In plasma, three major 
types of lipids namely cholesterol, phospholipids (PLs), and triglycerides (TGs) are present. Additionally, 
in plasma lipoprotein, cholesterol is found in free form that can esterified to long-chain fatty acids called 
cholesterol esters (CEs) [Figure 1.3 (b)] which can form covalent and non-covalent linkages in animal 
tissues.  Lipoprotein is composed of lipid and protein which forms a particle via non-covalent bonds. In 
addition, it consists of a non-polar lipid of PLs, free cholesterol and proteins. The main function of 
lipoprotein is to transport cholesterol or TGs around the human body. The four major categories of 
lipoprotein are known as chylomicron (CM), low density lipoprotein (LDL), very low-density lipoprotein 
(VLDL) and high density lipoprotein (HDL) [109].  
 Desirable - Less than 200 mg/dL (desirable level corresponding to lower risk for heart disease) 
 Borderline high - 200 to 239 mg/dL (borderline high risk) 
 High - 240 mg/dL and above (high risk) 
High cholesterol levels in the blood are associated with various disorders such as hypertension, 
atherosclerosis, nephrosis, myxedema, jaundice and myocardial infarction [107]. Low levels of 
cholesterol may result in hyperthyroidism, anaemia and maladsorption. Thus, it is very important to 
develop the POC devices for estimation of cholesterol. In this regard, microfluidic biosensor can provide 
an efficient, simple and reliable detection strategy for its regular quantification.  
 
 
 
 
 
 
 
 
Figure 1.4(i) The structure of lipoprotein molecule and (ii) LDL particle model [110]. 
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The physical and chemical characteristics of lipoproteins (density range between 1.019 and 1.063 
kg/L) are listed in Table 1.3. LDL particles vary in size and density and can carry 60–70% of the total 
serum cholesterol. The core of a lipid particle consists of CEs and TGs which are surrounded by PLs, free 
cholesterol and apolipoproteins (proteins) [Figure 1.4(i)]. Apolipoprotein B 100 is amphipathic in nature 
and highly insoluble in aqueous solution that can interact with lipid moieties of lipoproteins and is 
specialized to facilitate several biochemical steps in lipid metabolism. Figure 1.4(ii) is a pictorial 
schematic model of the LDL particle. Hydrophobic core LDL particle contains CEs and TGs where the 
hydrophilic outer shell of LDL contains the PLs and free cholesterol. Classifications of lipoproteins are 
shown in the Table 1.4. The major component of atherogenic lipoproteins is the apo B 100 which has 
been identified by the National Cholesterol Education Program (NCEP).  High density lipoprotein (HDL) 
is the smallest lipoprotein and carry 20– 30% of the total serum cholesterol [102]. The two major 
apolipoproteins of HDL are known as Apo A-I and apo A-II. All the apolipoproteins except apo B-100, 
are helical with a hydrophobic and a hydrophilic domain. HDL transports cholesterol away from arteries 
thus, it is known to be as good cholesterol (which can remove excess cholesterol in the blood and can help 
to protect you against heart diseases). 
 
Table 1.3 Classifications of lipoproteins with concentration [110] 
Lipoproteins Concentration (mg/dL) Classification Risks 
LDL cholesterol <100 
100-129 
130-159 
160-189 
≥ 190 
Optimal  
Near or above optimal 
Borderline 
High 
Very High 
 
Heart attack, 
Stroke, 
Hypercholesterolemia, 
Cardiovascular 
disease 
HDL cholesterol <40 
≥60 
Low 
High 
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Table 1.4 Classification of lipoproteins [110] 
Class Density 
(kg/L) 
Diameter 
(nm) 
Protein  
(%) 
Free 
Cholesterol 
(%) 
Esterified 
Cholesterol 
(%) 
Phospho-
lipids 
(%) 
Triglyce-
rides 
(%) 
HDL 1.063-1.21 8-15 33 7 40 46 6 
LDL 1.019 18-24 25 11 50 29 10 
VLDL 0.95-1.006 30-52 10 7 18 20 55 
CM <0.95 80-1200 <2 2 3 8 85 
 
 
Currently, several methods including ultracentrifugation, nuclear magnetic resonance (NMR) 
spectroscopy, electrophoresis, chromatography, Friedewald method etc. are being used for the estimation 
of cholesterol, LDL etc. in the clinical laboratories. The ultracentrifugation techniques are tedious, time 
consuming and have poor reproducibility thus, this method is not considered practical for use in clinical 
laboratories. However, ultracentrifugation can be considered as a reference method for estimation of HDL 
and LDL cholesterol. Another common method is Friedewald calculation which is used to detect LDL 
cholesterol from human serum sample. The Friedewald Eq. (1.1) is given by [102] 
                           LDL-cholesterol =TC – HDL-cholesterol – TG/5 (mg/dL)                                      Eq. 1.1 
In large scale studies, this method is commonly used in the clinical laboratory. However, the 
accuracy/precision is the major limitation of this method. Electrophoresis techniques can be used to detect 
lipids such as cholesterol and triglycerides (TGs) due to the differences in the size and charges of various 
lipoproteins. This method can be used for qualitative analysis of lipoproteins though it may not give a 
quantitative picture. Both ultracentrifugation and electrophoresis have disadvantages especially when the 
workload is high for routine tests in clinical laboratories. Chromatography technique is used to separate 
lipoproteins such as high density lipoprotein (HDL), low density lipoprotein (LDL), very large low 
density lipoprotein (VLDL) and CM from serum samples. The stability of this strategy is poor, due to 
using two columns with subsequent determination of cholesterol concentration using an online enzymatic 
reaction. 
In order to develop an efficient, fast and cost effectiveness detection strategy for cholesterol, LDL 
etc. the POC devices can play critical role in health-care diagnostics. An electrochemical technique for 
rapid detection of cholesterol using PDMS microchip capillary electrophoresis based on the enzymatic 
reaction have been reported by Ruecha et al. [111]. A very small volume of whole blood is only needed 
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for a fingerstick POC test and results are available soon after sampling, which is advantageous in self-
management of hypercholesterolemia. Earlier detection and disease management and cost-effectiveness 
are some other advantages offered by POC diagnostics. Researchers have also focused the nanostructured 
materials for electrochemical detection of cholesterol, LDL and triglyceride etc. Solanki et al. have 
reported a biosensor based on nanostructured cerium oxide film for triglyceride detection [112]. 
Nanostructured iron oxide platform has been developed for impedimetric cholesterol detection [113]. 
Electrophoretically deposited polyaniline nanotubes based electrode platform has been developed for 
cholesterol of detection [114]. Such techniques could perhaps be used for selective determination of 
HDL-C and LDL-C for POC. However, the miniaturization and requirement of huge amount of 
sample/reagent are the main disadvantages of the POC devices.  
1.6  Motivation of the work 
This research work is an effort to explore the possibility of developing low cost, simple, efficient and 
highly reliable strategy for detection of biomolecules, more specifically, cholesterol for its routine 
quantification. Having outlined, the exceptional qualities associated with microfluidics, the main focus of 
this research is to integrate microfluidics to realize compact POC devices. It is aimed at improving the 
state of art POC devices by structural innovation brought in through the recent developments in 
nanotechnology. Incorporation of nanostructured metal oxides on electrode surface would improve the 
biosensor efficacy such as detection limit, sensitivity, selectivity, detection time and long term functional 
stability of the devices. 
    Though this research is applicable to a wide variety of biomolecules, free, total and LDL cholesterol 
have been chosen as the targeted candidates for detection, due to its high importance in clinical health 
care and point-of-care applications. With this motivation, the main objectives in this thesis are described 
in the next Section.    
1.7 Objectives of the thesis 
The objective of this thesis is to design, develop, and characterize various microfluidic chips 
incorporating biofunctionalized nanostructured materials for POC diagnostics. To construct the 
microfluidic biosensors, PDMS has been selected as a suitable material for the fabrication of different 
microchannel architectures. The studies are aimed at “Development of nanostructured metal oxide-based 
microfluidic biosensors for the detection of free/total cholesterol and low density lipoproteins”. To 
achieve this objective, the following steps have been envisaged: 
1. Development and fabrication of microfluidic PDMS channels and ITO microelectrodes to 
complete the biochips. 
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2. Explore various nanomaterials for the modification of microfluidic electrodes and 
functionalization e. g. 
a. Anatase-titania (TiO2) nanoparticles  
b. Chitosan modified titania nanoparticles 
       c.   Nickel oxide (NiO) nanorods 
       d.   Nickel oxide and carbon nanotubes composite 
3. The biofunctionalization of these microfluidic electrodes with various biomolecules such as 
enzyme, antibody etc. and their characterization using various spectroscopic and morphological 
techniques.  
4. Electrochemical detection (using cyclic voltammetry, chronoamperometry, impedance 
spectroscopy etc.) of cholesterol and LDL.  
             I have selected some suitable nanostructured materials such as TiO2, NiO and their composites 
with chitosan and carbon nanotubes to be integrated with microfluidic assembly. Studies are carried out to 
immobilize these nanostructured microfluidic electrodes with biomolecules/proteins (cholesterol oxidase, 
cholesterol esterase, anti-apolipoprotein B, bovine serum albumin) via physical adsorption and covalent 
interactions. A systematic optimization of these microfluidic biochips is carried out by changing these 
proposed nanostructured metal oxides for cholesterol detection. In addition, characterization of these 
nanostructured metal oxides and their biofunctionalization is carried out. Comparative studies of these 
microfluidic biosensors for cholesterol detection are also investigated.  
1.8 Thesis overview 
The objective of this thesis is to design and develop various microfluidic chips that are capable of 
assembling biofunctionalized nanostructured materials for POC diagnostics. To construct the microfluidic 
biosensors, PDMS has been chosen as a suitable material for fabrication of different microchannels 
architectures using soft lithography technique in order to control the biological fluids such as cholesterol, 
LDL with buffer solutions. The patterned microelectrodes of indium tin oxide on glass substrate have 
been fabricated using photolithographic and wet chemical etching techniques. I have selected some 
suitable nanostructured materials such as TiO2, NiO and their composites with chitosan and carbon 
nanotubes to integrate with microfluidic assembly. These nanosctructured materials with biomolecules 
have been characterized using various spectroscopic and microscopic techniques. These synthesized 
materials have been utilized in the microfluidic systems in order to improve the biosensor efficacy. In this 
thesis, I have highlighted the materials synthesis and construction of highly efficient microfluidic 
biosensors for POC applications.  Free cholesterol, total cholesterol and LDL cholesterol are the target 
analytes which I have selected to monitor electrochemically using these proposed microfluidic devices. 
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Chapter 1 of this thesis gives a brief description of the POC diagnostics, a historical snapshot of 
microfluidic biosensors, utilization nanostructured metal oxides in biosensors and their integration for 
biomolecules detection with literatures survey. Motivation of thesis has been described in this Chapter. I 
have illustrated the importance of various target analytes such as free, total cholesterol and LDL detection 
using microfluidic assembly. Electrochemical detection and their integration of microfluidic biochips for 
various biomolecules such as cholesterol, LDL etc. detection have been demonstrated. The importance of 
cholesterol and LDL detection in human blood serum using microfluidic technique and their 
advantages/disadvantages has been added. In the Chapter 2, the basic principle and construction of 
microfluidics devices such as fluidic transports, scaling effect, diffusion, mixing etc. have been described. 
Microfluidic components and materials have been illustrated in this Chapter. A brief literature survey on 
microfluidics devices has been included. A brief introduction of biosensor principle, characteristics, types 
of biosensors and immobilization techniques has been presented. The importance and applications of 
synthesized nanostructured metal oxides such as TiO2, NiO and their nanocomposites with chitosan and 
carbon nanotubes (CH-TiO2 and CNT-NiO) in microfluidic biosensors have been included in this 
Chapter.  
Chapter 3 deals with a broad overview of various materials, fabrication and characterization 
techniques that have been adopted in this thesis for the development of microfluidic biosensors. Attempts 
have been made to give detailed of PDMS microchannels fabrication using various steps of soft 
lithography. I have described the wet chemical etching and photolithography techniques for patterned 
microelectrodes (indium tin oxide; ITO) fabrication. I have also illustrated an overview of the chemical 
synthesis of nanomaterials. Various characterization tools and methods have been discussed in this 
Chapter. The Chapter 4 describes the experimental and results relating to the fabrication of nanostructured 
anatase-TiO2 based microfluidic platform for free cholesterol estimation. The results of XRD, FT-IR, UV-
visible, AFM and TEM of this integrated microfluidic system have been illustrated. Free cholesterol has 
been estimated using electrochemical technique using this proposed microfluidic POC biosensor. 
Additionally, I have prepared another candidate of chitosan modified TiO2 nanoparticles for total 
cholesterol detection using microfluidic assembly. Chapter 5 gives the details of nickel oxide nanorods 
(NR-NiO) integration with microfluidic device for total cholesterol detection. Potential merits and 
demerits of this proposed microfluidic biosensor have been illustrated.  
Chapter 6 explains the step by step fabrication process of a microfluidic biochip based on a 
composite comprising of nanostructured NiO and carbon nanotubes (CNT-NiO) for total cholesterol and 
LDL estimation. The fabrication of the microfluidic biochip using CNT-NiO nanocomposite has been 
explained. Additionally, I have investigated the toxicity effect of these synthesized CNT, NiO and CNT-
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NiO in A549 cell line. I have characterized the CNT-NiO composite using various techniques such as 
XRD, Raman, XPS SEM and TEM. The electrochemistry of this proposed microfluidic biochip has been 
investigated using CV and EIS studies. The chronoamperometric results of the biochip for cholesterol 
oleate detection have been discussed. The Chapter 7 gives an overview of thesis summary and future 
prospects. The conclusion for each chapter has been described. A future prospect of the work including 
limitations and a new direction has been demonstrated.  
1.7 Conclusions 
In conclusion, I have given an introduction of POC diagnostics devices. A historical snapshot of 
microfluidic devices for detection of biomolecules has been highlighted. The state-of-the-art biosensors 
and their integration with microfluidics POC devices have been included. An overview of biosensors with 
the importance of nanomaterials has been explained with references to existing research literature. The 
next Chapter deals with the description of microfluidics. The basics principle and construction of 
biosensors have described. The details on nanostructured metal oxides have also been illustrated.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
Principles of Microfluidics, Biosensors and 
Applications of Nanostructured Metal Oxides    
 
 
 
 
 
 
 
 
 
 
 
 
26 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
2.1 Introduction 
This Chapter paves the basic principles of microfluidic devices including fundamentals of fluidic 
transportation, mixing, diffusion and scaling effects. The various components and materials for 
microfluidic devices have been illustrated. An overview of biosensor principle, types and immobilization 
techniques have been described. Current developments in nanostructured metal oxides/composites and 
their applications in biosensing devices have also been explained.  
2.2 Principle of microfluidics 
Microfluidic platforms find applications in many fields using the pressure driven laminar flow, lateral 
flow tests, linear actuated devices, centrifugal microfluidics, microfluidic large scale integration, 
electrokinetics, electrowetting and surface acoustic waves as depicted in Figure 2.1.1 [115-117]. Mark et 
al. have reported that a microfluidic platform provides a set of fluidic unit operations, which are designed 
for easy combination within a well-defined fabrication technology [115]. A microfluidic platform 
provides a generic and consistent way for miniaturization, integration, automation and parallelization of 
bio-chemical processes. Utilization of fluid transport models in light of the development of microfluidic 
devices have found many applications towards the drug design, delivery and detection, diagnostic 
devices. Many researchers have focused on specific microdevices using valves, pumps, actuators, mixers 
and reactors, sensors, and three-dimensional channels networks [116]. The transport processes including 
mixing, reactions, and separations in micro-domain play an important role in lab-on-a-chip devices. In a 
microchannel, the low-Reynolds numbers inherent in most microfluidic systems lead to laminar flows 
that can be predicted and designed in a uniform fashion. Researchers have investigated the fundamental 
transport and scaling principles of micro/nanofluidic flows for manipulation and analysis [115, 117]. 
Kamholz et al. have demonstrated the molecular diffusion in pressure-driven laminar flow in microfluidic 
channels [118]. Pamme et al. have described the fluid flow separations using microfluidic platform [119]. 
Fluid separation in microfluidics is commonly used in electrophoresis and chromatography via filtration 
and centrifugation. Liu et al. have explained mixing of two fluids in a microchannel [120]. Sudarsan et al. 
have described fluid mixing in planar spiral microchannels [121]. In a microfluidic flow, the continuum 
approximation of different fluidics characterization is important since it allows us to analyze with the 
same governing principles developed for macroscale fluid mechanics.  
2.2.1 Governing equations  
Fluid flow in micro or nanochannels with a characteristic length of more than 10 nm, the flow of a 
Newtonian, isotropic, and incompressible fluid can be described respectively by the continuity equation, 
and the Navier-Stokes equation [122]. The continuity equation is given by  
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                                                                                           Eq. 2.1.1 
where   is the napla operator,  
 
  
 is the total derivative operator in a three-dimensional Cartesian 
coordinate system and is given by  
                                       
 
  
 
 
  
  
 
  
  
 
  
  
 
  
 
 
  
                                                       Eq. 2.1.2 
and v=(u,v,w) is the velocity vector. The Navier-Stokes equation is derived from Newton’s 2nd law is 
given by 
                                                 
  
  
                                                                                Eq. 2.1.3 
 
where   is the density of the fluid and   is the dynamic viscosity of the fluid.  
 
2.2.2 Reynolds number and laminar flow 
Fluid flow can be characterized by the Reynolds-number which is a dimensionless number [123]. It can 
be defined as the ratio of inertial to viscous forces of the liquid in motion and is given by Eq. 2.1.4 
                                                         
              
             
 
   
 
                                                                   Eq. 2.1.4 
where u is the average flow velocity, L is the characteristic length,   is the dynamic viscosity, and   is the 
density of the fluid. The kinematic viscosity of water being u = 10
–6
 m
2
/s, the Reynolds number is of the 
order of 1. Typical Reynolds numbers vary from 10
-4
 to 1. Thus, a laminar flow would mean that the 
streamlines are locally parallel and that even obstacles in the flow will not induce any turbulence. 
Resistance per length of the channel wall increases when the channel diameter narrows. When 
downscaling to the microlevel, the flow resistance increases rapidly with narrowing channel diameter, 
compared to larger channels. This is the reason why laminar flow occurs in microchannels; viscous force 
dominates due to large surface to volume ratio.  Details and importance of Reynolds number have been 
described by Squires et al. [124]. Schematic description of fluid flow for (a) laminar and (b) turbulent is 
shown in Figure 2.1.2. Fluidic molecules transported in a parallel and predictable fashion, with no 
disruption between the layers is called laminar flow. At low velocities the fluid tends to flow without 
lateral mixing. In a laminar flow, the motion of particles of the fluid is very orderly with all particles 
moving in straight lines parallel to the channels walls. Laminar flow tends to occur at lower velocities, 
below the onset of turbulent flow.  
The Knudsen number has great importance in gas dynamics. It provides a measure of how 
rarefied a flow is, or how low the density is relative to the length scale of the flow. The Knudsen number 
is given by 
                                                           
 
                                                                                     Eq. 2.1.5 
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(a)
Smooth
Flow (b)
Rough
Flow
where   is the mean free path given in and L is some length scale characteristic of the flow. 
The different regimes of behavior are: 
 Re « 1 viscous effects dominate inertial effects 
 Re ≈ 1 viscous effect comparable to inertial effects 
 Re » 1 inertial effects dominate viscous effects 
In channel flows is, 
 Laminar, when Re < 2300  
 Transient, when 2300 < Re < 4000  
 Turbulent, when 4000 < Re  
 
 
Figure 2.1.1 Microfluidic platforms classified according to main liquid propulsion principle [115]. 
  
 
 
 
 
 
Figure 2.1.2 Schematic description the fluids flow for (a) laminar and (b) turbulent  
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2.2.3 Turbulent flow 
In turbulent flow, fluid molecules move in an irregular and unpredictable fashion. In this flow, the speed 
of the fluid molecules at a point continuously undergoes changes in both magnitude and direction. In 
turbulent flow vortices, turbulent flow occurs in general at high flow rates and with larger pipes. 
2.2.4 Transitional flow 
It is a mixture of turbulent and laminar flow. In this flow, turbulence occurs in the centre of the pipe while 
flow near the edges is laminar. During flowing, such flows behave in different manners in terms of their 
frictional energy loss. In this flow, the fluid molecules acquire an irregular fluctuation under an external 
disturbance. 
2.2.5 Pressure-driven flow  
In micro-domain, a pressure-driven flow can be characterized by liquid transport mechanisms based on 
pressure gradients resulting in stable laminar flow profiles [125]. In fluid mechanics, the pressure-driven 
flow at no-slip boundary condition states that the fluid velocity at the walls must be zero. The pressure-
driven flow produces a parabolic velocity profile and allows the straight forward way of moving fluid 
molecules in a microfluidic device. External or internal pressure sources such a syringes, pumps or 
micropumps, gas expansion principles, pneumatic displacement of membranes, etc. can be used to control 
liquid in microchannels. The samples and reagents can be injected through the inlet of chip either batch-
wise or in a continuous mode. The main drawback of using pressure as a means of transport is that the 
pressure driven flow will display a non-uniform velocity profile. Sia et al. have described the details of 
pressure-driven flow in microfluidic devices [126]. Schematic representation of typical pressure driven 
fluid flow is shown in Figure 2.1.3. It can be difficult to maintain the smoothness of the flow when using 
pumps to drive the flow in small microfluidic channels. 
In case of linear actuated devices, the liquid movement can be controlled by mechanical 
displacement such as a plunger. Fluid control is limited to a one-dimensional path, where the flow is 
dominated only in a linear fashion without branches. Segmented flow illustrates the principle of using 
small liquid droplets immersed in a second immiscible continuous phase (gas or liquid) as stable micro-
confinements within the microchannels [115]. In this case, flow can be transported using pressure 
gradients and can be merged, split, sorted, and processed without any dispersion in microchannels. In 
centrifugal microfluidics, all processes are controlled by centrifugal force, Euler force, Coriolis force and 
capillary force [127].  
Active pumping: Precise flow control in microfluidics is a key parameter to the proper functioning of 
devices. In active pumping, the fluid flow can be controlled using external sources, like mechanical 
displacement, centripetal force and electrical fields [128]. Syringe pump is one of the simplest 
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microfluidic pump widely used in laboratories. In order to move the plunger of syringe pump at a constant 
speed, a stepper motor can be used. It can be used for a wide range of volumes and flow rates. Main 
disadvantages are large dead volumes and significant flow hysteresis. Active pumping is confined to the 
research laboratories only.  
Passive pumping: The fluid flow rate in microfluidics can be manipulated using passive valves. Driving 
forces to move liquids in passive microfluidics are chemical gradients on surfaces, osmotic pressure, and 
permeation in PDMS or capillary forces. This microfluidic flow occurs spontaneously and is appealing, 
owing to their portability, zero power consumption and low dead volumes. These devices are attractive 
because of their low cost. A disadvantage is that the flow rates of fabricated devices are set in the design 
and thus can only be varied to a limited degree. 
2.2.6 Scaling effects 
In microfluidics, the scaling law is a physical phenomena and it can be different for different microscale 
devices compared to that of macroscale devices. The device miniaturization can change the ratio of 
different physical effects leading to new fluidic behaviours with new applications [129]. Squires et al. 
have reviewed various scaling effects for microfluidic devices at a nanolitre scale [130]. For example, 
surface tension dominates over gravitational forces, electric fields tend to be far more influential than 
pressure gradients and molecular diffusion becomes more significant relative to bulk fluid displacement. 
In particular, the fluid properties such as diffusion time, distance and surface-to-volume will be varied. 
The change of the spatial dimension or the size of the fluidic component of interest is characterized by the 
scaling factor,       , where    is the reference size. Miniaturization indicates that the scaling factor is 
smaller than unity (S < 1). On the other hand, different forces occurring in the micro- and nanoscale are 
categorized as surface forces and volume forces. The surface forces (surface tension and viscous friction) 
are proportional to the surface area, while volume forces such as weight, buoyancy force, or inertial force 
are proportional to the volume. The scaling of the ratio between surface force and volume force is given 
by  
                                             
             
            
 
 
 
 
  
  
 
 
 
                                                             Eq. 1.1.4 
 
where L, A, and V are the characteristic length, surface area, and volume, respectively. 
2.2.7 Capillary flow 
Fluid molecules can be transported via capillary action or capillary forces which results from the 
interaction of liquid, gas and solid surfaces, at the interface between them. For example capillary flow is 
utilized for a common commercially available pregnancy test strips for the intake of sample. In this case, 
the fluidic molecules are driven by capillary forces [131] and their movement is controlled by the 
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wettability and feature size of the porous or microstructured substrate. A color change can be seen in the 
detection area due to the chemical reaction. 
2.2.8 Diffusion and mixing  
Mixing strategies in microfluidics can be either active or passive depending on the operational 
mechanism. The active mixers utilize the external forces, beyond the energy associated with the flow for 
performing mixing. Mixing of fluids in microfluidics are difficult because flow is typically laminar and it 
depends on diffusion. Researchers have proposed different approaches for fluid mixing in microfluidics. 
Sudarsan et al. have demonstrated mixing of fluids in microfluidic devices [121]. In addition, the passive 
mixers avoid the problems by exploiting characteristics of specific flow fields to mix species without 
application of external electrical or mechanical forces. Passive mixers are reliable and cost effective 
compared to active mixers. Microfluidic platforms have been used to manipulate the distribution of 
chemical species. The chemical separations, for example, physically separate components of a 
multispecies mixture so that the quantities of each component can be analyzed and useful species can be 
concentrated or purified from a mixture [120]. Many biochemical assays such as DNA microarrays, 
require that a reagent be brought in contact with the entirety of a functionalized surface, i.e., that the 
reagents in the system are well mixed. The mixer benefits from a short path and efficient mixing at the 
cost of increased complexity in fabrication and packaging. 
2.2.9 Electrokinetics 
Another well known transport process in microfluidic devices is the use of electrokinetic flow [132]. In 
electrokinetics, the fluidic operations are controlled by electric fields acting on electric charges, or electric 
field gradients acting on electric dipoles. Depending on fluids, several electrokinetic effects such as 
electroosmosis, electrophoresis, dielectrophoresis, and polarization may produce in the microfluidic 
channel. The electrokinetic flow arises when a polar liquid is brought in contact with the solid channel 
wall when subjected to an electric field. Once the wall comes in contact with the polar liquid, the wall 
surface acquires an electric charge. This will cause the relocation of charges inside the liquid yielding a 
thin layer of ions at the wall surface oppositely charged to the charge of the wall. This is known as the 
Stern layer. Outside the Stern layer another thicker layer of excess charges is formed known as the diffuse 
layer. This layer contains an excess of charges of the same polarity as those in the Stern layer. The ions 
within the Stern layer are fixed whereas those in the diffused layer are mobile. Figure 2.1.4 shows the 
schematic of the representation of charges in a channel under electroosmotic conditions. 
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Figure 2.1.3 Schematic representation of a typical pressure-driven fluid flow 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1.4 Schematic of the configuration of charges in a channel under electroosmotic conditions 
showing the mobile charges the diffusive and fixed charges in the Stern layer. 
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The electric fields in microchannels can cause bulk fluid motion and the velocity of this motion is 
linearly proportional to the applied electric field. The velocity is dependent on both the material used to 
construct the microchannel and the solution in contact with the channel wall. This motion is known as 
electroosmosis, and stems from electrical forces on ions in the electrical double layer, a thin layer of ions 
that is located near a wall exposed to an aqueous solution. If the fluid velocity is interrogated at 
millimetre resolution, (e.g. the fluid flow can be observed by a light microscope), the fluid flow in a 
channel of uniform cross-section appears to be uniform. On the other hand, if the fluid velocity is 
interrogated with the nanometre resolution, the fluid velocity would be uniform far from the wall, but it 
would decay to zero at the wall over a length scale of  D ranging from approximately 0.5–200 nm. 
However, this flow comes with its own complications, as its velocity distribution is different from 
pressure driven flow. It is sensitive to chemical features at the interface, since  applied electric field can 
also move particles relative to the fluid or cause Joule heating (i.e., resistive heating) throughout the fluid. 
The electrowetting platforms utilize droplets immersed in a second immiscible continuous phase (gas or 
liquid) as stable micro-confinements. The droplets inhabit a hydrophobic surface that contains a one or 
two dimensional array of individually addressable electrodes. By varying voltages between electrodes, the 
droplets can be generated, transported, merged, split and processed.  
2.3 Components of microfluidic devices 
The microchannel in microfluidics system is an important component that can be used to control 
biological fluids, buffer solution etc. in uniform fashion [118, 126]. For coupling between two or more 
microfluidic systems, or between a microfluidic system and the exterior world, microchannel can be used. 
Other control elements such as valves and pumps, are complicated to be fabricated using silicon 
technology and then difficult to be integrated onto lab-on-a-chip systems. However, the use of ‘soft’ 
technologies based on elastomers offer elegant possibilities for valves and pumps. The injection of fluids 
is a practical difficulty and it does not always have a simple solution, especially when the sample is very 
small and not amplifiable (for example, proteins extracted from a single cell). The sample can be diluted 
to a large volume so that it can be manipulated more easily. However, this creates a series of difficulties, 
including the need for sensitive instrumentation. The injection of minute quantities of fluid remains an 
open problem in the management of fluid volumes. 
2.4 Materials for microfluidic devices 
Materials such as silicon, glass, polymers, plastics (cyclic olefin copolymer or polystyrene), paper 
(nitrocellulose or cellulose), waxes, and adhesives have been used to fabricate microfluidic devices [133]. 
In early microfluidic systems, silicon was used as a substrate owing to the wealth of existing 
microfabrication production. Many researchers have used standard photolithography and etching 
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processes to construct microfluidic channels of precise dimensions on silicon wafers. However, the focus 
shifted from silicon to glass substrates due to the number of advantages of glass over silicon. Glass is a 
transparent material since it allows the visualization of on-chip processes and is more compatible with 
electroosmotic flow than conductive silicon. In addition, glass can be easily bonded to a second substrate 
than silicon. The characteristics of glass such as surface stability, solvent compatibility, easy of 
fabrication etc. are beneficial for practical realization of a microfluidics device [134]. Nie et al. have 
reported a POC device that can be used to detect glucose, cholesterol, lactate, and alcohol etc. in blood or 
urine using patterned chromatographic paper (Whatman 1 Chr) [135]. This technique allows the 
reproducible conformal contact between the electrode and the paper channel and can be easily scaled to 
large numbers, requires a smaller quantity of analyte solution. Silicon has the added advantage that it can 
combine on-chip electronics with microfluidic networks. Besides this, silicon supports the most precise 
geometrical tolerance, which is becoming increasingly important as channel dimensions continue to 
decrease. Though from a cost point of view, PDMS is simpler and universal material for microfluidic 
applications compared to both glass and silicon wafers.  
Polymeric materials including polydimethylsiloxane (PDMS), polymethylmethacrylate (PMMA), 
polycarbonate (PC) etc. show superior properties such as chemical resistance, aging, mechanical, optical 
etc. over glass and silicon for a number of reasons [134, 136]. The last 10 years have witnessed a shift 
from silicon to polymeric micromachining as a low-cost alternative for the fabrication of microfluidic 
devices. In soft lithographic microfabrication, PDMS behaves like an elastic solid that maintains its 
molded structure when cured. The use of PDMS for microfluidic applications was first presented by 
George M. Whitesides in the mid-1990s [35-37]. In this method the elastomeric monomer is poured over 
a master mold structure (typically a silicon wafer with an inverse photoresist structure of the channel 
geometry) and is then cured. The cured structures can be simply peeled from the master and bonded to a 
planar substrate, forming the microchannel structures. The master mold can be reused multiple times to 
replicate devices. Details of this method have been described in the materials & methods section of 
Chapter 3.  
The PDMS, PC or PMMA have been widely used in majority of microfluidic research 
laboratories. The PDMS behaves like an elastic soft material that maintains its molded structure. It offers 
low cost, flexibility, and rapid prototyping. PDMS is known to have poor chemical compatibility with 
many organic solvents as it tends to swell upon contact, making it mainly suitable for aqueous 
applications. Modification of the PDMS surface is unstable over time. PDMS adsorbs small molecules 
and it can be deformed under pressure of pneumatic valves. High pressure operation on PDMS devices 
can lead to large alteration of channel geometry and hence is not desirable. Though, PDMS has gained 
widespread acceptance in the field of microfluidics, glass and silicon certainly have increased utility in 
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fabrication of microfluidic devices. Other polymers including PMMA and PC have also been explored for 
microfluidic applications. These materials adopt techniques like hot embossing and injection molding for 
device fabrication. PMMA is a thermoplastic material for high-resolution photoresists and it can be 
patterned into microchannels or other structures by hot embossing. In addition, PMMA is optically 
transparent and can be patterned by laser cutting. However, PMMA can restrict light transmission in the 
UV range, which limits its applicability in sensing.  PMMA can easily be integrated with metal electrodes 
and its surface can be functionalized for electrochemical sensing applications. PMMA is also used as an 
intermediate material for fabrication of microfluidic devices. Plecis et al. have demonstrated the 
fabrication of microfluidic devices based on glass–PDMS–glass technology [137]. Quake et al. have 
described the micro-nanofabrication using soft materials [138]. Sia et al. have described the fabrication of 
PDMS based microfluidic devices for biological studies [126].  
Surface modification of PDMS using various techniques such as air/oxygen/argon plasma, 
UV/ozone and corona discharge etc. can produce silanol terminations (SiOH) on its surface thereby 
leading to increased hydrophilicity. Hydrophilicity of PDMS is limited to a period of 20-30 minutes and 
is subjected to swelling in organic solvents. PDMS can restrict detection of shorter wavelength (near 400 
nm). Bodas et al. have described the formation of more stable hydrophilic surfaces of PDMS by plasma 
and chemical treatments [139]. Permanent modification of PDMS surface using various chemical 
treatments has been investigated. Wu et al. have developed a facile approach to modify PDMS using a 
vinyl-terminated initiator that is mixed with Sylgard 184 (PDMS oligomer and curing agent) [140]. But 
the modified PDMS surface becomes unstable over time. Bodas et al. have developed another approach to 
modify hydrophobic surface of Sylgard 184 PDMS using oxygen plus C2F6 and 2-hydroxyethyl 
methacrylate with exposure time of 15 min [139] and observed that the hydrophilicity of PDMS surfaces 
are increased to 2 days and 10 days, respectively. Researchers have modified the PDMS surface by self 
assembled monolayer (SAM) to reduce swelling resulting in improved stability [141]. 
2.5 Biosensors 
A sensor is a device that detects or measures a physical property and records, indicates or otherwise 
responds to it. A transducer is a device that converts an observed change (physical or chemical) into a 
measurable signal. It is an analytical device that enables the identification and quantification of an analyte 
of interest from a sample matrix, for example, water, food, blood, or urine [142]. A biosensor is an 
analytical device incorporating a biological sensing element connected to a transducer. Various 
definitions and terminologies are used depending on the field of applications. According to the IUPAC 
definition, “A biosensor is a self-contained integrated device which is capable of providing specific 
quantitative or semi-quantitative analytical information using a biological recognition element which is in 
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direct spatial contact with a transducer element” [142]. The “specific biological element” recognizes a 
specific analyte and, the changes in the sensor surface due to interaction of biomolecules or reaction are 
usually converted into electrical signal by the transducer. The bio-element may be an enzyme, antibody, 
antigen, living cells, nucleic acid, lectine, hormone, and tissues, etc. The bio-element is very specific to 
the analyte to which it is sensitive. It does not recognize other analytes. The large variety of sensor-
elements includes electric current, electric potential, intensity and phase of electromagnetic radiations, 
mass, conductance, impedance, temperature, viscosity, and so on. The “sensor” element transduces the 
change in the biomolecules into an electrical signal. Various components of a biosensor is shown in the 
Figure 2.1.5. The basics of biosensors, its various types and immobilization methods are discussed in this 
section.  
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Biosensor 
Components
Analyte
Enzymes, pH
Antigens, Antibodies, Proteins
DNA, PNA, RNA, Small molecules
Toxins, Viruses, Bacteria,  etc.
Bio-recognition 
Elements
Enzymes, pH
Antigens, Antibodies, Proteins
Cells, Tissues, 
DNA, PNA, RNA, Aptamers, Ribozymes
Receptors, Yeasts, Nucleic Acids etc.
Transducers
Amperometric, Potentiometric
Impedance
Absorbance, Reflectance, Refractance,  
Refractive Index
Surface Plasmon, Fluorence,
Chemiluminescence, Peizoelectric etc.
Figure 2.1.5 Main components of biosensor 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1.6 Schematic representation of (i) a three electrode based microfluidic biosensor and (ii) a 
typical biosensor.  
 
 
 
 
 
 
(ii) (i) 
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2.5.1 Characteristics of biosensors 
i. Accuracy 
ii. Sensitivity and specificity – no environmental interference,  
iii. Measurement range –susceptible to saturation? 
iv. Speed of response –e.g. nerve agents 
v. Re‐usability – antibody based often not re‐usable due to tight interactions 
vi. Self‐testing/ calibration 
vii. Physical robustness 
viii. Cost – capital, running 
ix. Acceptability and ease of use by users 
x. Product-safety 
 
2.5.2 Electrochemical biosensor 
An electrochemical biosensor measures current, voltage, impedance or capacitance based on an enzymatic 
catalysis of a reaction that produces electrons. This biosensor consists of a reference electrode, a counter 
electrode and a working electrode. In this biosensor, the target analyte involve an enzymatic reaction that 
takes place on electrode surface. This reaction on sensor surface can cause the electron transfer through 
the double layer that produces a current or can contribute to the double layer potential that produces a 
voltage. The rate of flow of electrons or measured current or potential is directly proportional to the 
analyte concentration at a fixed potential or zero current, respectively. Electrochemical biosensors can 
detect desired analytes without damaging the system [143]. In this configuration, bio-receptor molecules 
are either coated onto or covalently bonded to a transducer surface. The bio-receptor molecules react 
specifically with target analytes to be detected. Based on their operating principle by which chemical 
information is converted to a measurable signal, electrochemical sensor can be classified into three 
categories namely: potentiometric, amperometric and impedimetric, biosensors. Construction of an 
electrochemical cell for electrochemical biosensors measurement has been described in the next Section. 
Types of electrochemical biosensor are given below.  
2.5.3 Amperometric/potentiometric biosensor 
Amperometric sensors [144] measure the current change resulting from a chemical reaction between 
electroactive materials while a constant potential is being applied [Figure 2.1.7(i)]. The observed change 
in the current is related to the concentration of the species in solution. The working electrode of the 
amperometric biosensor is usually either a noble metal, ITO or a screen-printed layer covered by the 
biorecptor-element. By applying potential, the current (typically in nA to mA range) is measured due to 
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the conversion of electroactive species generated in the enzyme layer at the electrode surface. Several 
amperometric biosensors have been investigated for the estimation of various target molecules [145]. 
Potentiometric biosensors are based on ion-sensitive field effect transistors (ISFET), graphene-FET or 
bioFET as shown in Figure 2.1.7 (ii & iii). In the case of ISFET, the output signal can be measured due to 
ions (H
+
, pH etc.) accumulated at the ion-selective membrane interface. Carbon materials such as carbon 
nanotubes, graphene, etc. are explored for detection of biomolecules by varying drain potential/current in 
FET devices. Mao et al. have grown graphene vertically for the development of FET potentiometric 
biosensor [146]. 
2.5.4 Impedimetric/capacitive biosensor 
The impedance spectroscopy is a label-free technique that has been widely used for probing various types 
of biomolecular interactions such as enzymatic, immunosensors, DNA hybridization and protein-protein 
interactions [147]. When a target biomolecule interacts with a probe-functionalized surface, the electrical 
properties of the surface (e.g., dielectric constant or resistance) can change exclusively due to the 
presence of the target molecules. Thus, no label is required for impedance sensing. The electrical 
impedance can measure the resistance of an electrochemical cell when a voltage is applied. It can be 
defined as the ratio of the voltage to the current in the frequency domain. Impedance-based biosensors 
measure the electrical impedance of an interface with constant DC bias conditions. In an electrochemical 
cell, various phenomena such as electrode kinetics, redox reactions, diffusion and molecular interactions 
occur at the electrode surface that influences the flow of electrons for impedance analysis. The most 
interesting formats for evaluating electrochemical impedance data are the Nyquist and Bode plots.  
Capacitive biosensors utilize the change in dielectric properties and/or thickness of the dielectric 
layer at the electrolyte-electrode interfaces, due to the interaction of biomolecules. An ideal capacitor has 
the ability to store charge and thus, the electric capacitance between the working electrode and the 
electrolyte is         ; where, A is the area, d is the separation between the plates,    is the dielectric 
constant and   is the relative static permittivity. The circuit construction and basic theory of 
impedance/capacitive measurement has been explained in next Chapter. Lee et al. have developed an 
electrochemical impedance biosensor with aptamer-modified pyrolyzed carbon electrode for label-free 
protein detection [148]. Lee et al. have reported the strategy for one-chip electronic detection of DNA 
hybridization using precision impedance-based CMOS array sensor [149]. Wang et al. have developed a 
TiO2 nanowire bundle microelectrode based impedance immunosensor for rapid and sensitive detection of 
Listeria monocytogenes [150]. 
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2.5.5 Optical biosensor 
In an optical biosensor, the transduction process induces a change in same optical property of input light, 
namely absorption, transmission, reflection, refraction, phase, amplitude, polarization or frequency in 
response to the physical or chemical change produced by the biorecognition process [151]. Optical 
biosensors offer several advantages like high selectivity and specificity, remote sensing, isolation from 
electromagnetic interference, label free detection, real-time measurements and multi parameters detection. 
They can operate non-invasively or minimally invasive for in vivo measurements [152].  
One reliable and highly sensitive optical method for biosensor application is surface plasmon 
resonance (SPR). SPR is an optical phenomenon occurring at the interface between noble metals (e.g. 
silver, gold etc.) and dielectric materials that results in collective oscillations of the conductive electrons 
induced by light [153-155]. This change in SPR angle characteristics is the actual monitored signal, and 
the change over time form the sensorgram. Many researchers have investigated different approaches to 
fabricate gold nanoparticles [156] with various shapes and characteristics for label-free detection of 
biological molecules, such as glucose, cholesterol, low density lipoprotein and DNA via SPR. Recently, 
Feltis et al. demonstrated a low-cost handheld SPR-based immunosensor for the toxin ricin [157]. Luo et 
al. developed a multilayer PDMS array consisting of multiple gold spots for the real-time observation of 
immunocomplex formation using SPR [158].  
2.5.6 Piezoelectric sensors 
In a piezoelectric sensor, the piezoelectric effect is exploited to measure strain, force, pressure or 
acceleration by converting them to an electrical signal. In this mode, sensing molecules are attached to a 
piezoelectric surface wherein the interactions between the analyte and the sensing molecules set up 
mechanical vibrations that can be translated into an electrical signal proportional to the amount of the 
analyte. An example of such a sensor is quartz crystal micro or nano balance. Major disadvantage of 
piezoelectric sensors is that they cannot be used for truly static measurements [159]. 
2.5.7 Enzymatic biosensor 
Enzymatic biosensors provide a powerful platform for the POC diagnostics. In an enzymatic biosensor, 
enzyme is immobilized onto a suitable transducer and it produces a specific signal upon reaction with an 
analyte. The main purpose is to convert an enzymatic reaction into a suitable analytical signal 
(electrochemical, colorimetric, optical properties etc.). The thrust is towards developing biosensors for the 
easy detection of the most important parameters like blood-sugar, urea and cholesterol that may serve as 
an indicator about the onset of a disease. 
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Ever since the proposal of glucose biosensor in 1962 [65], several devices based on 
electrochemical biosensors have been developed [65]. Most of these devices are based on enzyme-
functionalized screen-printed disposable electrode strips that work on the principle of amperometric 
detection. These hand-held POC testing devices helps in self monitoring as well as getting quick, reliable 
and accurate results using small volume of samples. Quantitative analysis of glucose via biosensor 
primarily follows two mechanisms which are presented in Figure 2.1.7 (i and ii) [160]. Many approaches 
have been followed to obtain improved characteristics of glucose sensing devices by coupling it with 
microfluidics. Hou et al. have reported glucose microfluidics chip based on polymethyl methacrylate 
(PMMA) using CO2 laser and hot plate press bonding fabrication technique [161]. Compared to 
conventional detection methods, this chip has the advantage of self rotation effect resulting in improved 
mixing in a micromixer and promises rapid and low cost detection of glucose. Recent developments in 
nanotechnology and engineering have enabled immobilization of enzymes on to nanoparticles and 
nanostructures, which in turn can be functionalized on to the electrodes. Yu et al. fabricated a 
microfluidic chip where enzymes were immobilized on the single-walled carbon nanotube onto the 
PDMS channel [162].  
 Accurate determination of urea level in a biological sample is considered very important since change in 
urea concentration in blood (8-20 mg/dL) is an indicator for several diseases such as renal failure, hepatic 
failure, nephritic syndrome, etc. Generally, urease and glutamate dehydrogenase enzymes are used for the 
determination of urea level in the biological samples. Urease converts urea into hydrogen bicarbonate and 
ammonia whereas glutamate dehydrogenase converts ammonium ions, α-ketoglutarate and nicotinamide 
adenine dinucleotide (NADH) to L-glutamate and NAD+ as shown in Figure 2.1.7(iii). Electrons 
generated after conversion of NADH to NAD+ are measured for the estimation of urea concentration 
[163]. Microfluidics-based urea biosensors are of great demand in diagnosis because of high sensitivity, 
low consumption of materials/reagents, fast response time/reaction time, portability and high accuracy 
along with reusability. Nanomaterials have recently been used for immobilization of urease. Srivastava et 
al. immobilized enzymes covalently onto the gold electrode through self assembled monolayer with the 
help of 10-carboxy-1-decanthiol [164]. Sensitivity and detection range have been found to be improved 
when enzymes are immobilized on titania-zirconia composite [165]. The biochemical reaction of 
cholesterol detection is shown in the Figure 2.1. 7 (iv).  
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Figure 2.1.7 Schematic representation of reactions used in enzymatic biosensors such as (i) catalytic 
conversion of glucose into gluconic acid in the presence of potassium ferricyanide. At the surface of 
electrode, electron generated by conversion of Fe (II) to Fe (III), (ii) catalytic conversion of glucose into 
gluconic acid and H2O2 thereafter electron generation by electrochemical oxidation, (iii) biochemical 
reaction of urea biosensor and (iv) biochemical reaction of cholesterol biosensor [160]. 
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2.5.8 Immunosensor 
Immunosensor is based on an immunochemical reaction comprising of antigen or antibody as the 
recognition element that is spatially in contact with a transducer surface [166]. Immunosensor based 
devices can be used to detect immunocomplex formation by measuring change in resistance, current, 
refractive index, capacitance etc. A conventional immunoassay uses a monoclonal antibody comprising of 
a ‘Y’ shaped structure containing two antigen binding sites [Figure 2.1.8]. However, the antigen binding 
to an antibody involves highly specific interaction, making the immunoassay highly reproducible and 
highly specific, suitable for a range of target analytes for biosensing applications [Figure 2.1.9]. However, 
biological components like antibodies are very expensive and the conventional immunoassays are time 
consuming [167]. In this context, microfluidics integrated immunosensors would yield (i) sensitive 
detection, (ii) reduced biological component cost by using very minute volumes, (iii) increased 
functionality for surface treatment, (iv) decreased diffusion distance and fast detection times (v) 
portability etc. and thus, making it viable for POC diagnostics. The development of microfluidics coupled 
immunosenor platforms has gained immense attention towards an efficient and reliable biosensor.  
The immunosensors play an important role in the development of POC devices for detection of 
food pathogens, bacteria and virus due their high specificity and sensitivity and both label or label free 
rapid detection [167]. Many researchers have investigated label-free detection of different biological 
molecules, such as aflatoxins, low density lipoproteins, etc. using integrated SPR microfluidic devices. 
However, label free detection suffers with non-specific binding on the sensor surface. Reliability and 
stability are some of the other challenges that can be addressed by using reference electrode. On the other 
hand, labeled immunosensor measures a molecule attached to a receptor by optical, fluorescence or 
amperometric detection. Fluorescence microscopy can be used to detect fluorophores at a surface density 
even below 1 fluorophore/µm
2
 with a corresponding concentration of analyte in solution in the picomolar 
range. The electrochemical detection of a given label has several advantages such as high sensitivity and 
low cost. However, some of the disadvantages include washing and separation steps, increased 
complexity of the assay etc. Despite these interesting developments, the microfluidics immunosensor are 
yet to hit the commercial market. One of the major problems that delay the commercialization is the 
inability of integration and optimization of peripheral and supporting accessories on a single platform.  
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                      Figure 2.1.8 Schematic presentation of an antibody 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1.9 Immunological reaction  
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2.5.9 Nucleic acid biosensor 
A nucleic acid or DNA sensor is a biosensor that integrates a nucleic acid as the biological recognition 
element and an electrode as the electrochemical signal transducer [168]. Currently, DNA biosensors 
technologies are of much interest owing to their great promise for rapid and low-cost detection of specific 
DNA sequences. These technologies commonly rely on the immobilization of a single-strand (ss) 
oligonucleotide probe onto optical, electrochemical, or mass-sensitive transducers [168]. The probe DNA 
is specific to recognize the complementary DNA (called duplex) target sequence via hybridization 
resulting in a change in the measurable signal. Chen et al. have developed a simple and ultrasensitive 
electrochemical DNA biosensor based on DNA concatamers [169].  
2.6.0 Whole cell biosensor 
The whole-cell biosensor is constructed through the immobilization of cells, microorganisms or bacteria 
that act as sensing element instead of purified enzymes. The sensing element of whole-cell biosensor 
recognizes specific species of interest. Main critical point in the development of the modern cell-based 
biosensors is the immobilization of cells onto transducers in cellular conditions. Olaniran et al. have 
developed a whole-cell bacterial biosensor for rapid and effective monitoring of heavy metals and 
inorganic pollutants in waste water [170]. 
 
2.7 Immobilization of biosensors 
Immobilization or functionalization of biomolecules on a transducer surface is an important step to 
construct a biosensor [171]. The selectivity, stability, sensitivity and reproducibility of the biosensor are 
the dominant parameters that can be improved by determining an effective method for immobilization. 
Various methods have been reported for the immobilization of desired bio-molecules onto solid support 
materials. Figure 2.2.0 describes the various immobilization techniques and Table 2.1.1 summarizes the 
merits and demerits of these techniques.   
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Table 2.1.1: Various methods for immobilization of biomolecules with advantages and disadvantages 
[171]. 
 
Method Advantages Disadvantages 
Entrapment and 
encapsulation 
 Gentle treatment 
 No direct chemical modification 
 Specificity of biocatalyst and 
analyte interaction retained 
 Applicable for small analyte detection 
 High diffusion barrier to both substrate and 
product transport 
 Continuous loss of biocatalyst 
Covalent binding  Low diffusional resistance 
 Strong binding force between 
biocatalyst and matrix 
 Not affected by adverse 
conditions of pH, ionic strength 
 May involve harsh/toxic chemicals 
 Matrix not regenerable 
 Frequently occurring loss of activity 
Cross-linking Used in conjunction with    
entrapment to reduce loss of 
biocomponent activity 
 Harsh treatment with toxic chemicals 
 Covalent linkages formed amongst protein 
molecules rather than matrix 
Adsorption  Gentle treatment of biocatalyst 
 No modification of biological 
component 
 Matrix can be regenerated 
 Maximal retention of activity 
 Very weak bonds 
 Susceptible to changes in pH, temperature, 
ionic strength 
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Figure 2.2.2 Various immobilization techniques for biosensor construction [172]. 
 
 
Figure 2.2.0 Various immobilization techniques for biosensor construction 
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2.8 A brief literature survey of nanostructured metal oxides 
Nanonmaterials, especially nanostructured metal oxides (NMOx) have been extensively explored to 
develop biosensors [172]. Nanoparticles, nanocages, nanobelts, nanotubes, nanofibers, nanorods etc. of 
metal oxides are widely used as a transducer materials for electrochemical biosensors. NMOx have been 
used to catalyze biochemical reactions in the biosensor and have been predicted to exhibit novel 
functions. Consequently, the NMOx are being explored for application in drug delivery, tissue 
engineering, non-invasive sensors, in vitro and in vivo intracellular imaging, and biosensing [172]. The 
common NMOx includes Al2O3, SiO2, TiO2, ZrO2, ZnO, CeO2, MgO, Fe3O4, BaO, CuO, and V2O5 
utilized in the development of biosensor. In biosensor, these NMOx are known to play important role for 
immobilization of biomolecules and direct electron transfer between electrode and electroanalyte. Efforts 
are being made to explore the prospects and future challenges of NMOx for the development of 
microfluidic biosensing devices. To fabricate an efficient microfuidic biosensor, it is critical to select an 
NMOx that is suitable for immobilization of the desired biomolecules. The formation of a bio-interface 
depends on the characteristics of NMOx such as effective surface area, surface charge, biocompatible, 
energy, roughness, porosity, functional groups, and hygroscopic nature. The biomolecules (enzyme, 
antibody, DNA etc.) can bind with NMOx via physical adsorption or covalent interaction. The physical 
adsorption of a biomolecule with NMOx arises due to weak interaction known as Van der Waals 
electrostatic interaction depends on the surface morphology and net surface electric charge. The covalent 
binding of a biomolecule to an NMOx depends on the availability of functional groups that can be 
engineered during the chemical reactions of NMOx preparation. It has been observed that the rate of 
electron transfer depends on the NMOx–biomolecule functionalization. In addition, the microenvironment 
of NMOx can help an enzyme to retain its suitable conformational change that enhances the signal 
transduction and stability. Various NMOx and their biosensing applications have described in the Figure 
2.2.1. Solanki el al. have demonstrated the prospects of various metal oxides in the field of biosensor 
technology [172]. Chang et al. have proposed a high-sensitive detection strategy for carbohydrate antigen 
using a gold/ZnO thin film SPR-based biosensor [173]. Ahmad et al. have developed a highly sensitive 
amperometric cholesterol biosensor based on Pt-incorporated fullerene-like ZnO nanospheres [174]. Xiao 
et al. have described the growth of metal–metal oxide nanostructures on freestanding graphene paper for 
flexible biosensors [175]. Levine et al. developed a real-time, multiplexed electrochemical DNA detection 
using an active complementary metal-oxide-semiconductor biosensor array with integrated sensor 
electronics [176]. Kim et al. have developed an amperometric glucose biosensor based on sol-gel-derived 
zirconia/nafion composite film as encapsulation matrix [177]. Neouze et al. have described the surface 
functionalization of metal oxides nanoparticles using organic ligand [178]. The surface functionalization 
of NMOx plays an important role in attachment of biomolcules as well as in fabrication of the 
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bioelectrode. It can also reduce the aggregation of nanoparticles on a transducer surface. The main 
compounds used for surface functionalization of metal oxide nanoparticles are phosphonates and silanes. 
This may include alkoxysilane, ≡Si–OR (R=alkyl), hydrogenosilane, ≡Si–H, or chlorosilane, ≡Si–Cl, 
reagents. The main advantage of silanes is that they provide numerous functionalities such as amino, 
cyano, carboxylic acid, epoxy groups, etc. However, the surface functionalization may lead to more than 
one step of chemical treatment on biosensor resulting in device complexity. Thus, efforts have been made 
to immobilize biomolecules on desired nanostructure metal oxides surface via electrostatic interaction. 
Among the various NMOx, the two candidates namely TiO2 and NiO have been chosen to be integrated 
with microfluidic biosensor in this work. More details of TiO2 and NiO are described below.  
2.8.1 Titanium dioxide 
Titanium dioxide (TiO2) has attracted much interest in biomedical applications due to their high 
sensitivity and specificity for rapid analyte detection [179-185]. It offers high sensitivity due to their 
tunable band gap (1.8 and 4.1 eV) that depends on its crystal structure. The different crystalline structures 
can be obtained by tuning temperature during annealing. TiO2 has four crystalline polymorphs namely 
rutile, anatase, brookite and titanium dioxide (B). The titanium dioxide has been widely used in 
cosmetics, paints, ointments, toothpaste, etc. Researchers have utilized nanosctrucutred TiO2 in various 
fields such as photovoltaics, electrochromics, battery and electrochemical biosensors. The size and shape 
of nanostructured TiO2 is predicted to play an important role in the construction of the biosensor. The 
high surface area of TiO2 nanoparticles can be used to enhance the biofunctionalization on transducer 
surface. The crystalline nature of nanostructured TiO2 may be used to improve the heterogeneous charge 
transfer between electrode and bulk solution. Viticoli et al. have discussed the direct electron transfer to 
construct a third-generation biosensors using TiO2 nanostructured film. Cao et al. have developed a 
glucose biosensor using three-dimensional (3D) macroporous TiO2. In addition, the nanostructured TiO2 
provides optical transparency, biocompatibility, environmental safety and excellent electrochemical 
conductivity which improve the biosensor characteristics. The good biocompatibility of TiO2 helps to 
decrease the enzyme inactivation rate. Ayob et al. have reported synthesis of TiO2 nanowire for detection 
of DNA [179]. Bao et al. have developed the nanostructured TiO2 for direct electrochemistry and glucose 
biosensor applications [181]. Chavhan et al. have utilized TiO2 platform for detection of ascorbic acid 
[180]. Jardinier et al. used the atomic layer deposition of TiO2 photonic crystal waveguide biosensors 
[182]. Li et al. have developed a glucose biosensor using TiO2 sol-gel derived prussian blue nanoparticles 
[183]. Direct electrochemistry of hemoglobin on vertically aligned carbon hybrid TiO2 nanotubes and its 
highly sensitive biosensor performance has been described by Liu et al [184]. Si et al. have demonstrated 
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hierarchically structured one-dimensional TiO2 for protein immobilization, and mediator-free glucose 
sensing [185]. Nanostructured TiO2 has found wide applications in detection of biomolecules.  
               Nanocomposite materials consist of two or more phases, where one of the phase is in nanoscale 
dimensions. The structure, physical and chemical properties of these composite materials result in unique 
and fascinating mechanical, electrical, thermal, optical, electrochemical, and catalytic properties. Carrara 
et al. have synthesized a nanocomposite material of poly(o-anisidine) and TiO2 for biosensor applications 
[186]. Tak et al. have developed a ZnO–CNT hybrid nanocomposite based urea biosensor [187].  In 
addition, the nanocomposite based on inorganic materials and organic polymers for the fabrication of 
biosensors has been considered recently. Metal oxide-chitosan (bio-polymer) nanocomposite materials 
show the excellent film-forming ability, biocompatibility, non-toxicity, susceptibility to chemical 
modification and cost-effectiveness. It can act as a stabilizing agent for biomolecules immobilization. 
This chitosan polymer material can be used to reduce the agglomeration of metal oxide nanoparticles. 
Feng et al. have used a nanoporous CH–CeO2 nanocomposite matrix for the immobilization of single 
stranded DNA probe for detection of cancer gene [188]. Malhotra et al. have developed the metal oxide–
CH based nanocomposite for cholesterol biosensor [189].  
2.8.2 Nickel oxide 
NiO is a p-type with stable wide band gap semiconducting metal oxide that exhibits anodic 
electrochromism, and is being studied for applications in supercapacitors, smart windows, and dye-
sensitized photocathodes. In addition, NiO (II) is a functional material that has received much attention 
due to its applications in various fields, such as catalysis, fuel cell electrodes, gas sensors, 
antiferromagnetic layers, biosensor and p-type transparent conducting films. Nanostructured NiO has 
aroused much interest for development of health care devices. It provides the large surface area, high 
conductivity, catalytic activity, high carrier mobility, biocompatibility, stability, and excellent 
electrochemical properties. The high isoelectric point (IEP) of NiO (~10.7) can be helpful to immobilize 
biomolecules with low IEP via electrostatic interactions. The nanostructured NiO with different 
morphologies such as nanostrips, nanparticles, nanowires, nanorods, nanoflakes and nanospheres have 
been obtained by various methodologies namely precursor thermal decomposition method, template 
method, calcination, aqueous solution method and chemical co-precipitation method. Salimi et al. have 
described direct electron transfer and electrocatalytic activity properties of glucose oxidase and NiO 
nanoparticles [190]. Pang et al. have demonstrated the selective synthesis of nickel oxide nanowires and 
length effect on their electrochemical properties [191]. Niu et al. have developed a highly sensitive and 
selective nonenzymatic glucose biosensor using three-dimensional porous nickel nanostructures [192]. 
Kavitha et al. have synthesized the high-quality NiO nanorods for electrochemical and antibacterial 
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properties [193]. Xiong et al. have synthesized mesoporous NiO with various hierarchical nanostructures 
by quasi-nanotubes/nanowires/nanorods self-assembly for supercapacitor application [194]. Yadav et al. 
have developed nanostructured NiO film for application to fish freshness biosensor [195]. The attempts 
have been made to synthesize nanostructured NiO via chemical route for biosensing applications. The 
nanoscructured NiO allows direct functionalization with biomolecules due to high isoelectric point (10.6). 
The high surface to volume ratio, excellent electrocatalytic and charge transfer properties of NiO 
improves the biosensor sensitivity and detection limit. In addition, the hydroxide formation [Ni(OH)2] of 
NiO can be easily integrate with microfluidic system to develop a miniaturized analytical device for 
detection of biomolecules.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2.1 Different NMOx and their biosensing applications [172]. 
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2.8.3 Carbon nanotubes 
Carbon nanotubes (CNTs) have attracted much attention in the fabrication of nanodevices [196]. The 
surface chemistry and electronic properties of CNTs make them an ideal material for use in chemical and 
biosensing applications. Single walled carbon nanotubes (SWCNT) and multiwalled carbon nanotubes 
(MWCNT) are both widely used in biosensors. The graphene sheet (one atom- thick sheets of graphite) 
can be rolled up to prepare SWCNT. Structurally, only one cylinder is termed SWCNT whereas multi-
walled carbon nanotubes (MWCNT) consist of two or more concentric graphene cylinders. The graphene 
can wrap along the honeycomb graphene structure and is given by chiral vector    which is a result of a 
pair (n, m) of integers that correspond to graphene vectors        and       . The principle construction of CNTs 
from a graphene sheet along the chiral vector    is shown in Figure 2.2.2(i). It can be formed by rolling a 
graphene sheet into a cylinder along an (m, n) lattice vector in the plane. The key parameters of a 
nanotube are the (m, n) indices which determine the diameter and chirality. The chiral angle between 
hexagons and the tube axis, CNTs can be either metals or semiconductors, with band gaps that are 
relatively large (~0.5 eV for typical diameter of 1.5 nm) or small (~10 meV). The (n, 0) structure is called 
‘‘zigzag’’ and the structure where n = m (n,n) is called ‘‘armchair’’. Another type of CNT construction, 
which can be characterized by the equation where n > m > 0, is called ‘‘chiral’’. The chirality determines 
the mechanical, electronics, optical etc. of CNT. The diameter of CNTs varies from a few nanometres in 
the case of SWCNT to several tens of nanometres in the case of MWCNT. The structure of MWCNT is 
shown in Figure 2.2.2(ii). The lengths of the CNT are usually found in the micrometre range. Timur et al. 
have developed of a microbial biosensor based on CNTs modified electrode [197]. Martinez et al. have 
demonstrated a label-free DNA biosensors based on functionalized CNTs field effect transistors [198]. 
Abdolahad et al. a vertically aligned CNT-based impedance biosensor for rapid and high sensitive 
detection of cancer cells [199]. Wang et al. have reviewed CNTs based electrochemical biosensors [200]. 
The unique properties of CNTs make them extremely attractive biosensor field and electrochemical 
detection. 
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Figure 2.2.2 (i) The principle of CNT construction from graphene sheet along the chiral vector    [201] 
and (ii) MWCNT (www.turbosquid.com). 
 
 
 
 
 
 
 
 
 
 
 
 
 
(i) (ii) 
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The multifunctional properties of CNTs would result in improved efficacy of biosensor 
fabrication. CNTs are known to be an exciting material due to their flexibility, enhanced electrical 
conduction and act as a mediator for desired electrochemical biosensing. It improves the electro-activity 
of biomolecules leading to fast electron transfer. The chemical treatment of CNTs sidewalls might 
provide an additional impetus towards functionalization of biomolecules. This covalent interaction makes 
the enhanced performance of high enzyme or antibody loading. I have chosen CNTs (multiwalled) to 
construct the microfluidic device for point-of-care application due to low cost and ease of synthesis. 
CNTs may act as nanoelectrode that can be integrated with biomolecules to communicate with the outside 
environment by electron transportation. Therefore, the electronic properties of CNTs can be advantageous 
for chemical functionalization with a moiety and altering the structure whose intrinsic properties are 
electrically tunable. However, the poor solubility of CNTs in an aqueous media continues to be a concern. 
In order to improve the dispersion or agglomeration of CNTs, I have focused to integrate metal oxide 
(such as NiO) with CNTs. Ayala et al. decorated carbon nanotubes with nanostructured nickel particles 
via chemical methods [202]. Zhu et al. have used the CNTs beaded with ZnO nanoparticles for ultrafast 
nonlinear optical switching [203]. Zhang et al. have developed a highly sensitive nonenzymatic glucose 
sensor has been developed based on CNT-NiO [204]. Claussen et al. have reported an electrochemical 
biosensor of nanocube-augmented CNT networks [205]. The fabrication and results of the CNT-NiO 
nanocomposite based microfluidic biochip are described in Chapter 4 and 6. 
2.9 Conclusions 
This Chapter illustrates the basic principles towards the construction of microfluidics and biosensors. The 
literature surveys for microfluidics and biosensors have been discussed. A detailed overview of 
biosensors and various immobilization techniques have been described. Applications of nanostructured 
materials in fabrication of biosensors have been explained. In particularly, the role and importance of 
nanostructured metal oxides such as TiO2, NiO and composites materials (TiO2-CH, CNT-NiO) and their 
integration with biological as well as microfuidic systems have been described. In the next Chapter, the 
different materials, methods and various characterization tools used in experimental studies are discussed. 
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3.1 Introduction 
This Chapter gives a broad overview of various materials, fabrications and different characterization tools 
that have been adopted in this thesis for the development of microfluidic biosensors. The Chapter begins 
with the description of how PDMS microchannels can be fabricated using soft lithography. The various 
steps followed in the fabrication of PDMS microchannels have been discussed. Additionally, the steps 
involved in establishing microelectrodes for the biosensors have been explained. Modifications of the 
microelectrodes for various application including biofunctionalization using various nanostructured 
materials and composites such as TiO2, NiO, TiO2-CH and CNT-NiO are the major highlight of this 
chapter. The experimental techniques used for the synthesis of the nanostructured materials as well their 
surface modification have been explained. This is followed by description of all experimental protocols 
and procedures involved in biofunctionalization of electrodes. A discussion and justification on the 
various tools such as ultraviolet-visible spectroscopy (UV-Vis), Fourier transform infrared spectroscopy 
(FT-IR), X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), Zeta potential, Raman 
spectroscopy, transmission electron microscopy (TEM), atomic force microscopy (AFM) and scanning 
electron microscope (SEM)  that are employed for the characterization of these synthesized materials, has 
been added in this chapter.   Finally, efforts have been made to discuss the various electrochemical 
techniques such as chronoamperometric, cyclic voltammetry and impedance spectroscopy employed to 
characterize the developed microfluidic biosensor devices.  
3.1.1 Fabrication of PDMS microchannels  
Photolithography is a binary pattern transfer technique, where there is no gray-scale, color, or depth 
transferred to the image. Photolithography is an optical technique for transferring pattern onto a 
photosensitive substrate. It is similar to the lithographic printing process. Patterns are first transferred to 
an imagable photoresist layer.  Photoresist is a liquid that can be spread out onto a substrate, exposed with 
a desired pattern, and developed into a selectively placed layer for subsequent processing [206].  
The PDMS microfluidic channels (rectangular) have been fabricated by soft lithography 
technique [207]. It is termed as soft because of the use of soft elastomeric materials such as PDMS, 
PMMA etc. In soft lithography, instead of using a rigid photomask, a patterned elastomer is used as a 
stamp, mold, or mask to create the micro-patterns/structures. Replica molding, micro-contact printing, 
micromolding, and micro-transfer molding are some of the popular methods that are used in soft 
lithography. Figure 3.1.1 shows the schematic diagram of the creation of PDMS microchannel. Stepwise 
fabrication process has been described below. 
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 3.1.2 Mask fabrication 
Auto computer-aided design (AutoCAD
TM
) software has been used to design various masks needed for 
PDMS microchannel fabrication. The desired digitally designed mask is printed on to an optical 
transparency sheet using a high-resolution printer.  
3.1.3 SU-8 photoresist  
There are two types of photoresist namely positive and negative. In positive, the photoresist is exposed 
with UV light, wherever the underlying material has to be removed. The UV light changes the chemical 
structure of the resist so that it becomes more soluble in the developer solution. The exposed resist is then 
washed away by the developer solution, leaving windows of the bare underlying material. Therefore, the 
mask contains an exact copy of the pattern that remains on the Si wafer. In the case of negative resists, 
exposure to the UV light causes the negative resist to get polymerized, and more difficult to dissolve. 
Therefore, the negative resist remains on the surface wherever it is exposed, and the developer solution 
removes only the unexposed portions. Mask used for negative photoresist, therefore, contains the inverse 
of the pattern to be transferred [Figure 3.1. 2(a)].  
SU-8 is an epoxy-based photoresist [Figure 3.1. 2(b)] viscous polymer that is used to print 
microstructures of high aspect ratio (> 20).  The SU-8 has a maximum absorption for ultraviolet light at a 
wavelength of 365 nm (g-line). On exposure it undergoes a long molecular chain cross-linking causing 
the solidification of the material under exposure. Gamma butyrolactone is the primary solvent of SU-8 
series. It is highly transparent in the UV region and can allow thick (hundreds of micrometers) 
microstructures with nearly vertical side walls. After exposure and development, its highly cross-linked 
microstructure gives the material high stability against chemicals and radiation damage. 
The SU-8 photoresist (negative) is first spun onto a Si wafer using the photoresist spinner at a 
speed that achieves the required thickness. In order to get a 100 μm thick layer of SU-8 using SU-8 100, 
the wafer is spun at 500 rpm for 5 s, to spread out the photoresist, then at 1500 rpm for 30 s, to achieve 
the final thickness. The wafer should then be soft baked for the required time at the required temperature. 
The soft bake time is 10 min at 65°C, and 30 min at 90°C. The two-step baking is carried out to reduce 
internal stresses owing to thermal effects. 
3.1.4 Exposure 
The photomask is used to clamp between the Si/SU-8 substrate and a blank glass plate. The photoresist is 
exposed in a UV light at a dose of 400 mJ/cm
2
.  
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3.1.5 Post exposure bake 
A post-exposure baking is performed to crosslink selectively the exposed portions of the photoresist for 1 
min at 65°C and 10 min at 95°C. 
3.1.6 Development 
SU-8 developer is poured in a beaker, and a spray bottle with new SU-8 developer is prepared. The 
sample is developed in the SU-8 developer until all unexposed SU-8 is removed. To determine whether 
all the unexposed SU-8 is removed, the sample is removed from the beaker, rinsed with new developer, 
rinsed with isopropyl alcohol, and then blown dry gently with nitrogen air. 
3.1.7 PDMS molding 
PDMS is a group of polymeric organosilicon compounds that is referred to as silicones. The chemical 
formula for PDMS is CH3[Si(CH3)2O]nSi(CH3)3, where n is the number of repeating monomer 
[SiO(CH3)2] units and is shown in Figure 3.1. 1. The PDMS oligomer and crosslinking prepolymer of 
PDMS agent from a Sylgard 184 kit is mixed in a ratio of 10:1. A convenient way of mixing these agents 
is to place both in a disposable plastic bag, heat seal, and mix manually. The mixture can then be placed 
under vacuum for degassing. The PDMS mixture is poured onto Si/Su-8 mold and cured for 1 h at 65°C. 
After cooling, the PDMS can be carefully peeled off from the mold. This process creates a microchannel 
of the desired pattern. In our case, the channel height and width are 200 µm each and the length is 2 cm. 
The microchannel having reservoirs at the end are fabricated by punching holes at desired position in the 
PDMS slab. The PDMS film is sealed to a flat glass electrode surface to complete the microfluidic 
channel. If these are immediately pressed together, a tight bond will be created [Figure 3.1.3]. Otherwise, 
oxygen plasma can be used to treat both the glass substrate and the PDMS film for tight-sealing the 
channel. 
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Figure 3.1.1 Schematic representation of step by step PDMS microchannel fabrication using SU 8 
negative photoresist. 
 
 
 
 
 
 
 
 
Figure 3.1.2 (a) After exposing the photoresist pattern on Si wafer (negative and positive tone) and (b) 
chemical structure of SU 8. 
 
 
(a) (b) 
PDMS 
63 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.3 Photograph of a PDMS microchannel 
 
Figure 3.1.4 ITO patterning via wet chemical etching process 
Microchannel 
PDMS 
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3.1.8 Precautions  
i. The aligner has the ability to align masks to the existing patterns for multiple exposure steps. 
ii. All bake times are given with respect to baking on a hot plate. 
iii. Handle and store under nitrogen. This material has an extremely low flash point (–18°C). 
iv. After all baking steps, the sample must be allowed to cool slowly (at least 15 min) to room 
temperature before any further processing is done, to reduce internal stresses. This thermal 
relaxation time is crucial for survival of the mold. 
3.2 Wet chemical etching  
Chemical etching technique is used to remove layers selectively from the desired substrate. It is a low cost 
and easy process widely used in microfabrication [208]. In chemical etching, the masking material is a 
photoresist which can be patterned using photolithography. This technique is used for etching ITO in 
order to fabricate microfluidic electrode. 
3.2.1 ITO (In2O3:SnO2) etching by chemical Process 
Patterned microelectrode of dimensions 0.2×2.5 cm
2
 is fabricated onto indium tin oxide (ITO) coated 
glass slide (2.5×3.5 cm
2
) by wet chemical etching process using ITO etchant [Hydrochloric acid (HCl) + 
nitric acid (HNO3) + water (H2O) (1:0.1:1) at 40 °C] [209]. For this process, ITO glass substrate is 
masked with the commercially available cello masking tape film. The masking tape is removed from 
entire substrate accept the desired two patterned ITO electrode (electrode dimension: 0.2×2.5 cm
2
) using a 
sharp razor blade. After masking, the substrate is dipped on ITO etchant for 15 min. This etchant is 
selectively used to etch the ITO from the entire substrate and the ITO etchant cannot react with the 
masked area. Thus, after etching, the remaining mask is removed to form patterned ITO electrode on 
glass substrate. Various steps of chemical etching have been illustrated in Figure 3.1.4. 
3.2.2 ITO etching using photolithography  
Photolithographic technique has been used for the fabrication of patterned ITO microelectrodes with help 
of wet chemical method. Two patterned microelectrodes comprising of dimensions (0.2×2.5 cm
2
) have 
been prepared on ITO coated glass slide of size 2.5×3.5 cm
2
 by photolithographic technique. The ITO 
glass is cleaned with acetone prior to use. First, the positive photoresist (Shipley 1811) is spin coated onto 
ITO glass substrate at 3000 rpm for 20 s. In order to remove solvent, the photoresist coated substrate is 
soft baked using a hot plate for 1 min. Then, the substrate is exposed to UV radiation for 5 min through a 
given optical mask (high resolution black printed transparent sheet). The substrate is dipped in a positive 
photoresist developer solution for 10s to develop the pattern. The chemical ITO etchant (Zinc dust + HCL 
solution 15%) is used to etch ITO from exposed region [210]. After, ITO etching the remaining 
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photoresist onto ITO is removed by acetone. This patterned ITO electrode is then cleaned with acetone 
via sonication for 10 minutes and then with dichloromethane for 10 minutes, and finally washed 
thoroughly with water several times. These clean electrodes are placed in a vial wherein a mixture of 
H2O:H2O2 (30%):NH3 (25%) (5:1:1) is added and stirred for 1 h at 70
0
C. Then, the slides are washed with 
plenty of water and dried in an oven at 100
0
C for 4 h. 
Optically transparent ITO electrode has excellent chemical functional property for the fabrication 
of microfluidic biosensors. The surface of ITO coated substrate can be easily hydrolyzed or hydrophilic 
via chemical treatment (H2O:H2O2 :NH3) by introducing OH groups and can be directly modified by sol 
gel metal oxide via electrostatic interaction. Thus, ITO electrode is a suitable candidate for deposition of 
sol gel nanoparticles and immobilization of biomolecules in order to fabricate microfluidic biosensor. 
3.3 Chemical synthesis of nanomaterials 
Various methods for preparation of metallic and metal oxides nanoparticles like different gas phase and 
vacuum methods have been reported since the early 1980s [211, 212]. There are many methods for 
preparation of nanomaterials, including both attrition and pyrolysis. In attrition, macro- or micro-scale 
particles are kept in a ball mill, or a size-reducing mechanism. In pyrolysis, a vaporous precursor (liquid 
or gas) is enforced through an orifice at high pressure and burned. Pyrolysis often results in aggregates 
and agglomerates rather than single primary particles. Interestingly, chemical route for the synthesis of 
nanoparticles including sol-gel technique and colloidal synthesis route has also been developed. These 
materials possessed many attractive properties which are attributed to the high volume fraction of 
interfacial structures that are dissimilar from the crystalline structures of the core [211, 212]. The studies 
have been extended to nanocomposites, and very interesting properties with respect to toughness and 
strength have been reported [212]. Additionally, nanostructured powders attained through flame pyrolysis 
process have been commercialized for a long time, e.g. SiO2 or TiO2. Nanoparticles prepared through 
colloidal chemistry in liquid environments, industry (e.g. the fabrication of water glass), and also in 
biology. The stability of colloidal nanoparticles plays an important role in industrial and biosensing 
applications. The electrostatic stabilization is one of the mechanisms arising from van der Waals 
attraction and is counterbalanced by the repulsive Coulomb forces acting between the negatively charged 
colloidal particles in order to prevent the aggregation of the colloidal particles.  The use of this chemical 
colloidal route show the ways to interesting concepts for the research on nanomaterials synthesis.  
            The sol-gel process is a wet-chemical technique (also acknowledged as chemical solution 
deposition) broadly used in the fields of materials and biomedical science. These techniques are used 
primarily for the fabrication of metal oxides starting from a chemical solution (sol, abbreviated for 
solution), which proceeds as the precursor for an integrated network (or gel) of either discrete particles or 
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network polymers.  In all these studies, typical precursors are metal alkoxides and metal chlorides, which 
experiences hydrolysis and polycondensation reactions to figure either a elastic solid network or a 
colloidal suspension (or dispersion)  which is  a system composed of discrete (often amorphous) 
submicrometer particles dispersed to various degrees in a host fluid. The idea of zeta potential tailoring 
the surface modification for compatibility or specific reactivity is mentioned only in very few literatures. 
To facilitate a sufficient amount of dispersion, the particle surface should be compatibilized to the matrix 
and surface modification of the nanoparticles turn out to be a crucial means for the advance of suitable 
processing routes, or, reactive monomers are initiated into a given polymer, nucleation and growth have 
to be directed. This critical size range (or particle diameter) typically ranges from nanometers (10
−9
 m) to 
micrometers (10
−6
 m). 
3.3.1 Sol gel method 
Sol-gel method is a wet chemical process for synthesis of colloidal dispersions of inorganic and organic-
inorganic nanomaterials such as oxides and oxide-based nanohybrids [213]. Although the fabrication of 
different forms of final products requires some specific considerations, the fundamentals and general 
approaches in the synthesis of colloidal dispersions are the same. Sol-gel process offers many advantages, 
including low processing temperature and molecular level homogeneity. Sol-gel process is particularly 
useful in making complex metal oxides, temperature sensitive organic-inorganic hybrid materials, and 
thermodynamically unfavorable or metastable materials.  
          Typical sol-gel process consists of two steps namely; hydrolysis and condensation of precursors 
[214]. Precursors can be either metal alkoxides or inorganic and organic salts. Organic or aqueous 
solvents may be used to dissolve precursors, and catalysts are often added to promote hydrolysis and 
condensation reactions [Eq. (3.1.1 & 3.1.2): 
Hydrolysis: 
                                                                                                            Eq. 3.1.1 
Condensation: 
                                             MOM                  O       Eq.3.1.2 
Hydrolysis and condensation reactions are both multiple-step processes, occurring sequentially 
and in parallel. Each sequential reaction may be reversible. Condensation results in the formation of 
nanoscale clusters of metal oxides or hydroxides, often with organic groups embedded or attached to 
them. These organic groups may be due to incomplete hydrolysis, or introduced as non-hydrolysable 
organic ligands. The size of the nanoscale clusters, along with the morphology and microstructure of the 
final product, can be tailored by controlling the hydrolysis and condensation reactions. 
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3.3.2 Chemical and reagents 
The curing agent (Sylgard 184) has been obtained from Dow Corning (Midland, MI, USA). SU8-100 
negative photoresist, positive photoresist (Shipley-1818) and SU8 developer have been purchased from 
Microchem (Newton, MA, USA). ITO coated glass slides of thickness ~150-300 Å having a resistance of 
50 Ω/sq have been procured from Vin Karola Instruments. Titanium (IV) butoxide, chitosan, 2-methoxy 
ethanol, nickel nitrate [Ni(NO3)2].H2O, potassium hydroxide (KOH),  have been purchased from Sigma 
Aldrich, USA.  
The desired chemicals such as titanium (IV) butoxide, 2-methoxy ethanol, chitosan powder, 
nickel nitrate and potassium hydroxide have been purchased from Sigma Aldrich, USA. All biological 
chemicals such as cholesterol, cholesterol oxidase, cholesterol esterase, low density lipoprotein (LDL; 
MW: 3500 kda), apolipoprotein B-100 (AAB; MW: 515 kda), bovine serum albumin (BSA), N-
hydroxysuccinimide (NHS), N-ethyl-N0-(3-dimethylaminopropyl carbodiimide) (EDC) are of analytical 
grade and have been purchased from Sigma Aldrich. The surfactants such as polidocanol (Brij) and 
ethylenediaminetetraacetic acid (EDTA) have been purchased from Sigma Aldrich, USA.  
3.3.3 Sol-gel synthesis of anatase-TiO2 
Typical precursors are metal alkoxides and metal chlorides that undergo hydrolysis and poly condensation 
reactions to form a colloid of solid nanoparticles dispersed in a solvent. Sol-gel derived materials have 
diverse applications in optics, electronics, energy, space, biosensors, medicine (e.g., controlled drug 
release) and separation (e.g., chromatography) technology. Many researchers have employed sol-gel 
technique for fabrication of nanostructured metal oxide films on solid substrates for sensing applications 
[215].  
             To synthesize TiO2 nanoparticles, the starting material, i.e. titanium (IV) butoxide is dissolved in 
2-methoxy ethanol in order to prepare 5(wt%) precursor sol solution. The resulting sol is then hydrolyzed 
by drop wise addition of catalytic amount of H2O and nitric acid under continuous stirring. After 
completion of the hydrolysis, the sol is kept for aging for about 2 h at ambient temperature to polymerize 
the gel. The obtained transparent sol-gel solution is used to deposit film onto patterned ITO electrode on 
glass substrate using dip coating method. The TiO2 films are initially dried at an intermediate temperature 
of ~110
o
C for half an hour and finally annealed at 450
o
C for 2 h in air atmosphere. The proposed 
reactions involved in the synthesizes of TiO2 films onto ITO substrate are shown in Eq. 3.1.3. Figure 
3.1.5 shows the schematic representation of the crystalline structure of TiO2. 
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Figure 3.1.5 Schematic representation of the crystalline structure of TiO2  [216]. 
 
 
 
 
 
 
 
 
 
69 
 
3.3.4 Synthesis of chitosan (CH) and anatase-TiO2 composite 
The chemical structure of CH is shown in Figure 3.1.6. It is a linear polysaccharide composed of 
randomly distributed β-(1-4)-linked D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine 
(acetylated unit) [217]. It can be prepared by treating shrimp and other crustacean shells with the alkali 
sodium hydroxide. A CH (0.50%) solution is prepared by dissolving CH (50 mg) in 100 mL of acetate 
buffer (0.05 M, pH 4.2) solution. Calculated amount of anatase TiO2 (antTiO2) nanoparticles is dispersed 
in the CH solution (5 mg/ml) by stirring at room temperature and is sonicated for 30 minutes. A highly 
viscous solution of CH with uniformly dispersed antTiO2 nanoparticles is obtained. The selective 
deposition of antTiO2-CH solution is carried out on this fabricated patterned ITO electrode through a dip 
coating technique. Initially, the glass substrate with ITO microelectrode is masked using masking tape 
and only the desired electrode is selectively exposed by removing the masking tape over it. The substrate 
is then dried at 40°C for about 1 h after which the remaining masking tape film is removed from the 
substrate. This process results in a glass substrate containing antTiO2-CH/ITO (unmasked region) and 
bare ITO electrode (masked region). The antTiO2-CH/ITO film is washed with deionized water to remove 
any unbound particles. 
 
 
 
 
 
 
 
Figure 3.1.6: Chemical structure of chitosan 
 
 
 
 
 
 
70 
 
3.3.5 Co-precipitation method 
Co-precipitation is defined as the precipitation of one compound simultaneously with one or more other 
compounds to form mixed crystals [218]. Nanostructured metal oxides with controlled size, shape and 
structure can be synthesized using chemical, physical and biological routes. Among the various 
techniques, co-precipitation method for the synthesis of nanoparticles have become very popular and 
gained wide acceptance. The chemical synthesis of nanomaterials involves three steps, namely nucleation, 
growth and termination of reaction via precipitation of required precursor ion in solution phase. Reaction 
temperature and reagent conditions provide a rudimentary control of these three steps. The control of 
shape, size, stability and assembly of nanoparticles are achieved by incorporating different solvents, 
templates and capping agents such as polymeric molecules and biomolecules. The co-precipitation 
process is a very suitable method for synthesis of oxide powders. The main components of a solution 
consist of a solute and a solvent. Solution may be homogeneous mixtures (a physical combination of 
substances), which can be solid, liquid, or gas. There are three main mechanisms of co-precipitation 
namely; inclusion, occlusion, and adsorption. An inclusion happens when the impurities occupy a lattice 
site in the crystal structure of the carrier, known as crystallographic defect. This can occur when the ionic 
radius and charge of the impurity are similar to that of the carrier. An occlusion happens when an 
adsorbed impurity becomes physically trapped inside the crystal as it grows. An adsorbate is an impurity 
that is weakly bound (adsorbed) to the surface of the precipitate.  
3.3.6 Co-precipitated synthesis of nanostructured nickel oxide (nNiO)  
nNiO can be prepared using sol-gel, reverse-micelle, laser induced fragmentation and microwave 
irradiation techniques.
  
The controlled growth and high aspect ratio of synthesized nanowires is a 
challenge for functionalization with biomolecules including antibodies. The nNiO film has recently been 
used for immobilization of single stranded DNA via electrostatic interactions for Kala-azar detection 
[219]. A composite of NiO–CH based cholesterol biosensor has recently been reported via immobilization 
of cholesterol oxidase [220]. 
In order to synthesize nNiO [221], the nickel nitrate {Ni(NO3)2·6H2O; 0.5 M} and 0.2 M of 
potassium hydroxide (KOH) are dissolved in  deionized water to which KOH solution is added drop wise 
with constant stirring at room temperature (25
o
C) until pH 9.0 is reached. A green precipitate of Ni(OH)2 
thus obtained is centrifuged followed by washing with deionized water until neutral pH is achieved. This 
solution was dried at 80 ºC overnight. A nickel hydroxide gel is formed as shown in the reactions below. 
The Ni(OH)2 based films are calcinated at 400°C for about 2 h to form nNiO. 
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                Ni(NO3)2 + 2KOH                    Ni(OH)2 + 2 K(NO)3                                                                                       Eq. 3.1.4 
                      Ni(OH)2                                            nNiO + H2O                               Eq. 3.1.5 
A transparent viscous solution of nNiO is obtained on the ITO coated glass plate via dip-coating 
technique. To control the shape of nNiO, we have optimized the pH value of Ni(OH)2  solution before 
calcination. 
 
3.3.7 Synthesis of carbon nanotubes   
Precursors such as xylene, methane, ethylene, acetylene, benzene, and carbon monoxide are most 
commonly used for synthesis of MWCNT. Chemical vapor deposition (CVD) is one of the most popular 
methods for producing CNTs [222]. In this technique, thermal decomposition of a hydrocarbon vapour is 
achieved in the presence of a metal catalyst [Figure 3.1.6]. It is also known as thermal CVD or catalytic 
CVD and offers better control on the growth parameters. The process involves passing a hydrocarbon 
vapor (typically 15–60 min) through a tubular reactor in which a catalyst material is present at sufficiently 
high temperature (600–1200 °C) to decompose the hydrocarbon. CNTs grow on the catalyst in the 
reactor, which are collected upon cooling the system to room temperature. Volatile materials (ferrocene) 
directly turn from solid to vapor, and perform CVD while passing over the catalyst kept in the high-
temperature zone. Pyrolysis of the catalyst vapor at a suitable temperature liberates metal nanoparticles 
in-situ (process is known as floating catalyst method). Alternatively, catalyst coated substrates can be 
placed in the hot zone of the furnace to catalyze the CNTs growth. The CNTs (90%) are synthesized by 
catalytic CVD using a mixture of ferrocene acting as catalyst and toluene as a hydrocarbon source [222].
 
These CNTs are purified and functionalized through refluxing in concentrated nitric acid/sulphuric acid 
solution, generating a large number of COOH groups on the nanotubes surface.  
3.3.8 Synthesis of CNT-NiO composite 
Drop-wise addition of 0.2 M KOH (potassium hydroxide) solution along with COOH-terminated CNT to 
0.5M Ni(NO3)2·6H2O (nickel nitrate) solution in de-ionized water with constant stirring results in 
blackish green precipitate of nickel hydroxide [Ni(OH)2] at pH of ~11.8. Excess solvents are evaporated 
resulting in the precipitate that is dried at 80
o
C for 24 h resulting in a transparent viscous solution of 
nickel hydroxide modified CNT. This precipitate is maintained at pH 10.0. The thick gel-like Ni(OH)2 
modified CNT solution is deposited onto patterned ITO electrodes on glass substrate via dip coating. The 
electrodes are initially dried at ~110
o
C for about 1 h and finally annealed at 400
o
C in ambient conditions 
for about 2 h to remove any solvent resulting in the formation of CNT(0.1%)-NiO and CNT(0.2%)-NiO 
onto ITO surface. 
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3.4 Characterization techniques 
The prepared nanoparticles, composites based electrodes/bioelectrodes have been characterized using 
various spectroscopic techniques such as UV-Vis, FT-IR, Raman, XRD, Zeta potential and XPS. The 
different microscopic techniques such as SEM, AFM and TEM have been used to characterize the 
fabricated microfluidic electrodes. Electrochemical studies such as CV, chronoamperometry (CA), 
chronocoulometry (CC) and EIS techniques have been carried out to investigate the electrochemical 
properties and detection of biomolecules. 
3.4.1 UV-Vis spectroscopy 
The absorption or reflectance spectroscopy uses light in the visible and adjacent (near-UV and near-
infrared) ranges [223]. In the region of electromagnetic spectrum, the molecules undergo an electronic 
transition resulting in the changes of electronic structure of ions through the excitations of bonded and 
non-bonded electrons. In this process, the promotion of electrons happens from the ground state to higher 
energy states. For visible and ultra-violet spectrum, electronic excitations occur in the range 200-900 nm. 
There are many factors which influence the relative energies of molecular orbitals (i.e., solvents, 
position/conformation of substituents, etc.) and information of these factors is necessary in electronic 
spectroscopy. The strength of electronic spectroscopy lies in its ability to measure the extent of multiple 
bond or aromatic conjugation within molecules or macromolecules. Longer the conjugation, longer is the 
maximum wavelength of the absorption spectrum. It can be useful to identify the conducting state of 
metal oxide nanoparticles as well as carbon materials. The technique is used in a quantitative way to 
determine concentrations of an absorbing species in solution, using the Beer-Lambert law [Eq. 3.1.7]. 
                                                                                                                                           Eq. 3.1.6 
where, A is the measured absorbance,    is the intensity of the incident light at a given wavelength, I is 
the transmitted intensity, L the pathlength through the sample, and c the concentration of the absorbing 
species. For each species and wavelength,   is a constant known as the extinction coefficient. The 
absorbance of nanoparticles is found to decrease as particle size decreases resulting in a sharp increase of 
the binding energy. It is a very useful technique to compare between bulk and nanomaterials as well as 
particles size estimation using effective mass approximation model.  
                                                           
 
  
 
 
  
  
     
  
                                             Eq. 3.1.7    
where, ΔE is the increase of the band gap energy,   =5.7 is the relative dielectric constant, and me =0.19 
m0 and mh =0.8m0 are the effective masses of electrons and holes, respectively.  
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In our studies, the UV-visible spectroscopy has been used to confirm the formation of sol-gel 
derived nanostructured TiO2, TiO2-CH, NiO, CNT, and CNT-NiO and find their band gap energies. These 
measurements have been carried out using a UV-visible spectrophotometer (Perkin Elmer, Lambda 950) 
with the resolution of 0.05-5 nm (NIR resolution: 0.2-20 nm) in the wavelength range from 175-3300 nm 
using Deuterium and Tungsten halogen light sources. Figure 3.1.6(i) shows an example of the absorption 
spectrograph obtained from cysteine capped cadmium sulfide (Cys-CdS).  It has been found that the value 
of the radius of Cys-CdS quantum dots is about 4-6 nm. 
3.4.2 Fourier transform infrared (FT-IR) spectroscopy 
FT-IR technique provides information about the various functional groups present in the compound [224]. 
It involves absorption of electromagnetic radiation in the infrared region of the spectrum, which results in 
changes in the vibration energy levels of molecule. The FT-IR spectrum represents the molecular 
absorption and transmission, creating a molecular ﬁngerprint of the sample. Usually, most molecules have 
vibrations in the form of stretching, bending etc. FT-IR is an interesting technique in identifying organic 
compounds that have polar chemical bonds (such as OH, NH, CH etc.) with good charge separation 
(strong dipoles). A Michelson interferometer [Figure 3.1.8(i)] is used for the FT-IR measurement. Light 
from the polychromatic infrared source is collimated to a beam splitter, where, 50% of the light is 
refracted towards a fixed mirror and 50% is transmitted towards a moving mirror. Light is reflected from 
the two mirrors back to the beam splitter and 50% of the original light passes into the sample. One beam 
travels through a ﬁxed length and the other is constantly changing as the mirror moves, the signal which 
exits the interferometer is the result of these two beams “interfering” with each other. The resulting signal 
is called an interferogram and is measured with all frequencies simultaneously. The measured 
interferogram signal cannot be interpreted directly. Thus, the decoding of the individual frequencies is 
required and can be accomplished via the well-known mathematical technique called the Fourier 
transformation. This transformed spectrum can be used for desired analysis. 
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Figure 3.1.7 The absorption spectra of Cys-CdS quantum dots using UV-visible spectrophotometer 
model, Perkin Elmer, Lambda 950  
 
 
 
 
 
 
 
Figure 3.1.8 (i) Schematic diagram of the operation of FT-IR, Perkin-Elmer, Model 2000 
(www.gasera.fi), and (ii) FT-IR spectra of reduced graphene oxide film. 
 
In this thesis, the FT-IR measurements have been carried out to confirm the presence of metal 
oxide nanoparticles, composites and their functionalization with biomolcules such as enzymes, antibodies 
etc. Since every functional group has a unique vibration energy, the IR spectra is indication of their 
fingerprints. The prepared samples have been characterized using this technique and their descriptions 
have been included in the results and discussion sections. A FT-IR spectrum of reduced graphene oxide 
(ii) (i) 
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(rGO) film is shown in Figure 3.1.8 (ii) as an example. The peaks seen at 1600-1700 cm
-1
 is indication of 
the functional COOH groups on rGO. 
3.4.3 Raman spectroscopy 
Raman spectroscopy allows the detection and identification of molecules through their unique vibrational 
and rotational energy level structures [225]. When a strong light source (laser) is focused on a substance, 
most of this energy will be scattered elastically. This process is called Rayleigh scattering. The molecules 
of the substance get excited to a virtual electronic state and would immediately fall back to their original 
state by releasing a photon [Figure 3.1.9(a)]. The energy of this scattered photon is equal to that of the 
incoming light. A molecule may also fall back from an excited electronic state to an energy state that is 
higher (Stokes type scattering) or lower (anti-Stokes type scattering) than the original state. The 
difference in energy between the incoming and scattered photon (Raman shift) corresponds to the energy 
difference between vibrational energy levels of the molecule. The different vibrational modes of a 
molecule can therefore be identified by recognizing Raman shifts (or ‘bands’) in the inelastically scattered 
light spectrum [Figure 3.1.9(a)]. 
A wide variety of substances such as minerals, organic molecules, fluids, gases etc. can be 
identified directly through Raman studies. The Raman scattering is effective for covalent bonds, and very 
weak for ionic bonds. However, the infra-red spectroscopy also measures the vibrational energies of 
molecules. The absorption of light in the infrared region of the spectrum, offers a spectrum that 
corresponds to specific vibrational modes. For Raman active molecules, there should be a change in the 
polarizability of the molecule during the vibration indicating that molecules undergo a positional change. 
FT-IR active molecules should undergo dipole moment change during their vibrations. Thus, when a 
molecule is symmetrical, e.g. O2, no FT-IR absorption peaks can be observed, since the molecule cannot 
change its dipole moment. Figure 3.1.9 (a) shows a simplified energy level diagram for Raman 
spectroscopy. Raman spectra of pristine CNTs and COOH functionalized CNTs shown in Figure 3.1.9(b). 
It can be seen that the intensities of the disorder and graphidic peaks are changed due to functionalization 
of CNTS. 
 
3.4.4 X-ray diffraction (XRD)  
In order to investigate the crystallographic structure, crystalline size (grain size) and preferred growth 
orientation of nanostructured samples, the XRD technique has been used. The XRD pattern can be 
recorded using an X-ray diffractometer, wherein the peak broadening data are obtained by measuring the 
average of peak broadening in the five strongest diffraction peaks. The mean crystallite size can be 
76 
 
determined from the peak broadening in the X-ray diffraction spectrum using the Debye-Scherrer Eq. 
3.1.7    
                                                               D = 0.9λ /β cos θ                                                                 Eq. 3.1.7    
where, D is the average crystallite size (Å), λ is the wavelength of X-rays (Cu Kα: λ = 1.5418 Å), θ is the 
Bragg diffraction angle, and β is the full width at half maximum (FWHM) (in radians).  
For a crystalline solid sample, the beams are scattered from lattice planes separated by a distance 
d (interplanar). The scattered waves interfere constructively, but they remain in phase since the path 
length of each wave is equal to an integer multiple of the wavelength. The path difference between two 
waves undergoing scattering is given by 2 d sinθ, where θ is the scattering angle. The condition for 
constructive interference from successive crystallographic planes (h, k, and l) of the crystalline lattice, is 
given by Bragg’s law, as 
                                                                       θ   λ                                                                 Eq. 3.1.8    
where, n is an integer, and λ is the wavelength. The diffraction pattern may obtained by measuring the 
intensity of scattered waves as a function of scattering angle. The intensities known as Bragg peaks are 
obtained in the diffraction pattern, when scattered waves satisfy the Bragg condition [Figure 3.2.1]. 
XRD measurements have been carried out using the model: Max 2200 diffractometer, Rikagu 
with Cu Kα radiation of 1.54 Å. The voltage and the current of X-ray tube were 40 KV and 40 mA, 
respectively. A step scanning is performed with a step size of 0.01
o
/step and the integration time of 8 
s/step to get noise free XRD graph.  
3.4.5 Scanning electron microscopy (SEM) 
SEM is a very useful technique and widely used to study the surface morphology and topography. It 
provides high-magnification and can have resolution of a few nanometers. Tungsten is used to emit 
monochromatic electrons with typical energy of 20-30 keV. These electrons are focused by condenser 
lenses to form a beam with a very fine spot size ~ 1 to 5 nm. This beam passes through a pair of scanning 
coils in the objective lenses that deflects the beam in a raster fashion over the sample surface. This beam 
of primary electrons interacts with sample volume ranging from less than 100 nm to 5 μm and generates 
signals (secondary electrons, internal currents, photon emission etc.). These signals are detected by 
detectors. The final image is produced on the screen through cathode ray tube. In addition, SEM can 
provide information about the sample composition near the surface and is known as energy dispersive 
spectroscopy. In the present work, SEM has been used to study the morphology of nanostructured metal 
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oxides and its nanocomposite-based film. A LEO microscope (image b) has been used for all the 
measurements.  
 
 
 
 
 
 
 
Figure 3.1.9 (a) Energy level diagram for Raman spectroscopy. The shift in wavelength between the 
excitation light (λe) and the scattered light (λs) is related to Raman shift (ΔV in cm
-1) according to: ΔV = 
(1/λe) + (1/λs). (b) Raman spectra of pristine CNTs and COOH functionalized CNTs.  
 
 
 
 
 
 
 
Figure 3.2.1 Bragg diffraction  
 
 
 
 
(a) 
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3.4.6 Transmission electron microscopy (TEM) 
The TEM studies have been carried out to investigate the morphological shape, size and distribution of 
nannomaterials [226]. Figure 3.2.2(A) represents the schematic of a TEM. A thin solid specimen (< 200 
nm) is bombarded in vacuum with a monoenergetic focused beam of electrons. The high resolution results 
from the smaller de Broglie wavelength associated with high-energy electron beam and its ability to focus 
the electron beam. For example, electrons having energy of 100 keV corresponds to a de Broglie 
wavelength of 3.7×10
-3
 nm. TEM operates with the electron beams having energy in the range of 20-200 
keV. The spatial resolution is large for higher energy electron beams. The beam has sufficiently high 
energy to propagate through the specimen. The transmitted electron signals are magnified by a series of 
electromagnetic lenses. TEM offers two modes to study a desired specimen: image and diffraction. The 
image mode contrast must be induced in order to produce image for analysis. Many contrast-forming 
mechanisms exist and the interpretation of images is complicated due to the interplay of the different 
mechanisms. The most common imaging techniques in TEM are mass-thickness imaging, diffraction 
imaging and phase contrast imaging. In the diffraction mode, the pattern of the diffracted electrons is 
obtained from the electron-illuminated sample. When the electron beam is incident on the sample, 
scattering events occur since all the illuminated parts of the sample act as scattering sources. Interference 
causes coherently scattered beams when Bragg’s law is fulfilled. The coherently scattered beams are 
recorded as a “spot”. This spot pattern of the diffracted electron beam from the selected sample area is 
called the selected area electron diffraction (SAED) pattern. It provides information about the crystalline 
structure and crystal orientation. A key requirement for TEM samples is the electron transparency, as a 
thick sample would cause too many interactions leaving no intensity in the transmitted beam. A thick 
sample also increases the risk of multiple scattering of electrons and the resulting image would be 
difficult to interpret. In the present work, TEM samples have been prepared by dispersing powder sample 
in ethanol using sonication and a small drop of that solution is casted onto a carbon coated copper grid. 
Figure 3.2.3(B) show an example of TEM image of gold nanoparticles. 
3.4.7 Atomic force microscopy (AFM) 
AFM is a high-resolution scanning probe microscopic technique. It consists of a cantilever with a sharp 
tip (or probe) at its end which is used to scan the specimen surface [227]. The cantilever is made using 
silicon with a tip radius of curvature on the order of nanometer. When the tip is brought in proximity of a 
sample surface, force between the tip and the sample results a deflection of the cantilever according to 
Hooke's law. Different kinds of forces such as mechanical contact force, Van Der Waals force, capillary 
force, chemical bonding, electrostatic forces, magnetic forces etc. can be measured using AFM. The 
deflection is measured using a laser spot reflected from the top surface of the cantilever into an array of 
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photodiodes. The AFM can be operated in contact mode or dynamic (non-contact or "tapping") mode. In 
static mode, the cantilever is dragged across the surface of the sample and the contours of the surface are 
measured directly using the deflection of the cantilever. In dynamic mode, the cantilever is externally 
oscillated at or close to its fundamental resonance frequency or a harmonic. If the tip was scanned at a 
constant height, it may collide with the surface resulting in damage. Thus, a feedback mechanism is 
employed to adjust the tip-to-sample distance to maintain a constant force between the tip and the sample. 
The tip or sample is mounted on a 'tripod' of three piezo crystals, each responsible for scanning in the 
three (x, y and z) directions.  
3.4.8 Zeta potential and and Brunauer-Emmett-Teller (BET) studies 
Zeta potential is a measure of the magnitude of the electrostatic or charge repulsion or attraction between 
particles [228], and is one of the fundamental parameters known to affect stability. Its measurement 
reveals detailed insight into the causes of dispersion, aggregation or flocculation, and this information can 
be applied to improve the formulation of dispersions, emulsions and suspensions. Figure 3.2.3(i) shows a 
microscopic portion of a particle surface immersed in water. Zeta potential is defined as the electrical 
potential at the shear plane with respect to the bulk liquid. Colloidal particles dispersed in a solution are 
electrically charged due to their ionic characteristics and dipolar attributes. Each particle dispersed in a 
solution is surrounded by oppositely charged ions called the fixed layer. Outside the fixed layer, there are 
varying compositions of ions of opposite polarities, forming a cloud-like area. This area is called the 
diffuse double layer, and the whole area is electrically neutral. When a voltage is applied to the solution in 
which particles are dispersed, particles are attracted to the electrode of the opposite polarity, accompanied 
by the fixed layer and part of the diffuse double layer, or internal side of the "sliding surface". Zeta 
potential is considered to be the electric potential of this inner area including this conceptual" sliding 
surface". As this electric potential approaches zero, particles tend to aggregate. The NiO nanoparticles 
and carbon nanotubes have been characterized using measured Zeta potential. The  pore  size  distribution  
and  total surface area of the TiO2 and antTiO2-CH  are calculated by means of the BET and Barrett-
Joyner-Halenda (BJH)  methods and Autosorb software  (Quantachrome  Instruments,  USA). BET 
explains the physical adsorption of gas molecules such as nitrogen multilayer adsorption on a solid 
surface. This method is utilized to evaluate the precise specific surface area of materials as a function of 
relative pressure using a fully automated analyzer. The technique includes external area and pore area 
evaluations in order to determine the total specific surface area in m
2
/g yielding important information in 
studying the effects of surface porosity and particle size in many applications. 
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Figure 3.2.2(A) TEM instrument (TEM, JEOL JEM-2000 EX) and (B) TEM image of gold nanoparticles. 
 
 
 
 
 
 
 
  
 
 
Figure 3.2.3 (i) Schematic representation of zeta potential (www.malvern.com) and (ii) XPS of the C1s 
region of rGO deconvoluted into characteristic peaks. 
 
 
 
 
 
 
(ii) (i) 
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3.4.9 X-ray photoelectron spectroscopy (XPS)  
XPS technique is a surface-sensitive quantitative method that measures the elemental composition at the 
parts per thousand range, empirical formula, chemical state and electronic state of the desired material 
[229]. XPS spectra can be obtained by irradiating the material with a beam of X-rays at ultra-high 
vacuum conditions in order to measure the kinetic energy and number of electrons that escape from the 
top 0 to 12 nm of the material being analyzed. It is a surface chemical analysis technique that can be used 
to analyze the surface chemistry of the material. It is used to measure: (a) elemental composition of the 
surface (top 1–10 nm), (b) empirical formula of pure materials, (c) elements that contaminate the surface, 
(d) chemical or electronic state of each element in the surface, (e) uniformity of elemental composition 
across the top surface (mapping) and (f) uniformity of elemental composition as a function of ion beam 
etching (or depth profiling). I have investigated the surface functionalization of ChEt-ChOx onto CH-
TiO2 and CNT-NiO surface. XPS of the C1s region of rGO is deconvoluted into characteristic peaks 
[Figure 3.2.3 (ii)]. 
3.5 Electrochemical techniques 
 Various electrochemical techniques such as cyclic voltammetry (CA), chronoamperometry (CA), 
impedance spectroscopy are used to characterize the electrochemical properties of the synthesized 
material [230].  
3.5.1 Electrochemical cell 
A basic circuit diagram for electrochemical measurement is shown in Figure 3.2.4. In potentiostatic mode, 
a potentiostat/galvanostat (PGSTAT) may be used to control the potential of the counter electrode (CE) 
against the working electrode (WE) accurately so that the potential difference between the WE and the 
reference electrode (RE) is well defined, and corresponds to the value specified by the user. In 
galvanostatic mode, the current flow between the WE and the CE is controlled. The potential difference 
between RE and WE and the current flowing between CE and WE are continuously monitored. By using 
a PGSTAT, the value specified by the user (i.e. applied potential or current) is accurately controlled, 
anytime during the measurement using a negative feedback mechanism. 
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Figure 3.2.4 Electrochemical cell circuit for electrochemical measurement [source: 
http://surface.metrohm.com] 
       The CE is connected to the output of a control amplifier (CA) that forces the current to flow 
through the electrochemical cell. The value of the current is measured using a current follower (CF) or a 
shunt resistance (CR), for low and high currents, respectively. The potential difference is measured 
between the RE and S with a differential amplifier (DA). The PGSTAT switch is set depending on the 
mode the instrument is used(amperometry, potentiometry, chronoamperometry, impedance etc.) The 
signal is then input to the CA, along with the waveform Ein at by digital-to-analog converter through the 
summation point. The potential is measured between RE and S and the current is measured between WE 
and CE. The ground connector can be used to connect external devices to the same ground of the 
PGSTAT. The counter electrode, also known as “auxiliary electrode” is used to close the current circuit in 
the electrochemical cell. It is usually made of an inert material (Pt, ITO, Au, graphite, glassy carbon etc.) 
that does not participate in the electrochemical reaction. Because the current is flowing between the WE 
and the CE, the total surface area of the CE (source/sink of electrons) must be higher than that of the WE 
so that it will not be a limiting factor in the kinetics of the electrochemical process under investigation. 
The reference electrode has a stable and well-known electrode potential and it is used as a point of 
reference in the electrochemical cell to control potential and current measurement. The high stability of 
the reference electrode potential is usually reached by employing a redox system with constant (buffered 
or saturated) concentrations of each participants of the redox reaction. Moreover, the current flow through 
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the reference electrode is kept close to zero (ideally, zero). which is achieved using the CE to close the 
current circuit in the cell together with a very high input impedance on the electrometer (> 100 GΩ). 
There are two commercially available types of reference electrodes, that are commonly used namely; 
Ag/AgCl and saturated-calomel electrodes. 
(a)  Ag/AgCl Electrode: There is a Ag wire that coated with AgCl and dipped into NaCl  solution. 
   AgCl+e-      →   Ag+ Cl-   ; (E0 = +0.22V) 
(b) Saturated-Calomel Electrode: Calomel is the other name of mercurous chloride (Hg2Cl
2
). 
            Hg2Cl
2
  →   2Hg + 2Cl2 ; (E0 = +0.24V) 
Working electrode is the electrode in an electrochemical system on which the reaction of interest 
occurs. In an electrochemical system with three electrodes, the working electrode can be referred to as 
either cathodic or anodic depending on whether the reaction on the working electrode is a reductive or an 
oxidative. One common working electrode can be made of inert materials such as Au, Ag, Pt, ITO, glassy 
carbon (GC) and Hg drop and film electrodes etc. The size and shape of the working electrode also varies 
depending on the application. 
3.5.2 Cyclic voltammetry (CV) 
CV is a technique that measures the current that develops in an electrochemical cell under conditions 
where voltage is in excess of that predicted by the Nernst equation [231]. CV can be performed by 
cycling the potential of a working electrode, and measuring the resulting current. CV is used to study the 
electrochemical properties of an analyte in a solution. The plot of the current at the working electrode vs. 
the applied voltage gives the CV of a redox reaction. 
             The potential of the working electrode is measured with respect to a reference electrode which 
maintains a constant potential and produces an excitation signal. Figure 3.2.5 (i) shows an input excitation 
signal for CV measurement and (ii) its output signal which is called CV resulting from a single electron 
reduction and oxidation.  
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Figure 3.2.5 (i) Input signal or excitation signal for CV measurement and  (ii) output signal of a CV . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.6 Electrochemical system that includes electron transfer along with its Randles equivalent 
circuit. 
Consider the following reversible reaction:  
                                                                                                                                         Eq. 3.1.9 
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Electrode potential (E) is given by 
                                                                                                                                               Eq. 3.2.1 
where, Ei is the initial potential in volts, (v) is the sweep rate in volts s
-1
, and t is the time in seconds. 
When the direction of the potential sweep is switched, the equation becomes, 
                                                                                                                                              Eq. 3.2.2 
where, Es is the potential at the switching point. Electron stoichiometry (n): 
                                                                  
     
 
                                                                   Eq. 3.2.3 
where (Epa) is the anodic peak potential, (Epc) is the cathodic peak potential, and (n) is the number of 
electrons participating in the redox reactions. Formal reduction potential (E°) is the mean of the Epc and 
Epa values: E° = (Epa + Epc)/2. Figure 3.2.6 describes the process that occurs in simple electrode reactions. 
In case of reduction, a species (O) capable of receiving an electron from the electrode diffuses to the 
surface, receives an electron and diffuses away from the surface. Current at the surface is generated by the 
transfer of electrons from the electrode to the redox species. In solution current is carried by migration of 
ions. 
 In a typical CV, the capacitive current is small compared to the current from electron 
transfer (Faradaic current). Faradaic current depends on two facts, the kinetics of electron transfer and the 
rate at which the redox species diffuses to the surface. For the redox couple Fe(CN)6 
3-/4-
, the kinetics of 
electron transfer are reasonably fast, so that it can be assumed at least for the moment that, at the surface, 
the concentrations of Fe(CN)6
3-
 and Fe(CN)6
4-
 can be described by the Nernst equation as below 
                                                              
        
   
        
   
                                                         Eq. 3.2.4 
where, E is the applied potential and E°  is the formal electrode potential. When the concentration of 
Fe(CN)6
3-
 molecules decreases, potential of electrode surface becomes more negative. It is being reduced 
to Fe(CN)6
4-
. The peak current in a CV species is described by Randles-Sevcik Eq. 3.2.5. 
                                                             ip     9 000 n
    D1  C 1                                              Eq. 3.2.5 
where ip = redox peak current (A), n = number of electrons transferred in the redox event (1), A= electrode 
area (cm
2
), D = diffusion coefficient (cm
2
/s), C = surface concentration (mol),   = scan rate (mV/s)]. The 
cyclic voltammetry studies of the fabricated electrodes have been conducted in phosphate buffer (PBS, 50 
mM, pH 7.0, 0.9% NaCl) at the potential range from -0.5V to +1.0V [Figure 3.2.7]. 
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Figure 3.2.7 CV studies of various fabricated electrodes such as (a) NiO/ITO, (b) NiO-CdS/ITO and (c) 
AAB/NiO-CdS/ITO 
3.5.3 Chronoamperometry and chronocoulometry  
For chronoamperometric measurement, the steady state current is measured as a function of time while a 
potential is applied between the working and reference electrodes [232]. The input and output signal of a 
chronoamperometric measurement is shown in Figure 3.2.8(i). A diffusion layer is developed between the 
solution media and electrode surface. Diffusion controls the transfer of analyte from the bulk solution of 
higher concentration to the electrode. Thus, there is a concentration gradient from solution media to the 
electrode surface. Cottrell equation can be used to describe this situation. It defines the current-time 
dependence for linear diffusion control at an electrode. 
                                                                i  nF C0 
D
 t
                                                                     Eq. 3.2.6 
where, i is the current, n is the number of electrons transferred in the reaction, F is the Faraday constant, 
A is the electrode area, D is the diffusion coefficient,    is the analyte concentration and t is the time. For 
example, the chroamperometric response of rGO/ITO electrode have been conducted in PBS, 50 mM, pH 
7.0, 0.9% NaCl  at the potential -0.3 V [Figure 3.2.9]. 
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Chronocoulometry [231] involves measurement of charge vs. time response to an applied 
potential step waveform [Figure 3.2.8(ii)]. The shape of the resulting chronocoulogram can be understood 
by considering the concentration gradients in the solution adjacent to the electrode surface. 
Chronocoulometry is useful for measuring electrode surface areas, diffusion coefficients, time window of 
an electrochemical cell, adsorption of electroactive species, and the mechanisms and rate constants for 
chemical reactions coupled to electron transfer reactions. The charge (Q) vs. time (t) curve (the Anson 
equation) is obtained by integrating the Cottrell equation is given by 
                                                  
 nF C0D0
1  
1  
t1                                                                               Eq. 3.2.7 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.8(i) Current vs. time for chronoamperometric measurement and (ii) charge vs. time for 
chronocoulometric studies. 
 
 
 
 
 
 
 
(i) (ii) 
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Figure 3.2.9 Chronoamperometric response of rGO/ITO electrode have been conducted in PBS, 50 mM, 
pH 7.0, 0.9% NaCl  at the potential -0.3 V.  
The Anson equation assumes the diffusion to a planar electrode following an instantaneous potential step, 
and it is instructive to see how accurate this assumption is. This can readily be achieved by a plot of Q/t 
vs. t, which should be constant if the Anson equation is obeyed. 
3.5.4 Impedance spectroscopy 
Impedance is a measure of the ability of a circuit to resist the flow of electrical current. Electrochemical 
impedance is usually measured by applying a sinusoidal AC potential to an electrochemical cell and then 
measuring the current through the cell [231-233]. The response to this potential is an AC current signal. 
This current signal can be analyzed as a sum of sinusoidal functions (a Fourier series). The excitation 
signal, expressed as a function of time, has the form 
                                                                   Et  E0 sin  t                                                               Eq. 3.2.8 
where,    is the potential at time t,    is the amplitude of the signal, and   is the radial frequency. The 
relationship between radial frequency   (radians/s) and frequency f (Hz) is given by 
                                                                      f                                                                            Eq. 3.2.9 
In a linear system, the response signal, It, is shifted in phase, φ  and has a different amplitude, I0 
                                                                  It  I0 sin  t φ                                                            Eq. 3.3.1 
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The electrical impedance (Z) is the ratio of the incremental change in voltage, Et to the resulting change in 
current, I0, and Z is given by Eq. 3.3.2. 
                            
Et
I0
 
1
 
 
E0 sin   ft 
I0 sin   ft  φ 
  0
sin   ft 
sin   ft  φ 
                                                  Eq. 3.3.2 
where Y is the complex admittance and the impedance is described either by the modulus     and the 
phase shift φ or by its real ( ′) and imaginary ( ″).The impedance is then represented as a complex 
number, 
                                      
E
I
  0 exp  φ   0 cos φ   sin φ                                                  Eq. 3.3.3 
The most frequently used equivalent circuit for modeling the EIS experimental data is the 
Randles circuit that comprises of an electrolyte (RS), in series with the double layer capacitance (Cdl), 
charge-transfer resistance (RCT) and Warburg impedance (Zw or ZD). The Nyquist plot includes a 
semicircle region lying on the real axis followed by a straight line. The linear part (ψ =  /4), observed at 
the low frequency range, implies a mass-transfer limited process, whereas the semicircle portion, 
observed at high frequency range, implies a charge-transfer limited process [Figure 3.3]. The imaginary 
component, at high frequency falls to zero because it offers zero impedance. As the frequency drops, the 
capacitance Cdl offers high impedance and hence current flows mostly through RCT and RS. The double 
layer capacitance or constant phase element (CPE) can be calculated from the frequency at the maximum 
of the semicircle (  = 2f = 1/RctCdl). The charge-transfer resistance Rct and the double layer capacitance 
Cdl are the most important electrical parameters in analyzing the impedance signal change for antibody-
antigen interaction. Figure 3.3.1 shows the EIS spectra of  the Au (a), TGA/Au (b), CysCdS/Au (c) and 
AAB-CysCdS/Au electrodes in PBS solution (50 mM, pH 7.4, 0.9% NaCl) containing 5 mM 
[Fe(CN)6]
 −/4−
.  Both Nyquist and Bode plots are obtained and have been used to determine the relative 
change in surface-charge resistance. Interfacial Rct and Cdl in Nyquist plot of impedance are obtained from 
real   ′) and imaginary    ′′) impedance at different frequencies using the following equation (7) for a 
parallel RC circuit. 
                          Rs  
Rct
1   RctCdl
 Rs  
Rct
1   Rct
 Cdl
  
  Rct
 Cdl
1   Rct
 Cdl
   
′    ′′                                Eq. 3.3.4 
where, Rs is the electrolyte solution resistance and Rct is the charge transfer resistance or polarization 
resistance. The frequency associated with maximum   ′′ and Rct are used to calculate Cdl using the 
following equation (8).   
                                                             RctCdl  
1
  fmax
                                                                  Eq. 3.3.5 
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where,    is the time constant and fmax is the maximum frequency. The Warburg resistance (Zw) can be 
obtained through Nyquist plot and an equivalent circuit to describe the electrical response at electrode. In 
the plot, the Warburg impedance is expressed by an intercept of straight line having a slope of unity and 
can be derived from the following Eq. 3.3.6. 
                     w    Wint   
Rctλ
   
  1    ;   Wint  Rs  Rct  Rct
 λ Cd                                      Eq. 3.3.6 
where,  λ   
 f
 D0
 
 b
 DR
    f and  b are forward and backward electron-transfer rate constants, D0 and DR 
are the diffusion coefficients of oxidant and reductant. The Rs and Rs +Rct values are obtained from 
standard commercial software available with the instrument. The electron transfer rate (k0) of an electrode 
can be calculated using charge transfer kinetics: 
              
                                                                           0  
RT
n F  Rct C
                                                          Eq. 3.3.7 
 
where R is the gas constant, T is the temperature, n is the electron transferring constant of the redox 
couple, F is Faraday constant, A is the effective area of the electrode, and C is the concentration of the 
redox couple in the bulk solution. 
Electrolyte resistance: The resistance of an ionic solution depends on the ionic concentration, type of 
ions, temperature, and the geometry of the area through which current flows. The resistance can be 
defined as, R=ρl/ , where, ρ is the solution resistivity, A is an area, and l is the length.  
Double layer capacitance: An electrical double layer is an interface between the electrode and 
electrolyte solution. The charged electrode is separated from the charged ions which form a capacitor. 
The value of the double layer capacitance depends on many factors such as electrode potential, 
temperature, ionic concentrations, types of ions, oxide layers, electrode roughness, impurity adsorption, 
etc.  
Charge transfer resistance: A resistance can be formed by a single kinetically controlled 
electrochemical reaction at equilibrium under a fixed potential. In a redox reaction, the electrons enter the 
electrode and the generated ions diffuse into the electrolyte. The relation between the potential and the 
current is given by 
                              i  i0  
Co
Co
 exp  
αnF 
RT
  
CR
CR
 exp  
  1 α nF 
RT
                                                        Eq. 3.3.8 
where, i0 is the exchange current density, Co is the concentration of oxidant at the electrode surface,  Co
  is 
the concentration of oxidant in the bulk, CR is the concentration of reductant at the electrode surface,   is 
the overpotential, α is the reaction order, T is the temperature and R is the gas constant. When the 
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concentration in the bulk is the same as at the electrode surface, Co =Co
  and CR=CR
 , the Eq. 3.3.8 is 
called the Butler-Volmer equation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 A Nyquist plot of EIS measurement, where, Cdl is the double-layer capacitor, Rct is the 
polarization resistance, Rs is the solution resistance and ZW is Warburg impedance.  
 
 
 
 
 
 
 
 
 
Figure 3.3.1 EIS spectra of various electrodes in PBS solution (50 mM, pH 7.4, 0.9% NaCl) containing 5 
mM [Fe(CN)6]
 −/4− 
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Warburg impedance: Diffusion can create impedance which is called Warburg impedance and is 
dependent on the frequency of the potential perturbation. At low frequencies, the reactants diffuses which 
increases the Warburg-impedance while at high frequencies, the Warburg impedance is small. Warburg 
impedance is given by Eq. 3.3.6. 
Constant phase element (CPE): In EIS experiments, capacitor is not behaved ideally. It acts like a 
constant phase element as defined below.  The impedance of a capacitor is given by 
                                                    C E  
1
 i  α  0
                                                                    Eq. 3.3.9 
where,  0 is the capacitance (C) and α =1 for an ideal capacitor. 
 
3.6 Conclusions  
The photolithography, soft lithography, and wet chemical etching techniques for PDMS microchannels 
and ITO microelectrodes have been illustrated in this Chapter. Various protocols followed for chemical 
synthesis of organic and inorganic nanomaterials and their composites for microfluidic devices have been 
illustrated. Different techniques such as SEM, TEM, AFM, XRD pattern, Zeta potential, UV-visible and 
FT-IR spectroscopy that are used to characterize the morphological and structural properties of 
synthesized nanomaterials and biofunctionalized microfluidic electrodes in this thesis has been explained. 
Also, electrochemical techniques such as CV, CC, CA and EIS employed to investigate the 
electrochemical properties of nanostructured materials, nanocomposite and bioelectrode have been 
explained. The next Chapter describes the results relating to the development of microfluidic cholesterol 
biosensors prepared using antTiO2 and TiO2-CH matrices.   
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
CHAPTER 4 
 
Part I: Nanostructured anatase-TiO2 based 
 microfluidic platform for free cholesterol estimation  
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4.1 Introduction 
Nanostructured metal oxides are well known to have unique abilities in promoting fast electron transfer 
kinetics between desired electrodes and active enzyme sites. In this chapter, an n type semiconductor 
nanocrystal TiO2 is explored for potential use as a biosensor transducer material in microfluidic 
biosensor. TiO2 has received significance research attention due to its unique properties like high surface 
area, structural uniformity, stability, negligible protein denaturation and excellent biocompatibility [234]. 
TiO2 nanoparticles synthesized by numerous techniques provide superior electrical, optical and magnetic 
properties that are unlike from their bulk counterparts. The TiO2 having a wide band gap of 3.2 eV for 
anatase and 3·05 eV for rutile and they are multifunctional materials. The nanostructured TiO2 has been 
extensively used in tissue engineering, drug delivery, membranes, antimicrobial coating, photocatalysis, 
filters, solar cells, gas sensors and biosensors [235]. Among the various metal oxides, TiO2 may play an 
important role as a transducer material for microfluidic biosensor because of their unique ability to 
promote faster electron transfer between electrode and active site of desired enzyme. Incorporation of 
nanostructured metal oxides onto the microfluidic electrode surface helps in increased loading of the 
desired biomolecules. The use of nanostructured TiO2 may perhaps result in enhanced biomolecules 
adsorption and improved diffusion efficiency [236].  
The functional properties of TiO2 depend on its crystallographic structure. The crystallographic 
polymorphs of TiO2 include rutile (tetragonal), anatase (tetragonal) and brookite (orthorhombic), and TiO2 
(B). Among the many polymorphs, anatase TiO2 (ant-TiO2) is known to be high-purity single crystal with 
a high percentage of reactive (001) facets that may cause enhanced catalytic activity, better stability and 
selectivity [236-238].
 
The formation of TiO2 octahedrons is the key mechanism of anatase crystallization. 
The anatase polymorph of TiO2 is formed by face sharing of TiO2 octahedrons while rutile by edge 
sharing. The higher annealing temperature (greater than 650 °C) of titanium hydroxide can form rutile 
TiO2 from anatase TiO2 (less than 450 °C).  
The nanostructured TiO2 may induce a desired protein to be adsorbed on the nano-sized surface 
and may perhaps provide effective orientation for electron transfer between a desired protein and the 
electrode [239]. The ant-TiO2 nanobelts have been used for electrochemical determination of the perfect 
match and mismatch of single nucleobases at the physiological pH [236].
  
It has been reported that porous 
nanocrystalline TiO2 film not only retains biological activity of enzymes, but also can be used for 
increased loading capacity of enzyme molecules [235]. Various matrices including metal oxides and 
carbon nanotubes have been used to immobilize cholesterol oxidase (ChOx) for fabrication of cholesterol 
biosensor. Wang et al. have demonstrated TiO2 nanowire bundle microelectrode-based impedance 
immunosensor for rapid and sensitive detection of Listeria monocytogenes [240]. However, the 
integration of nanostructured TiO2 with a microfluidic device has not yet been explored. Moreover, the 
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oxygen containing  antTiO2 surface  may lead to enhanced heterogeneous electron transfer rate leading to 
fast response times of the microfluidic sensor. The antTiO2 nanoparticles can be used to electrochemically 
activate the active site of an enzyme due to the presence of gibbosities on the antTiO2 surface resulting in 
decreased tunneling distance between active site of enzyme and electrode leading to enhanced 
electrochemical current. Part I of this Chapter discuss results of the studies relating to fabrication of a 
microfluidic cholesterol sensor based on ChOx functionalized with highly crystalline nanostructured ant-
TiO2. In part II of this chapter, the mesoporous TiO2 nanoparticles has been modified by chitosan for the 
fabrication of microfluidic biochip towards the detection of total cholesterol. 
4.2.0 Experimental section 
4.2.1 Fabrication of microfluidic biosensing platform 
Details description and protocols for the fabrication of ITO microelectrodes and PDMS microchannels 
have been given in Chapter 3. The synthesis of ant-TiO2 nanoparticles using sol gel technique has been 
also described in Chapter 3 (Section: 3.3.3). I have deposited Ti(OH)4 sol on patterned ITO electrode via 
dip coating technique and utilized for biomolecule functionalization. The Ti(OH)4 film is initially dried at 
~110
o
C for about 1h and is finally annealed at 450
o
C for about 2h to obtain ant-TiO2. In order to 
immobilize ChOx, the stock solution of ChOx (1mgdl
−1
) of 24Uml
−1
 is freshly prepared in phosphate 
buffer (50mM) at pH 7.0. The stock solution of cholesterol is prepared in 10% triton X-100 and was 
stored at 4
o
C. The proposed mechanism for preparation of ChOx/ant-TiO2/ITO bioelectrode and 
immobilization of ChOx is shown in [Figure 4.1.1]. 10 µL of ChOx solution is uniformly spread onto ant-
TiO2/ITO electrode using physical adsorption technique and electrostatic interaction occurs between 
ChOx and ant-TiO2 This ChOx/ant-TiO2/ITO bioelectrode is rinsed in 50 mM PBS (pH 7.0) in order to 
wash out any unbound ChOx from the electrode surface. 
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Figure 4.1.1 Pictorial representation of the microfluidic system for cholesterol detection 
 
4.2.2 Precautions 
(i)  Care should be taken while using nitric acid during synthesis of ant-TiO2 nanoparticles. 
(ii. Care should be taken while using strong acid treatment for selectively etching the ITO from glass 
plate.   
 
4.3.0 Results and discussion 
4.3.1 X-ray diffraction studies 
XRD pattern from ant-TiO2 powder [Figure 4.1.2(a)] shows dominant peaks at 2θ: 25.4˚ and 48.2˚, 
corresponding to the diffraction [101] and [200] planes indicating presence of the anatase phase of TiO2. 
The diffraction pattern corresponding to [004], [105], [211], [204], [166] and [215] planes (JCPDS 89-
4921, 89-6975) further supports the presence of anatase phase in TiO2 with good crystalline structure. The 
crystallite size of anatase-TiO2 nanoparticles obtained from the distinct peak (101) at 25.4° using Debye-
Scherrer equation has been found to be 15.4 nm and the crystallite strain of anatase-TiO2 has been 
estimated to be 2.9× 10
-3
 using Williamson and Hall plot. 
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4.3.2 UV-Visible studies 
The ant-TiO2 has a broad absorption band from 280 to 400 nm in the UV region with a maximum 
absorption around 294 nm [Figure 4.1.2(b)]. A predominant blue shift in the   absorption spectra due to 
quantum size effect of the nanocrystalline ant-TiO2 compared to absorption spectra of the bulk TiO2 is 
observed. The optical band gap energy of these TiO2 nanoparticles has been estimated to be 3.4 eV which 
is slightly higher than that of bulk anatase phase (3.2 eV).   
4.3.3 FT-IR studies 
FT-IR spectra of ant-TiO2/ITO exhibits characteristic peaks at 514 cm
-1
 corresponding to vibrational 
bending of Ti-O bond in the finger print region [Figure 4.1.3(a)]. The peaks found at 844 and 1263 cm
-1
 
correspond to C-H and C-O stretching bonds, respectively. The band seen at 3600 cm
-1 
is assigned to 
stretching and deformation of the O–H bond due to absorption of water molecules. The FTIR spectra of 
ChOx/ant-TiO2/ITO film (b) exhibits band at 1637 cm
-1
 arising due to N-H stretching in amide II 
indicating presence of ChOx on ant-TiO2 film. 
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Figure 4.1.2 XRD spectrum of TiO2 powder and (b) UV-visible spectra of ant-TiO2/ITO film 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1.3 FT-IR studies of (a) ant-TiO2/ITO and (b) ChOx/ant-TiO2/ITO 
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Figure 4.1.4 (a) AFM images for ant-TiO2/ITO electrode and (b) AFM for ChOx/ant-TiO2/ITO 
bioelectrode 
 
 
 
 
 
 
 
  
Figure 4.1.5 Histogram plot for average size of ant-TiO2 nanoparticles 
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4.3.4 AFM studies 
Figure 4.1.4 shows AFM images of nanostructured ant-TiO2 on the ITO surface that are well-aligned, 
porous, monodispersed and uniformly distributed (image a and b). The average size of the ant-TiO2 is 
found to be ~27 nm [Figure 4.1.5]. The rms surface roughness of ant-TiO2 electrode is ~0.63 nm. The 
ant-TiO2 surface gets uniformly covered after it is functionalized with ChOx [image b] and results in 
decreased roughness (0.49 nm) revealing that the nanosized ant-TiO2 provides a favourable environment 
for adsorption of ChOx molecules via electrostatic interactions. 
4.3.5 EIS studies 
In electrochemical impedance spectroscopy (EIS), electron transfer resistance (RCT) controls the electron 
transfer kinetics of the redox probe at the electrode interface and it is found to be 23.0 kΩ [Figure 4.1.6(i), 
curve  a] for ant-TiO2/ITO electrode. RCT decreases to 10.2 kΩ in the case of ChOx/ant-TiO2/ITO 
bioelectrode [curve b]. These results reveal that a regular arrangement in the ant-TiO2 nanocrystalline film 
with restricted orientations provides direct and faster electron communication between enzyme and the 
electrode surface.  
 
 
 
Figure 4.1.6(i) EIS studies of (a) ant-TiO2/ITO electrode and ChOx/ant-TiO2/ITO bioelectrode, (ii) The 
CV of (a)  ant-TiO2/ITO electrode and (b) ChOx/ant-TiO2/ITO bioelectrode at scan rate (30 mV/s) in 
PBS (50 mM, pH 7.0, 0.9% NaCl) containing 5mM [Fe(CN)6]
3−/4−
. 
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4.3.6 CV studies 
The CV studies have been conducted on ant-TiO2/ITO (a) and ChOx/ant-TiO2/ITO (b) in the potential 
range of -0.5V to +0.9V at constant flow rate [Figure 4.1.6 (ii)].  The anodic peak potential (Epa) and 
cathodic peak potential (Epc) for the ChOx/ant-TiO2/ITO bioelectrode have been found to be respectively, 
0.598V and -0.304V. The magnitude of peak current (1.33×10
-5
A) is found to be higher after 
immobilization of ChOx compared to that of the ant-TiO2/ITO electrode (8.99×10
-6
A). This is attributed 
to the monodispersive nature of ant-TiO2 that provides a suitable microenvironment for immobilization of 
ChOx. The observed excellent electrocatalytic characteristics of ant-TiO2 reveal enhanced electron 
communication between active site of ChOx and the electrode. It can be speculated that these 
nanoparticles may directly communicate with the active sites of enzymes and act as electron mediators 
that establish electronic paths from the active sites of enzymes to the ITO electrode surface. Alternately, it 
may perhaps be assigned to the presence of strong electrostatic interactions and gibbosities on the ant-
TiO2 surface resulting in decreased tunneling distance between active site of ChOx and the electrode 
leading to enhanced peak current. 
4.3.7 Scan rate studies 
Cyclic voltammetry of ChOx/ant-TiO2/ITO bioelectrode has been carried out as a function of scan rate 
from 20 to 80 mV/s at 30µL/min [Figure 4.1.7(i)].
 
A proportional increase of redox current (Ia is anodic) 
with respect to square root of scan rate is observed indicating diffusion-controlled system [inset: Fig. 
3.7(i)].
  
It is found that ΔEp increases with the scan rate revealing facile electron transfer between the 
redox probe and electrode. The surface concentration of ChOx/ant-TiO2/ITO bioelectrode estimated from 
plot of Ip versus scan rate (ν
1/2
) using Brown–Anson model has been found to be 7.53 × 10-7 mol/cm2. The 
value of diffusion coefficient of ChOx/ant-TiO2/ITO bioelectrode has been found to be 3.38 × 10
-4
 
cm
2
/sec estimated from the slope of Ip vs ν
1/2
 plot using Eq. 4.1.1 
                                                 
       ν
   
                                                             Eq. 4.1.1 
where n is the number of electrons transferred,  F is Faraday constant (96485.34 C mol
−1
),  A is surface 
area (0.004 cm
2
), R is gas constant (8.314 J mol
−1
 K
−1
), I
*
  is surface concentration of bioelectrode 
(mol/cm
−2
), T is 298K and Ip/ν is the slope of calibration plot.  
4.3.8 Effect of diffusion 
The diffusivity of ions for ant-TiO2/ITO electrode has been calculated using Randles–Sevcik equation 
from CV response at various flow rates (0-50µL/min) [Figure 4.1.7(ii)]. The plot between diffusivity and 
flow rate reveals that the diffusion near the electrode surface increases with the increase in the flow rate 
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of solution (inset). The higher diffusivity of the ions towards the electrode is perhaps responsible for 
faster response time and higher sensitivity.  
4.3.9 Effect of pH 
The effect of pH (5.0–8.0 at 25°C) on ChOx/ant-TiO2/ITO bioelectrode has been investigated using CV 
to estimate optimum enzyme activity [Figure 4.1.8]. The highest current is obtained at pH 7.0 revealing 
that bioelectrode is most active at this pH [inset: Figure 4.1.8]. Thus, all the experiments are carried out at 
a pH of 7.0 at 25°C. 
 
 
 
Figure 4.1.7(i) CV of ChOx/ant-TiO2/ITO bioelectrode as a function of scan rate in PBS (50mM, pH 7.0, 
0.9% NaCl) containing 5mM [Fe(CN)6]
3−/4−
 and (ii) CV for different flow rates (0-50µL/min) as a 
function of flow rate [inset: Diffusivity for the ant-TiO2/ITO electrode]. 
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Figure 4.1.8 CV of ChOx/ant-TiO2/ITO bioelectrode as a function of pH of the buffer solution (inset: plot 
between the current response and pH of solution). 
 
4.4.0 Estimation of microfluidic parameters 
The Reynolds number (Re) is very important and is the most frequently used dimensionless number in 
fluid dynamics and defined as the inertial force to viscous forces. The flow of a fluid through a 
microfluidics channels can be characterized by Re defined as Eq.4.1.1 
                                                               
      
 
                                                                          Eq. 4.1.2                      
where L is the characteristic length of channels, µ is the viscosity (10
-3 
Pa s), Vavg is average velocity of 
fluid (0.083×10
-2
 m/s) and ρ is fluid density (~103 kg/m3) from which Re number has been found to be 
0.166 indicating that fluid flow is very low resulting in completely laminar. The surface to volume ratio 
(S/V) is calculated as 4997.5 cm
-1
. This high value indicates large scale redox conversion leading to the 
higher sensitivity as compared to the conventional electrochemical cell.  
4.4.1 Estimation of free cholesterol 
Electrochemical response of the microfluidic sensor based on ChOx/ant-TiO2/ITO bioelectrode as a 
function of cholesterol concentration (0.64–10.3 mM) is shown in Figure 4.1.9(a). During electrochemical 
measurements, various concentrations of cholesterol are injected into the microchannels (0.8μL/each 
channel) at a constant flow rate of 30 µL/min. The observed increased oxidation peak current may 
perhaps be due to fast charge transfer from flavin adenine dinucleotide (FAD) center of ChOx to TiO2 
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matrix (Figure 4.1.9). The anodic peak current is found to increase linearly on addition of cholesterol and 
the linearity is obtained as 1.3-10.3 mM [inset: Figure 4.1.9(a)]. The ChOx/ant-TiO2 based-microsystem 
shows a better sensitivity of  94.65 μA/mM/cm2 compared to those of other cholesterol biosensors (Table 
4.1.1). The low value of Michaelis–Menten constant (Km) obtained as 0.14 mM using Lineweaver–Burke 
plot reveals higher affinity between the active sites of ChOx onto the surface of ant-TiO2 that perhaps 
directly participate in the biochemical reaction.  
4.4.2 Selectivity studies 
The selectivity of ChOx/ant-TiO2/ITO bioelectrode has been determined by comparing magnitude of the 
current response by adding normal concentration of interferents such as glucose (5 mM), ascorbic acid 
(0.05 mM), uric acid (0.1 mM), urea (1 mM), and lactic acid (5 mM) to the cholesterol solution  (2.6 mM) 
under microfluidics condition [Figure 4.1.9(b)].
 
The current response of this sensor chip remains nearly 
same except for lactic acid/ascorbic acid wherein there is increase of about 5% [inset: Figure 4.1.9(b)]. 
The bioelectrode achieves 95% of steady state current in less than 5s indicating fast electron exchange 
between electrode and enzymes. The reproducibility of different bioelectrode has been investigated using 
cholesterol concentration (2.6 mM) under identical conditions using CV response and it is found to be  > 
3% error [Figure 4.2(a)]. The storage stability of this bioelectrode has been determined by observing the 
current response using CV study at 2.6 mM cholesterol concentration at regular intervals of 7 days for 
about 35 days. The bioelectrode shows a 97% response [Figure 4.2(b)] in 35 days revealing very good 
shelf life.   
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Figure 4.1.9(a) CV curves of ChOx/ant-TiO2/ITO bioelectrode at different cholesterol concentration, (b) 
linear plot of response studies of ChOx/ant-TiO2/ITO bioelectrode as a function of cholesterol 
concentration (50–400 mg/dl and (c) CV curves of ChOx/ant-TiO2/ITO bioelectrode in presence of 
interferents. (d) Current responses of various interferents.  
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Figure 4.2.0 (a) Reproducibility studies for different bioelectrodes at same flow rate and (b) stability 
studies of the ChOx/ant-TiO2/ITO bioelectrode (inset: current response vs days). 
 
4.4.3 Potential merits and demerits of the ChOx/ant-TiO2/ITO bioelectrode based microfluidic 
sensor 
The fabricated ChOx/ant-TiO2/ITO bioelectrode based microfluidics biosensor offers a suitable platform 
for free and total cholesterol detection. The high aspect ratio of this microfluidic device offers high 
sensitivity and selectivity to the amperometric detection of cholesterol compared to other reported 
literature (Table 4.1.1).  This may attributed to the small geometry of the device which offers a negligible 
capacitive current, reduced ohmic drop of potential, improved mass transfer and radial diffusion. The 
nanostructured TiO2 plays an important role to enzyme (cholesterol esterase and cholesterol oxidase) 
immobilization and facilitate fast electron heterogeneous transfer from enzyme active site to electrode. 
The metastable anatase form is the most stable due to the lower average surface energy whose equilibrium 
crystal shape is largely dominated by the very stable (101) surface. The hydrophobic nature of PDMS 
microchannels into this electrode system offers low cost, flexibility, rapid prototyping and making it 
mainly suitable for aqueous applications. The flow rate of this microfluidic platform is an important 
parameter and plays a crucial role towards the wettability of the surface that can be controlled using 
surface chemical treatment. It has been observed that the ITO etching process is an inexpensive and low 
cost method compared to that of silicon and glass which is known to be expensive and time consuming. 
This microfluidic biosensor shows better reproducibility, low Km value and suitable for detection of free 
and total cholesterol in physiological condition.  
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The direct attachment of biomolecules (such as cholesterol esterase and oxidase) with TiO2 is a 
major problem due to low isoelectric point (~5.5) of TiO2. The isoelectric point of enzyme molecules is 
found to be 4.5. This low isoelectric point of ant-TiO2 nanomaterial on microfluidic transducer surface 
can cause a low adsorption capability of enzyme molecules leading to lesser sensitivity and poor film 
stability. It has been observed that this microfluidic biosensor shows a poor detection limit (1.2 mM for 
free and 3.8 mM for total cholesterol, respectively) compared to that in other reported literatures [Table 
4.1.1]. 
 
 
Table 4.1.1 Characteristics of microfluidics based cholesterol biosensor along with those reported in 
literature 
 
 
4.4.4 Conclusions 
The fabrication of a low cost microfluidics biosensor for free cholesterol detection has been 
demonstrated.  The PDMS microchannel has been fabricated using soft lithography technique and ITO 
coated glass plate has been etched using a wet chemical etchant. Highly crystalline ant-TiO2 nanoparticles 
are selectively deposited on microfluidic transducer surface for direct immobilization of cholesterol 
oxidase molecules. The integration of PDMS microchannel and electrodes (working and counter) on glass 
substrate has been carried out via conformal contact (reversible attachment) during amperometric 
measurement.  This integrated microfluidics biosensor provides improved sensitivity and low Km value 
Working 
electrode 
Microfluidic 
used 
Detection 
range 
(mM) 
Lower 
detection 
limit 
Sensitivity Km value References 
CNT Yes 1.25 -10.0  0.25 mM 0.0512 
nA/mM/cm
2
 
…….. 241 
Au wire Yes 1.293 -6.4  0.1 mM ………. …….. 242 
Gold 
nanoparticles 
No Up to 2.1  0.060 mM 0.13  
μA/mM/cm2 
2.94 mM 243 
ZnO No Upto 7.7  0.012 mM 1.53 nA/mM/cm
2
 0.22 mM 244 
Aligned Au  
nanowires 
Yes 0.01–0.060  ................. 0.85 μA/mM/cm2 17.1 mM 245 
Anatase-TiO2 Yes 0.64-10.3  0.64 mM 94.65 
µA/mM/cm
2 
 
0.14 mM Present 
work 
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arising due to both higher surface-to-volume ratio of ant-TiO2 nanocrystals and small geometry of the 
microfluidics system. The reproducibility studies on different ant-TiO2 based bioelectrodes shows no 
significant change in current response. Effort will make to conduct the selectivity test of the fabricated 
biosensor in presence of albumin concentration. This miniaturized microfluidics sensor requires minimal 
instrumentation and can be readily integrated with micro-electronics in a chip-based format. The 
electrochemical response of this microfluidics sensor depends upon flow rate of the solution that 
influences response time and diffusion coefficient.  
Surface modification of TiO2 nanoparticles might be useful for improving the absorption of 
biomolecules onto the microfluidic transducer surface. Chitosan is a good candidate for this purpose. 
With this idea, chitosan modified TiO2 nanoparticle is explored for electrode modification in a cholesterol 
biosensor. Due to reversible attachment between the microchannel and electrodes in this biosensor 
system, the same geometry of PDMS microchannel has been used for fabrication of micro-device. To 
overcome same of the demerits of this microfluidic biosensor, efforts have been made to utilize antTiO2-
CH as transducer surface with similar geometry and the results have been described in Part II of this 
Chapter. 
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Part II: Mesoporous titania-chitosan composite based microfluidic 
biochip for cholesterol detection 
 
4.5 Introduction 
The experimental details relating to development of electrochemical microfluidic sensor based on anatase 
titania and chitosan nanocomposite for the estimation of total cholesterol is presented in the remaining 
sections. The anatase titania nanoparticles-grafted chitosan (antTiO2-CH) has been selectively dip-coated 
onto ITO-patterned microelectrode and the surface is physically immobilized using the mixture of ChEt 
and ChOx.  
The electroactive chitosan (CH) a deacetylation product of chitin, is a functional and basic 
polysaccharide composed of β-1,4-linked glucosamine that can be easily extracted from the exoskeleton 
of shrimps and crabs [246].This biomaterial offers excellent film forming ability and acts as a stabilizing 
agent. Besides this, it is cost–effective, biocompatible and biodegradable. The nanoporous structure of 
CH can be used to obtain enhanced dispersion of the TiO2 nanoparticles that may provide sufficient 
electron-conducting paths and high surface area for adsorption of biomolecules such as enzymes, proteins 
etc. [247]. The mesoporous structure of titania can promote adsorption of CH as well as biomolecules and 
improved electron diffusivity. The high porosity and excellent surface area of titania could thus provide a 
favorable platform for incorporation of CH resulting in higher loading of biomolecules. The available 
functional groups such as the amino (NH2), hydroxyl (OH) etc. of CH offers a hydrophilic environment 
for loading of enzyme molecules on transducer surface. Feng et al. have developed a nanoporous metal 
oxide-CH matrix for immobilization of single stranded DNA probe for detection of a cancer gene [240]. 
Thus, the mesoporous structure of CH provides the fast heterogeneous electron transfer rate resulting in 
improved electrochemical properties. The direct attachment of biomolecules onto antTiO2 surface is 
presently a major limitation as its surface can absorb only a limited number of desired biomolecules due 
to weak inter-molecular interactions with the biomolecules. This limitation can perhaps be overcome by 
using a nanocomposite material comprising of a biopolymer (e. g. chitosan) and antTiO2 nanoparticles. 
The nanocomposite of TiO2 with chitosan acts as a template for dispersion of antTiO2 nanoparticles, 
thereby facilitating better enzyme functionalization.  
The integration of the mesoporous antTiO2-CH with microfluidic device may improve the 
biosensor efficacy due to improve electrochemical properties of nanocomposite for total cholesterol 
detection. Easy film forming ability, biocompatibility, higher enzymes loading capacity and cost 
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effectiveness of this mesoporous antTiO2-CH nanocomposite provide a suitable platform to incorporate 
with microfluidic module for biomolecules detection. I have used the ac impedance spectroscopic 
technique for determination of total cholesterol concentration. The bienzyme functionalized antTiO2-CH 
electrode has been characterized using electron microscopy, UV-visible spectroscopy, Brunauer–
Emmett–Teller surface area, Fourier transform infra-red and X-ray photoelectron spectroscopy 
techniques. 
4.5.1 Biosensing Platform  
The selective deposition of antTiO2-CH solution has been carried out on this fabricated patterned ITO 
electrode via dip coating. Initially, the glass substrate with ITO microelectrode is masked using a masking 
tape and only the desired electrode is selectively exposed by removing the masking tape over it. The 
substrate is then dried at 40°C for about 1 h after which the remaining masking tape film is removed from 
the substrate. Masking glue on substrate surface has removed using acetone treatment.  This process 
results in a glass substrate containing antTiO2-CH/ITO (unmasked region) and bare ITO electrode 
(masked region). The antTiO2-CH/ITO film is washed with deionized water to remove any unbound 
particles. 
The fresh solution of 1mg/ml cholesterol esterase (ChEt) and 1mg/ml cholesterol oxidase (ChOx) 
are mixed in the ratio 1:1 and 10µl solution of this mixture is uniformly spread onto antTiO2-CH surface 
via physical absorption and is kept in a humid chamber for 12 h at 4
o
C. The surface charged antTiO2 
nanoparticles interact with –NH2/OH groups of CH [cationic amine-rich polysaccharide (pH 4.2)] via 
electrostatic interactions and hydrogen bonding. The ChEt and ChOx are negatively charged at pH 7.0 
and can be immobilized onto the positively charged antTiO2-CH via electrostatic interaction. This ChEt-
ChOx/antTiO2-CH based bioelectrode is washed with 50 mM PBS (pH 7.0) in order to remove any 
unbound enzymes from the electrode surface. The bioelectrode is stored at 4
o
C when not in use. It has 
been found that the ChEt-ChOx/antTiO2-CH/ITO bioelectrode shows very high catalytic behavior in 
phosphate buffer at pH 7.4 (50mM, 0.9% NaCl) containing [Fe(CN)6]
3−/4−
(5mM). The PDMS 
microchannel is reversibly sealed to a glass substrate comprising of ITO electrode and ChEt-
ChOx/antTiO2-CH/ITO bioelectrode, respectively. The various steps involved in the fabrication of the 
microfluidic device are shown in Figure 4.2.3. Electrochemical investigations for this impedimetric 
microfluidic chip have been carried out using an Autolab Potentiostat/Galvanostat (FRA analyzer) in 
phosphate buffer saline [PBS, (50 mM, pH 7.0, 0.9% NaCl)] containing [Fe(CN)6]
3−/4− 
(5mM). The flow 
of buffer solution and analyte are optimized using electrochemical technique through this chip and 
1µL/min is found to be optimum flow rate. The fabricated microfluidic biochip is shown in Figure 4.2.1. 
Figure 4.2.3 shows a photograph of microfluidic biochip. 
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Surface profiling and the thicknesses of the films of the film structure are carried out using an 
optical profiling system (NanoMap-D, Aep Technlogy, U.S.A.). The thicknesses are measured by an 
optical profiler in noncontact mode. Figure 4.2.2 shows an optical 3D profiling image of the ITO film 
coated on a glass in which the thickness   was calculated ~299 ±36 nm. Then antTiO2-CH was deposited 
on the ITO by dip coating method and the thickness was found ~196±30 nm.  
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Figure 4.2.1 Functionalization of bienzyme onto antTiO2-CH surface for cholesterol detection. 
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Figure 4.2.2: 3D optical profilometric image for (a) ITO on glass film 
 
 
 
 
 
 
 
 
 
Figure 4.2.3 A photograph of the fabricated microfluidic biochip 
 
4.6 Results and Discussion 
4.6.1 UV-visible, FT-IR, Raman and BET surface analysis 
The absorption spectrum of chitosan (curve a) solution shows a maximum absorption at 200 nm in the 
UV region due to presence of the functional groups (–NH2 and –OH) of chitosan [Figure 4.2.4(i)]. The 
absorption of antTiO2 nanoparticles begins from 352 nm and a maximum value is observed at 249 nm due 
to the band ed ge transition (curve b). The blue shift of the absorption edge is the evidence for the 
quantum confinement effect that occurs during the growth of nanoparticles. The absorption intensity is 
found to be higher in case of the antTiO2-chitosan (curve c) matrix due to electrostatic interaction 
between CH and antTiO2 nanoparticles.  
Glass 
ChEt-ChOx/antTiO2-CH/ITO 
ITO 
PDMS slab 
Glass 
ITO 
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The FT-IR spectra of antTiO2/ITO exhibits an IR peak at 523 cm
−1 
in the finger print region due 
to vibrational band of Ti-O bond [Figure 4.2.4(ii), spectra a]. The peaks found at 819 and 1241 cm
−1 
respectively, correspond to C-H and C-O stretching bonds. The band seen at 3593 cm
-1 
is assigned to 
stretching and deformation of the O–H bond due to absorption of the water molecules. Figure 4.2.4(ii) 
shows the FT-IR spectra of CH (spectra b) that exhibits bands at 3200–3450 cm−1 due to the stretching 
vibration mode of OH and NH2 groups. The band at 1652 cm
−1 
arises due to amide I group (C–O 
stretching along with N–H deformation mode). The 1564 cm−1 peak is attributed to NH2 group due to N–
H deformation, 1400 cm
−1
 peak is due to C–N axial deformation (amine group band), 1317cm−1 peak is 
due to COO− group in the carboxylic acid salt and 1063 cm−1 is attributed to the stretching vibration 
mode of the hydroxyl group. The peak at 612 cm
−1 
in the finger print region is attributed to antTiO2 
grafted CH. This absorption band occurs at a higher wavenumber than that of the pure antTiO2 
nanoparticles due to the interactions between CH and the antTiO2. The presence of antTiO2 nanoparticles 
in CH facilitates immobilization of ChEt-ChOx via amine and hydroxyl group. After immobilization of 
ChEt-ChOx on mesoporous antTiO2–CH surface (spectra c), intensity of the absorption peaks becomes 
higher and broader due to overlap of the functional groups of enzymes corresponding to amide I (1652 
cm
−1
) and amide II (1545 cm
−1
), respectively, indicating immobilization of the bienzyme (ChEt-ChOx) 
onto this  matrix. 
Raman spectral analysis [Wi, Tec, Gy] has been carried out at a wavelength of 532 nm. Figure 
4.2.4(iii) illustrates the room temperature Raman spectra of the TiO2 and antTiO2-CH. The resultant 
spectra indicate the intensification of the lowest-frequency Eg mode. A strong Raman peak emerges at 
196 cm
−1
 at the high-frequency side of the Eg mode and which is assigned to the anatase phase of TiO2.  
In addition, B1g, A1g and Eg modes are detected at 396, 517 and 642 cm
−1
, respectively which also support 
the anatase phase of TiO2 and antTiO2-CH samples. It appears that, in the antTiO2-CH structure, there is 
not much alteration detected when evaluated with bare TiO2, signifying that the antTiO2-CH synthesis did 
not destroy the characteristic structural morphology of TiO2. 
The specific surface area and porosity of the TiO2 and antTiO2-CH are studied by using the N2 
adsorption and desorption isotherms which is shown in Figure 4a. Table 1 shows the pore size distribution 
of the TiO2 and antTiO2-CH from Brunauer–Emmett–Teller (BET) measurements. It is found that the two 
isotherms of samples show stepwise adsorption and desorption branch belonging to type IV curves, hence 
representing the occurrence of mesoporous material. A hysteresis loop with a stepwise adsorption and 
desorption branch is observed at extensive range of pressure (P/Po) for the mesoporous TiO2 and antTiO2-
CH which indicates that the synthesized materials have extensive mesoporous structure. To examine pore 
size and pore volume distribution, a curve of the pore size distribution is inspected by desorption branch 
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of the BJH data as shown in the inset of the Figure 4.2.4(iv). The average pore diameter of mesoporous 
TiO2 is found to be 6.287 nm with ~80% mesoporosity of total pore volume of 0.2961cc/g. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.4(i) UV visible spectra of chitosan (a), antTiO2 nanoparticles (b) and antTiO2-CH (c), (ii) FTIR 
spectra of (a) antTiO2 film, (b) antTiO2-CH/ITO and (c) ChEt-ChOx/antTiO2-CH/ITO film. (iii) Raman 
spectra of TiO2 and antTiO2-CH showing pure anatase phase. (iv) The N2 adsorption and desorption 
isotherms of ant-TiO2 nanoparticles, inset shows the pore size distribution of ant-TiO2 nanoparticles. 
 
The total pore volume of mesoporous antTiO2-CH is 0.1265 cc/g and the mesoporosity of 83%. 
Analyzing BET results, it is perceived that titania nanoparticles have an elevated surface area of 188.2 
m
2
/g than antTiO2-CH showing 90.83 m
2
/g. The shrink in surface area of antTiO2-CH is believably due to 
(i) (ii) 
(iii) (iv) 
117 
 
the blocking tendency of pore entrances of TiO2 particles by chitosan molecules. Table 4.1.2 shows the 
pore size distribution of antTiO2 nanoparticles and chitosan modified antTiO2 nanoparticles.  
 
4.6.2 XPS studies  
Figure 4.2.5(i) shows XPS wide scan spectrum obtained for the antTiO2–CH/ITO (a) and ChEt-
ChOx/antTiO2–CH/ITO (b) electrodes. The peaks found at 199.5 eV, 284.2 eV, 496.5 eV and 530.5 eV 
are attributed to Cl 2p, C 1s, Sn 3d and O1s of antTiO2–CH, respectively. In spectrum (b), the 
characteristic peak seen at 398.5 eV is assigned to the presence of N 1s present in the bienzyme (ChEt-
ChOx). The additional peak found at 1069.5eV is assigned to Ti-Auger. The relative atomic concentration 
(%) and full width half maxima (FWHM) of the carbon, oxygen and nitrogen peaks are summarized in 
Table 4.1.3. The atomic concentration of N 1s of ChEt-ChOx/antTiO2–CH/ITO bioelectrode increases to 
2.48% compared to that of antTiO2–CH/ITO electrode (1.23%). This indicates that antTiO2–CH/ITO 
electrode surface facilitates immobilization of ChEt-ChOx via electrostatic interactions. The XPS spectra 
in the carbon 1s region of deposited antTiO2–CH/ITO electrode [Figure 4.2.5(ii)], is deconvoluted into 
the characteristic peaks using Shirley type baseline and Lorentzian-Doniac-Sunsic curves with Gaussian 
profile. The deconvoluted C1s core-level spectrum of antTiO2–CH sample consists of three peaks. The 
first, situated at 284.5 eV is assigned to the existence of the C-C and C-N binding in CH. The second 
peak, located at 286.3eV, is attributed to the chemical binding of the C in C-O and C-OH bonds, and the 
third peak is  at 288.06 eV, is related to the N-C=O chemical binding in the acetamide group of CH. After 
bienzyme immobilization, the peaks found at 284.5 eV, 286.3eV and 288.06 eV are slightly shifted 
towards lower binding energy and one additional peak at 281.8 eV is observed [Figure 4.2.5(iii)]. After 
peak fitting of the N1s core-level spectrum of antTiO2–CH, three peaks appear at 398.3, 401.4, and 406.2 
eV [Figure 4.2.5(iv)].  
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Figure 4.2.5 (i) Wide scan XPS of various films, (ii) XPS spectra of the C1s region of antTiO2-CH film 
after deconvolution, (iii) the C1s region of ChEt-ChOx/antTiO2-CH film, (iv) N 1s core level spectra of 
antTiO2-CH film and (v) N 1s core level spectra of ChEt-ChOx/antTiO2-CH film. 
(i) (ii) 
(iv
) 
(iii
) 
(v) 
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Table 4.1.2 Pore size distribution from BET data. 
 
 
 
 
Table 4.1.3 The atomic concentration (%) and full width half maxima (FWHM) of C, O and N elements 
present in antTiO2–CH/ITO and ChEt-ChOx/antTiO2–CH/ITO electrodes from XPS analysis. 
 
            The first peak is assigned to the chemical binding of N in the amine and acetamide (NH2) groups, 
while the second peak is assigned to the chemical binding of the N in the protonated amine (NH3
+
) 
groups. The third peak is attributed to chemical binding of the N in the nitrate group. In case of the 
biofunctionalized film, these peaks are slightly shifted towards higher binding energy [Figure 4.2.5 (v)]. 
And the atomic ratio of element (N) and peak intensity is found to be changed indicating bienzyme 
immobilization onto antTiO2–CH surface via electrostatic interaction. 
4.6.3 Morphological studies 
The surface morphology of nanoparticles and chitosan coated nanoparticles are explored using field 
emission-scanning electron microscopy (FE-SEM). The titania nanoparticles are dispersed uniformly 
throughout the ITO surface with arrangement of aggregated nanoparticles. It also illustrates that the 
Sample 
details 
p/p0 Total pore 
volume 
(cc/g) 
BET area 
(m
2
/g) 
Macropore 
volume 
(cc/g) 
Mesopore 
volume 
(cc/g) 
Micropore 
volume 
(cc/g) 
Average 
pore 
diameter 
(nm) 
ant-TiO2 0.99707 0.2961 188.2 0.02286 0.2373317 0.0359083 6.287 
antTiO2-
CH 
0.99940 0.1265 90.83 0.00772 0.1059716 0.0128164 5.571 
Elements/Atomic concentration 
(%) 
C (FWHM) O(FWHM) N(FWHM) 
antTiO2–CH /ITO 43.3 (1.96) 34.8 (2.08) 1.23(3.6) 
ChEt-ChOx/ antTiO2–CH /ITO 61.3 (3.34) 25.7 (3.02) 2.48 (1.9) 
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nanoparticles are densely distributed with a slight range of dispersion. Nanosized particles exhibit smooth 
surface morphology. FE-SEM analysis of titania nanoparticles confirms their particle size ranging from 
10 to 35 nm. The average diameter of the TiO2 particles is calculated to be ~27 nm by analyzing the 
micrographs. The FE-SEM [Figure 4.2.6(a)] studies reveal the porous morphology of (antTiO2–CH) film 
indicating the formation of antTiO2–CH hybrid. This may be attributed to electrostatic interactions 
between cationic CH and surface charged antTiO2 nanoparticles grafted in the CH network [Figure 
4.2.6(b)]. The micrograph reveals that the hybrid surface (Figure 4.2.6(b)) is coated with TiO2 
nanoparticles. After enzyme incorporation on antTiO2–CH surface (image c), the film morphology has 
changed their structure. This may be due to the three dimensional environment of hybrid surface that 
promotes complex coating formation appear with number of apexes and voids. This may be due to porous 
surface structure of antTiO2–CH provides increased loading capacity of the bienzyme (ChEt-ChOx). 
 
 
 
 
 
 
 
 
 
Figure 4.2.6(a) FE-SEM image of antTiO2 nanoparticles and (b) antTiO2-CH. (c) FE-SEM image of 
antTiO2-CH film with enzyme immobilization. 
 
4.6.4 Cyclic voltammetric studies 
Figure 4.2.7(i) shows the cyclic voltammogram of (a) antTiO2-CH/ITO electrode and (b)ChEt-
ChOx/antTiO2-CH/ITO bioelectrode with potential range of  -0.9V to +1.0 V conducted in PBS 
containing 5 mM [Fe(CN)6]
3-/4-
. The magnitudes of peak currents measured for the antTiO2-CH/ITO 
electrode are found to be 7.43 µA (anodic) and -15.6 µA (cathodic) with peak-to-peak separation voltage 
of 1.2V. The peak current (anodic) of ChEt-ChOx/antTiO2-CH/ITO bioelectrode is higher (11.9 µA; 
curve b) compared to that of the antTiO2-CH/ITO (curve a) resulting in fast electron communication 
through antTiO2-CH matrix and redox active site of ChEt-ChOx molecules. This indicates that 
nanoporous CH with antTiO2 facilitates activation of enzyme active sites resulting in enhanced current 
due to improved heterogeneous electron transfer. The high electrocatalytic activity of antTiO2 in presence 
(c) (b) (a) 
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of bienzyme indicates superior performance of the redox process. The antTiO2 nanoparticles can be used 
to activate active site of the enzyme leading to decreased tunneling distance for diffusion of electrons 
from bulk solution leading to enhanced current. The observed significant increase in the heterogeneous 
electron transfer rate results from the strong interaction of ChEt-ChOx with antTiO2-CH based electrode 
as compared to that of antTiO2-CH/ITO electrode. 
The effect of the scan rate on the electrochemical response of bioelectrode is shown in Figure 
4.2.7(ii). The peak current increases linearly with increase of the scan rate from 20 to 160 mVs
–1
 (inset).  
The magnitude of current of both anodic peak (Ia) and cathodic peak (Ic) observed for ChEt-
ChOx/antTiO2-CH/ITO bioelectrode increases linearly with the scan rate (20-110 mV/s) indicating 
heterogeneous pseudo reversible fast electron-transfer process. The magnitude of Ia/Ic is calculated to be 
as 0.7<1. It can be seen that anodic potential shifts towards positive side and the cathodic peak potential 
[inset: Figure 4.2.7(ii)] shifts in the reverse direction indicating a surface-controlled process. The values 
of slope, intercept and correlation coefficient are given by Eq.4.1 (4 & 5) 
                                     
                                             Eq. 4.1.4 
                                         
                                    Eq. 4.1.5 
The magnitude of charge associated with the adsorption or desorption of an adsorbate gives an indication 
of the number of surface catalyst atoms present in the matrix. The electrical charge (Q) is defined as the 
integral of cell current (I) with respect to time (t) and is given by 
 
                                                                                                                                              Eq. 4.1.6 
The adsorption charge associated with a known adsorbate on the electrode surface (Qm) and the charge 
associated with monolayer coverage of the said adsorbate (Qad), can be related to the electrochemical 
surface area, Aec (cm
2
) by 
                                                                  
   
  
                                                                           Eq. 4.1.7 
The concentration of electroactive bienzyme associated with the antTiO2-CH surface can be determined 
by integrating the anodic peak according the Eq. 4.1.6 
                  
 
     
                                                                        Eq. 4.1.8 
where,   is the number of mol/cm2, Q is the charge obtained by integrating the anodic peak, n is the 
number of electrons involved in the reaction (1) and F is Faraday’s constant. It has been found that the 
surface concentration of the ChEt-ChOx/antTiO2-CH/ITO is 5.3×10
-9 
mol/cm
2
.The diffusion coefficient 
(or diffusivity) of the electrolyte containing redox species from CV response at different scan rate has 
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been estimated using the Eq. 3.2.5 (Chapter 3). The higher diffusivity (76.37 × 10
-6
 cm
3
/s) of the redox 
species for ChEt-ChOx/antTiO2-CH/ITO bioelectrode is responsible for faster response times. 
4.6.5 Chronoamperometric studies 
The effect of flow rate of this microfluidic sensor has been investigated using chronoamperometric 
technique. Figure 4.2.7(iii) shows chronoamperometric response of the antTiO2-CH/ITO electrode (a) and 
ChEt-ChOx/antTiO2-CH/ITO (b) as a function of flow rate (0.01-15 µL/min). It has been observed, that 
the chronoamperometric current increases with increasing flow rate (buffer solution) upto 5µL/min after 
which the current becomes saturated (curve a). It appears that the electrode exhibits higher diffusion with 
increasing flow rate. This is because the diffusivity of redox species increases with higher buffer flow rate 
due to improved mass transport resulting from the increased fluid velocity. In case of the ChEt-
ChOx/antTiO2-CH/ITO bioelectrode, the current initially rises with flow rate (buffer solution on addition 
of cholesterol (25 mg/dl) upto 1µL/min after which it decreases [Figure 4.2.7(iii), curve b]. This may 
perhaps be assigned to the retention time for flux of electro active species in the biochemical reaction. 
After 1µL/min flow rate, the retention time is found to be lesser resulting in decreased response current. It 
may perhaps be due to the fact that the cholesterol molecules move away from the sensing surface via 
microchannel prior to completion of the biochemical reaction onto the sensor surface resulting in 
decreased current. Thus, the electrochemical measurements have been carried out at the optimum flow 
rate 1.0 µL/min.  
4.6.6 Electrochemical impedance spectroscopy (EIS) studies  
The results of EIS studies conducted on this bioelectrode show two semicircles (charge transfer 
resistances) of Nyquist plots as shown in the Figure 4.2.9. The charge transfer resistances, Rct1 and Rct2 for 
both circuits of antTiO2-CH/ITO electrode have been found to be as 22.0 kΩ and 3.1 ×10
5
 Ω, 
respectively, at 0.6V bias potential [Figure 4.2.7(iv), curve a].  This is because the antTiO2-CH matrix has 
increased electroactive surface area of electrode resulting in easier electron transfer from the medium to 
electrode due to increased diffusion of redox species onto surface charged antTiO2-CH surface. In 
particular, experimentally obtained Rct in the antTiO2-CH matrix can be explained as (i) diffusion of 
antTiO2 nanoparticles into CH molecules to obtain changed oxidation state, and (ii) this diffusion may 
result in increased conductivity and hence compensate for the higher resistance of CH due to larger 
molecules. The Rct further decreases (Rct1=16.8 kΩ and Rct2=2.7 ×10
5
 Ω for both equivalent circuits) after 
the immobilization of ChEt-ChOx onto antTiO2-CH surface revealing that mesoporous antTiO2-CH 
provides a desirable microenvironment for the immobilization of bienzyme [Figure 4.2.7(iv), curve b]. 
The bienzyme (ChEt and ChOx) re-arranges its structure which presents better conformation onto 
antTiO2-CH surface and the secondary and tertiary structure of ChEt-ChOx perhaps play important roles 
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towards the increased availability of the active sites. Thus, the ChEt-ChOx/antTiO2-CH/ITO bioelectrode 
provides easier electron transfer due to increased active sites for electrical contact between electrode and 
the redox label in solution resulting in lower electrochemical impedance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
 
Figure 4.2.7(i) CV of (a) antTiO2-CH/ITO electrode and (b) ChEt-ChOx/antTiO2-CH/ITO bioelectrode in 
PBS solution (50 mM, pH 7.0, 0.9% NaCl) containing 5 mM [Fe(CN)6]
3−/4−
 , (ii) CV of ChEt-
ChOx/antTiO2-CH/ITO bioelectrode as a function of scan rate [20-160 (mV/s)] in ascending order, inset: 
anodic and cathodic peak current vs scan rate (mV/s)
-1/2
, (iii) chronoamperometric response current vs 
flow rate (µL/min) of (a) antTiO2-CH/ITO electrode and (b) ChEt-ChOx/antTiO2-CH/ITO bioelectrode, 
and (iv) electrochemical impedance spectroscopy (EIS) of (a) antTiO2-CH/ITO electrode and (b) ChEt-
ChOx/antTiO2-CH/ITO bioelectrode, (inset: zoom image). 
 
Figure 4.2.8(i) shows EIS spectra of ChEt-ChOx/antTiO2-CH/ITO bioelectrode obtained as a 
function of flow rate (0.01- 5 µL/min). It has been observed that the Rct2 of the semicircle gradually 
increases, with increased flow rate of cholesterol solution containing [Fe(CN)6]
3−/4−
 ions. This may be due 
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to increased number of [Fe(CN)6]
3−/4−
 at the higher fluid velocity. After 1µL/min, the impedance of ChEt-
ChOx/antTiO2-CH/ITO bioelectrode increases slowly and becomes saturated (inset). This optimum flow 
rate of 1µL/min has been used to conduct EIS measurements.           
Figure 4.2.8(ii) shows EIS spectra of ChEt-ChOx/antTiO2-CH/ITO bioelectrode as a function of 
applied potential (0 – 0.7 V). It has been seen that there are two semicircles that appear (zoom image) in 
low frequency region and high frequency region as shown in equivalent circuit model. The Rct2 values of 
semicircle 2 in low frequency region of the ChEt-ChOx/antTiO2-CH/ITO bioelectrode have been found to 
increase linearly with increased potential [inset, Figure 4.2.8(ii)]. This reveals facile electron transfer 
kinetics wherein resistance controls the electron transfer kinetics of the redox probe at the electrode. The 
depression angle ( ) is an important parameter by which the semicircular displaced below the real axes is 
related to the width of the relaxation time distribution [6]. It can be seen that arc of the semicircle with 
least   value, is less distorted from centre of the real axis and can be estimated using the relation   
         where, n is the fractional exponent. Figure 4.3(i) shows the variation of depression angle ( ) 
for ChEt-ChOx/antTiO2-CH/ITO bioelectrode as a function of applied potential. It is observed that values 
of ( ) for ChEt-ChOx/antTiO2-CH/ITO bioelectrode decrease on increasing the potential from 0 to 0.7 V. 
The electric double layer or constant phase element (Cdl) has been found to decrease with increasing 
potential. This suggests that the resistance represented in the semicircle of the Nyquist plot depends on 
the bias voltage. Thus, the Rct2 values are found to increase at higher potential indicating that the charge 
transfer at low frequency is dependent on polarization potential, thus the high potential of 0.6V has been 
chosen for biosensing. 
The bioelectrode has been further characterized by analyzing the following important parameters 
such as heterogeneous electron transfer rate constant (k0) and time constant (τ) for redox probe containing 
[Fe(CN)6]
3−/4−
 ions [31]. The corresponding k0 of the modified electrode has been calculated using charge 
transfer kinetics. The k0 value of the ChEt-ChOx/antTiO2-CH/ITO bioelectrode obtained as 2.03 ×10
-6 
is 
higher than that for antTiO2-CH/ITO electrode (1.7×10
-6
), indicating a faster electron exchange between 
the redox probe. The ChEt-ChOx immobilization on antTiO2-CH/ITO shows a sluggish electron charge 
transfer rate constant resulting in the generation of low capacitance at the electrode surface. The high 
value of time constant (τ) for the ChEt-ChOx/antTiO2-CH/ITO compared to that of the antTiO2-CH/ITO 
electrode is observed due to the slow diffusion of [Fe(CN)6]
3−/4−
 ions at the electrode enzyme 
layer/solution interface. The surface coverage (θ), is calculated using the relation  
                                                           
               
                  
                                                          Eq. 4.1.9 
where θ is the fraction of occupied binding sites. The                 and                    are 
respectively, the surface specific charge transfer resistances of antTiO2-CH/ITO electrode and ChEt-
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ChOx/antTiO2-CH/ITO bioelectrode. The value of θ has been determined to be as 0.87, indicating more 
than 87% surface coverage of the antTiO2-CH/ITO electrode by ChEt-ChOx molecules. 
4.6.7 Impedance response studies 
The electrochemical impedimetric response of the microfluidic ChEt-ChOx/antTiO2-CH/ITO bioelectrode 
obtained as a function of cholesterol concentration (2–500 mg/dl) in PBS solution containing [Fe(CN)6]
3-
/4- 
is shown in Figure 4.3(ii). During electrochemical measurements, various concentrations of cholesterol 
are injected into the microchannels at a constant flow rate of 1.0 µl/min. A Faradic impedance spectrum 
(Nyquist plot) includes two semicircle regions observed at higher and lower frequencies corresponding to 
electron-transfer limited process. 
 
   
 
 
 
 
 
 
 
 
Figure 4.2.8(i) EIS spectra of ChEt-ChOx/antTiO2-CH/ITO bioelectrode as a function of flow rate (0.01-
5.0µL/min), inset: plot between charge transfer resistance (Rct2) and flow rate (µL/min) and (ii) EIS 
spectra of ChEt-ChOx/antTiO2-CH/ITO bioelectrode at different potential (0.1-0.7 V), inset: the plot 
between Rct2 value and logarithm of potential. 
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Figure 4.2.9 Randles equivalent circuit model for EIS measurement, where Rs= solution resistance, Rct= 
charge transfer resistance, Qdl= constant phase element or double layer capacitance, W= Warburg 
impedance. 
 
The electronic impedimetric circuit of the electrochemical system has been shown in Schematic 
6.1.3. It can be seen that change in the second semicircle diameter (Rct2) is higher compared to that of the 
first semicircle as shown in Figure 4.3(ii). The charge transfer resistance of microfluidic ChEt-ChOx/CH-
antTiO2/ITO bioelectrode (Rct2) reveals electron-transfer kinetics of redox probe at the electrode interface 
which decreases with increasing cholesterol oleate concentration [Figure 4.3(iii)]. This can be attributed 
to the fact that in presence of ChEt on antTiO2-CH /ITO electrode, the esterified cholesterol get converted 
to cholesterol and fatty acid. Again, ChOx converts cholesterol to choleste-4-ene-3-one and H2O2. The 
generated electrons during the re-oxidation of ChOx after enzymatic reaction are transferred to the CH-
antTiO2/ITO electrode via Fe(III)/Fe(IV) couples that help in enhanced charge transfer rate leading to 
decreased Rct2 value. A linear calibration curve [Figure 4.3(iv)] has been fitted between Rct2 and logarithm 
of cholesterol concentration revealing linearity from 2 to 400 mg/dl in the detection range of 2-500 mg/dl. 
The linear regression equation is Rct2(Ω) = 27.9 kΩ - 6.77 kΩ mg
-1
dl × [cholesterol oleate concentration 
(mg/dl)] with a correlation coefficient of 0.996. The ChEt-ChOx/antTiO2-CH/ITO based microfluidic 
chip yields excellent sensitivity (67.7 kΩ/mg/dl) compared to that in other literature [248]. The sensitivity 
of the mesoporous TiO2 grafted CH microelectrode based impedance enzymatic sensor is several-folds 
higher, revealing that the combination of a microfluidic impedance sensor with biopolymer-
nanostructured microelectrodes provides a technology for more sensitive detection of esterified 
cholesterol. The low apparent Michaelis–Menten constant (  
   
) obtained (1.3 mg/dl) indicates that the 
ChEt-ChOx/antTiO2-CH/ITO bioelectrode has higher affinity towards the esterified cholesterol compared 
to other reported literature. This may be due to the incorporation of mesoporous antTiO2 nanoparticles 
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into chitosan matrix, that is capable of binding strongly with the desired enzyme. It has been observed 
that the reported cholesterol biosensors show poor detection limit, range and larger detection time as 
shown in Table 4.1.4. This proposed impedimetric microfluidic biosensor shows a lower detection limit 
of 0.2 mg/dl and a wide detection range of 2-500 mg/dl. The biosensing characteristics of ChEt-
ChOx/antTiO2-CH/ITO bioelectrode along with those reported in literature are summarized in Table 
4.1.4. Thus, the method of detection (EIS) and the integration of antTiO2-CH matrix to the microfluidic 
device is an efficient, fast and low cost technique for total cholesterol detection.  
4.6.8 Reproducibility studies 
The reproducibility of the ChEt-ChOx/antTiO2-CH/ITO bioelectrode has been investigated at 100 mg/dl 
cholesterol concentration, no significant change in Rct2 value is observed after repeated for atleast 15 
times as evidenced by the observed low standard deviation (RSD) of  3.19% (n=5) indicating good 
precision. The ChEt-ChOx/antTiO2-CH/ITO bioelectrode shows good repeatability as indicated by the 
RSD 2.2 % (n = 15) for 100 mg/dl cholesterol concentration, after 15 times washing/repetition of the 
bioelectrode. No significant decrease in current is observed till repeated usage of 12 times, after which the 
bioelectrode shows slight decrease in current response that may be arising due to the denaturation of 
biomolecules. 
4.6.9 Effect of stability and specificity 
The shelf-life of the ChEt-ChOx/antTiO2-CH/ITO bioelectrode measured in intervals of 1 week has been 
estimated to be 8 weeks. The decrease in the value of Rct2  has been found to be about 10% up to about 8 
weeks after which the current decreases resulting in about 80% loss in about 10 weeks. The specificity of 
this enzymatic sensor is mainly dependent on the bienzyme (ChEt-ChOx) immobilized onto the sensor 
surface. To evaluate the specificity of the mesoporous antTiO2-CH based impedance enzymatic sensor, 
glucose (5 mM),  uric acid (0.1 mM), and urea (1 mM) analytes present in human serum sample, are 
tested at a concentration of 100 mg/dl (cholesterol oleate) using CV. No significant change in current 
response has been observed as evident by low relative standard deviation of 4.4 % [Figure 4.3.1]. 
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Figure 4.3 (i) Dispersion angles versus potentials for ChEt-ChOx/antTiO2-CH/ITO bioelectrode, (ii) EIS 
response spectra of ChEt-ChOx/antTiO2-CH/ITO bioelectrode as a function of cholesterol oleate 
concentration (at flow rate of 1μL/min) (iii) plot between Rct2 and concentration of cholesterol oleate [2-
500 mg/dl] and (iv) the microfluidic sensor linear fit curve between EIS response and logarithm of 
cholesterol oleate concentration  in the range of 2-500 mg/dl. 
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Figure 4.3.1The selectivity studies in presence of various interferents. 
 
Table 4.1.4 Sensing characteristics of cholesterol biosensor along with those reported in literature 
 
 
 
 
Working 
electrode  
Detection 
technique 
Detection 
range 
(mg/dl) 
Detection 
limit 
(mg/dl) 
Sensitivity  Km Value 
(mg/dl) 
References 
Fe2O3 EIS 0.25-400  0.24 86Ω/mg dl
-1
  0.08 [248] 
Chitosan-
CeO2 
CV 10-400  5.0  47 μA/mg dl-1 3.5  [249] 
Chitosan-
SnO2  
CV 5-400  5.0  34.7 μA/mg dl-
1
 
146.9  [250] 
Chitosan-ZnO  CV 3-300  …….  2.0 μA/mg dl-1 8.8  [251] 
TiO2-CH EIS 2-500 0.20 67.7 k Ω/mg 
dl
-1
 
1.3 Present 
Work 
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4.7.0 Potential merits and demerits  
This impedimetric microfluidic biosensor shows excellent sensing characteristics towards total cholesterol 
detection. It has been seen that biosensor characteristics using impedance (using EIS) method is improved 
compared to the amperometric detection (using CV) of cholesterol. Compared to other biosensors, this 
microfluidic biosensor exhibits very low detection limit with a wide detection range of 2-500 mg/dl. After 
chitosan incorporation onto titania, the pore volume decrease from 0.2961 cc/g to 0.1265 cc/g (i.e. 
42.72% porosity or pore volume) and the surface area is also decreased due to chitosan coating which has 
blocked the pore entrances. It has been observed that the signal to noise ratio (SNR) is higher resulting in 
higher sensitivity. The incorporation of positively charged CH biopolymer onto mesoporous antTiO2 
matrix shows excellent adsorption ability of enzyme molecules resulting in improved stability. CH helps 
not only the dispersion of antTiO2 nanoparticles but also results in enhanced electron transfer properties. 
It can be seen that the detection time for one impedance scan using frequency response analyzer is about 3 
min, which is higher compared to that of CV scan (30 s) for one particular cholesterol concentration. 
Impedance is a complex analysis compared to amperometric analysis.     
4.8 Conclusions 
I have fabricated a microfluidic chip based on dispersive antTiO2 nanoparticles grafted nanoporous CH 
for total cholesterol detection. Using ac impedance approach, the impedance changes due to catalytic 
reaction of enzymes and detectable cholesterol molecules in this enzymatic microfluidic chip has been 
investigated. The morphological (AFM, SEM) and spectroscopic (UV, FT-IR, XPS) investigations of 
antTiO2-CH matrix indicate immobilization ChEt-ChOx and quantification of functional groups present 
in transducer surface. The electrochemical properties of the fabricated microfluidic chip have been 
investigated using CV, chronoamperometry and EIS techniques. This microfluidic chip showed excellent 
performance as a microscale platform. The impedance analysis of this microfluidic device offers small 
instrument size, low reagent consumption, and system automation, indicating that this microfluidic device 
has a high potential for the POC medical applications. The low cost, high sensitivity and low detection 
limit can be accounted for high electronic conductivity of antTiO2 grafted CH and good catalytic activity 
of the nanoparticles. In addition, the CH not only enhances the electrode forming ability but also 
improves dispersion of antTiO2 nanoparticles at surface.  
The application of TiO2 nanoparticles in the microfluidic platform for biofunctionalization is a 
major concern due to its low isoelectric point resulting in poor biomolecules absorption on transducer 
surface. There is a scope to utilize other metal oxides which having high isoelectric point for 
immobilization of biomolecules in order to improve sensitivity, detection limit and other related 
parameters. The antTiO2-CH based microfluidic biosensor results in increased complexity for POC 
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applications. The higher potential of fabricated microfluidic system using antTiO2-CH matrix is a 
limitation for POC application. Keeping this in view, nanostructured NiO having higher isoelectric point 
and better electrochemical properties has been explored for development of the microfluidic POC 
cholesterol biosensor. The next Chapter describes the fabrication and characterization of a microfluidic 
biochip using nanostructured NiO for total cholesterol estimation.  
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Highly efficient microfluidic biochip based on  
nanostructured nickel oxide 
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5.1 Introduction 
This chapter describes results of the studies relating to the application of nickel oxide nanorods (NR-NiO) 
biosensor integrated with microfluidics for total cholesterol detection. First, I describe the integration of 
the microfluidic biosensor chip for total cholesterol detection. Attempts have been made to discuss the 
details relating to synthesis and characterization of nickel oxide nanorods, followed by the 
electrochemical characterization of the device. Finally, the merits and performance of this biosensor chip 
for total cholesterol estimation are compared with the studies described in the preceding Chapter.  
Recent years have seen significant advances in the development of nanofluidics-based devices 
using one-dimensional (1D) nanostructured materials such as nanorods, nanotubes, nanowires and 
nanorings due to their novel properties [252, 253]. These 1D nanostructures act as “electronic wires” that 
can provide direct channels for electron transport from enzymes’ active sites to current collector leading 
to improved loading of biomolecules (enzymes) due to large-area scaffold. Among the 1D materials, the 
rod-like geometries with well-defined crystal surfaces have been reported as advantageous for transport of 
charge carriers such as electrons and ions [254]. The application of microfluidics-based devices to 
biosensing has recently grown exponentially because of their exceptional merits over conventional 
devices in terms of portability, microscale bioanalysis, automated drug discovery, lower cost, quick 
diagnosis, sample and reagent consumptions [75]. The integration of a microfluidics device (lab-on-a 
chip) with 1D nanorods provides a promising approach in development of a smart biosensing chip that 
can be used to monitor desired analytes [255].  
Many groups have reported the use of nanorods/nanotubes for bio-sensing, filtration and sample 
separation based on microfluidics devices [256]. Shi et al. have fabricated a low cost, high throughput and 
highly parallel mix-and-match nanodevices of integrated nanopillar arrays using soft UV nanoimprint 
lithography and reactive-ion-etch techniques for long DNA molecule separation [257]. Koto et al. have 
developed molecular sensor arrays composed of vertical germanium nanowires that function as a FET 
based microfluidic channel on silicon resulting in improved sensing performance with response time less 
than 10 s [258].  
 Nanostructured nickel oxide (NiO) is an antiferromagnetic semiconductor with a wide band gap 
of ∼3.6 eV that can be used for fabrication of optoelectronic devices, FET and biosensors [259]. NiO with 
different morphologies, including nanoparticles, nanostrips, nanorods, nanosheets and hollow spheres 
have recently been reported for various applications including biosensing [260]. The rod-like 
nanostructured NiO has been found to be stable in air and does not degrade with immobilization of 
biomolecules. The selective binding of molecules to the nanostructured NiO and a Debye length 
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comparable to the nanostructure may perhaps strongly influence its surface, giving rise to enhanced 
sensitivity [261]. In addition, NiO nanorods offer attractive properties likes high isoelectric point (IEP; 
10.8), high electro-catalytic property and sensitivity that enhance the intensity of an electrochemical 
signal. However, 1D NiO platform offers higher accumulation of charges on the surface in comparison to 
the 2D nanostructured NiO due to its improved electrical properties. A nanostructured NiO based 
genosensor for diagnosing Visceral Leishmaniasis (Kala azar) has been demonstrated and it has been 
found to be an excellent matrix for immobilization of biomolecules [219]. Li et al. have used NiO hollow 
nanospheres due to their high specific active sites and electrocatalytic activity via controlled precipitation 
of metal ions with urea using carbon microspheres as templates for application to glucose biosensor [259]. 
The cholesterol biosensors based on gold nanowires have been fabricated by electroplating 
anodized alumina template integrated onto a microfluidic platform by dielectrophoresis coating [262]. 
Singh et al. have demonstrated that chitosan modified NiO nanoparticles can act as good acceptors of 
electrons generated during re-oxidation of cholesterol oxidase (ChOx) that are transferred to electrode via 
Ni
+2
/Ni
+3
 redox couple resulting in increased electrochemical current and exhibit the sensitivity upto 
0.808 μA/(mg dl cm2) [220]. This nanostructured chitosan-NiO matrix shows Michaelis–Menten constant 
(km) value of 0.67 mM attributed to favourable conformation of ChOx and higher loading onto transducer 
surface. However, there is a considerable scope to improve the biosensing performance in terms of 
sensitivity, Km value, reducing use of reagents/samples, low cost and miniaturization for total cholesterol. 
5.2 Experimental section 
5.2.1 Fabrication of microfluidic biosensor 
The synthesis of NR-NiO using co-precipitation method has been described in the third Chapter, (Section: 
3.3.6). The transparent thick gel-like Ni(OH)2 solution is deposited onto patterned ITO on the glass 
substrate via dip coating. Finally, this glass substrate containing Ni(OH)2/ITO and bare ITO electrodes are  
annealed at 400 
o
C under  ambient conditions for about 2 h to remove any solvent. ITO microelectrodes 
have been fabricated as described before. In order to immobilize the desired enzymes, 1 mg/ml 
cholesterol esterase (ChEt) and 1 mg/ml cholesterol oxidase (ChOx) are mixed in the ratio 1:1 and 10 µl 
solution of this mixture is uniformly spread onto NR-NiO/ITO microelectrode via physical adsorption 
(Figure 5.1.1) and is kept in a humid enviroment for 12 h at 4 
o
C. The values of ionization electron 
potential (IEP) of NiO and enzymes (ChEt-ChOx) are found to be 10.8 and 5.3, respectively. The NiO 
matrix is positively charged in contrast to the enzymes that are negatively charged resulting in 
electrostatic interactions. This ChEt-ChOx/NR-NiO/ITO bioelectrode is washed with 50 mM PBS (pH 
7.0) in order to remove any unbound enzymes from the electrode surface. The bioelectrode is stored at 4 
o
C when not in use. Nickel oxide nanorods-based electrode is co-immobilized with ChEt-ChOx to serve 
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as the working electrode (ChEt-ChOx/NR-NiO/ITO) and bare ITO microelectrode serves as counter 
electrode. PDMS microchannels tightly sealed onto the glass substrate containing ITO and ChEt-
ChOx/NR-NiO/ITO electrodes (Figure 5.1.1) via conformal contact (reversible sealing) act as the 
microfluidics biosensor chip. To avoid fluids leakage during experiment, the ITO substrate is clamped 
with PDMS slab. All the two electrodes and microchannel are embedded on the same chip.   
 
5.2.2 Precautions 
(i) The temperature should be maintained constant during fabrication of PDMS microchannels. The 
oxidizing material which may cause a reaction with PDMS must be avoided. 
(ii) Direct contact of eye with PDMS may cause temporary redness and discomfort.  
(iii) The correct stoichiometry of precursor material is needed for co-precipitation of NiO.  
 
 
Figure 5.1.1 The microfluidic chip used for total cholesterol detection (ordered arrangement of nanorods 
on this chip is assumed for easy representation). 
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5.3 Results and discussions 
5.3.1 XRD studies 
The X-ray diffraction (XRD) studies [Figure 5.1.2] reveal the purity and crystallinity of the synthesized 
nickel oxide nanorods (NR-NiO) with the face-centred cubic (a) 4.1 Å and space group Fm3m (225),   
[JCPDS Card No. 78-0423].  All the peaks are assigned to the diffraction pattern resulting from the (111), 
(200), (220) and (222) planes of the cubic NiO, respectively. This observation indicates that the resultant 
NiO nanorods are mainly dominated by (111) facets. The intensity ratio between two planes (111) and 
(200) of NR-NiO [inset: Figure 5.1.2] calculated to be 5.2 is much higher than that of bulk NiO (1.45), 
indicating preferred crystallization along the plane (111). The d111 value of NiO nanorods is found to be 
0.241nm for the plane (111) which is the same as from the HR-TEM studies. The peaks seen at 50.9° and 
60.5° corresponding to the planes (124) and (143) are due to ITO coating on the glass substrate. 
5.3.2 Raman studies 
The Raman spectra of NR-NiO powder show several bands above 400 cm
-1
 at room temperature (25 
o
C) 
[Figure 5.1.3]. The vibrational band due to one phonon (1P) at 507 cm
-1 
corresponds to transverse optical 
(TO) mode arising due to excitation wavelength of 532 nm. This 1P band has very small intensity 
indicating good crystallinity.  The peak due to two-phonon (2P) seen at ~713 cm
-1
 is assigned to 2TO 
modes and the at ~1090 cm
-1
 is attributed to the 2LO (longitudinal optical) mode. The band found at ~713 
cm
-1
 exhibits low intensity at room temperature indicating presence of NR-NiO.
 
In the ultra violet (UV)-
visible spectra, a strong observation peak is observed at ~379 nm corresponding to intra-3d transition of 
Ni
2+
 in NiO structure [inset: Figure 5.1.3] as compared to that of the bulk NiO (484nm). This result shows 
blue shift to 105 nm indicating formation of the nanostructured NiO. This is because nanostructures 
are laterally quantum confined and occupy energy levels that are different from the traditional continuum 
of energy levels or bands found in a bulk material.  
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Figure 5.1.2 X-Ray diffraction pattern of NR-NiO nanorods onto ITO film (inset: powder XRD  pattern 
of NiO nanorods) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1.3 Raman spectroscopy studies of NiO nanorods (inset: UV-vis absorption spectrum of NR-
NiO) 
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5.3.3 FT-IR studies 
In FT-IR studies [Figure 5.1.4], the infrared peak found at 545 cm
-1
 in the fingerprint region (curve a) 
corresponds to vibrational bending of Ni-O. The dominant peak found at 1263 cm
-1
 arises due to the 
formation of bicarbonate (HCO3) stretching on NR-NiO film. The absorption bands seen at ~1000–2500 
cm
−1 
are assigned to the O–C=O symmetric and asymmetric stretching vibrations and the C–O stretching 
vibration, which indicates that the NiO nanorods tend to strongly physically adsorb CO2. The presence of 
peak at 1632 cm
-1
 peak [curve (b)] corresponds to amide 1 band of ChEt and ChOx reveals 
immobilization of enzymes. The band found at 545cm
-1
 for NiO is shifted to 600 cm
-1
 due to 
incorporation of the enzyme (ChEt and ChOx) molecules. The band found at (3500-3700 cm
-1
) is 
assigned to the O–H stretching vibration in the NiO film. 
 
 
 
 
 
 
 
 
 
 
 
 
        
 
Figure 5.1.4 FT-IR spectra of (a) NR-NiO/ITO film and (b) ChEt-ChOx/NR-NiO/ITO film. 
 
5.3.4 TEM studies 
The high resolution-transmission electron microscopy (HR-TEM) studies have been conducted to unravel 
the NiO microstructure shape, size and surface morphology. For the HR-TEM studies, NiO nanorods 
dispersed in methanol are deposited onto the carbon coated copper grid by drop casting and dried in an 
open atmosphere. Figure 5.1.5(a) shows agglomeration of NiO nanorods. The majority of NiO nanorods 
exhibit nearly straight line appearance [inset: Figure 5.1.5]. The solid rods-like shapes tend to organise the 
long axes parallel to each other. The structural orientation of the individual nanorod of size (length= 
141 
 
~38nm; dia=~8nm) has been investigated via high-resolution TEM [Figure 5.1.5(b)] and it shows 
presence of moire fringes. These results reveal the presence of nanorods with conical tips in NiO. These 
NiO nanorods exhibit a low aspect ratio (length-to-width ratio) of ~4 indicating elongated nanostructure. 
The clear lattice fringes illustrate that the nanorods are highly crystalline in nature [Fig. 3(c)]. The spacing 
between the two adjacent fringes for different planes is found to be 0.245 nm and 0.20 nm [Figure 
5.1.5(c)]. The interplanar spacing of 0.245 nm [inset: image c] corresponds to the (111) plane revealing 
anisotropic growth of the nanorod along (111) direction. The selected area electron diffraction (SAED) 
pattern consists of five diffraction rings with different radii [inset: Fig. 4.4(b)]). The diameter of the 
diffraction rings in the SAED pattern is proportional to          .   The 1st, 2nd, 3rd, 4th and 5th rings 
correspond to (111), (200), (220), (311), and (222) planes, respectively. These solid rod-like shapes of 
NiO may be beneficial for loading of enzymes due to higher surface area. However, a thick transparent 
layer of visible enzymes (ChOx-ChEt) containing consistent distribution of ChOx-ChEt is clearly visible 
on the individual nanorods [Figure 5.1.5 (b)]. These results indicate that NiO nanorods act as matrix or 
substrate for loading of biomolecules. 
5.3.5 Electrochemical characterization 
The EIS technique has been used to measure impedance of the electrode-electrolyte interface in response 
to a small AC signal as a function of frequency (0.01 to 10
5
 Hz) [Figure 5.1.6(i)]. The modification of 
electrode surface results in change in the value of charge transfer resistance (RCT). The diameter of 
semicircle plot in EIS spectra gives a value of RCT that reveals electron transfer kinetics of the redox 
probe at the electrode/electrolyte interface. The Nyquist diagram of the EIS curve shows that the RCT 
value of NR-NiO/ITO electrode is 19 kΩ (curve a). This is due to presence of NiO nanorods on electrode 
surface that is insulating in nature thus impeding diffusion of the ferri/ferro cyanide [Fe(CN)6]
3-/4-
 ions 
from bulk solutions to electrode surface resulting in enhanced charge transfer resistance. After co-
immobilization of ChEt and ChOx on NR-NiO electrode surface, the charge transfer resistance (RCT) 
decreases to 8.08 kΩ (curve b) implying that enzyme molecules are indeed absorbed onto NR-NiO/ITO 
surface suggesting that immobilized enzymes molecules bind strongly with NiO nanorods on the 
electrode surface. This low value of RCT (curve b) is because of the enhanced catalytic activity of the 
enzyme and favourable electron transfer kinetics of NiO nanorods that enable rapid oxidation/reduction of 
the [Fe(CN)6]
3-/4-
 ions that reach the electrode surface. In addition, NiO nanorods perhaps establish an 
electronic pathway that reduces the tunnelling distance to diffuse ions (or electrons) between enzymes 
active centre and electrode revealing that the bioelectrode is more conductive in nature in agreement with 
the results of the CV studies.  
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Figure 5.1.5 HR-TEM analysis of (a) synthesis NiO nanorods (inset: zoom image nanorods), (b) single 
nanorods micrograph with length 36.7nm and width 8.3nm (inset: SAED pattern of NiO nanorods), (c) 
lattice fringes of as-synthesis NR-NiO different planes (inset: lattice fringe for (111) plane and zoom 
image) and (d) ChEt-ChOx immobilization onto NR-NiO (inset: image at low resolution). 
 
 
 
 
(a) (b) 
(c) (d) 
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CV studies are carried on the NR-NiO/ITO electrode and the ChEt-ChOx/NR-NiO/ITO 
bioelectrode in the potential range from -0.8 V to +0.9 V in PBS buffer containing 5 mM [Fe(CN)6]
3-/4- 
at 
a scan rate of 30 mV/s. [Figure 5.1.6(ii)]. In CV, the ChEt-ChOx/NR-NiO/ITO bioelectrode shows well-
defined oxidation and reduction peaks at +0.399 V and -0.14 V, respectively, with peak-to-peak 
separation of 0.53 V. These anodic/cathodic peaks arise due to presence of the nanorods that provide 
confined 1D channels for transportation of electrons from enzyme active site to the electrode. The anodic 
peak current of ChEt-ChOx/NR-NiO/ITO bioelectrode is higher (curve b) compared to that of the NR-
NiO/ITO electrode (curve a) resulting in fast electron communication towards the matrix and ChEt and 
ChOx molecules. This indicates that a larger surface area of nanorods facilitates higher mass diffusion 
efficiency due to electrochemical activation of the active sites of enzymes resulting in enhanced redox 
current. The high electrocatalytic activity of NiO nanorods results in a superior performance of the 
cholesterol biosensor.  
 
 
 
 
 
 
 
Figure 5.1.6(i) EIS of (a) NR-NiO/ITO electrode and ChEt-ChOx/NR-NiO/ITO bioelectrode and (ii)  CV 
of (a) NR-NiO/ITO electrode and (b) ChEt-ChOx/NR-NiO/ITO bioelectrode in PBS solution (50 mM, pH 
7.0, 0.9% NaCl) containing 5 mM [Fe(CN)6]
3−/4−
. 
 
5.3.6 Scan rate studies  
The CV studies of the ChEt-ChOx/NR-NiO/ITO bioelectrode have been carried out as a function of scan 
rate (30-110 mV/s) [Figure 5.1.7]. The magnitude of current of both anodic peak (Ipa) and cathodic peak 
(Ipc) observed for ChEt-ChOx/NR-NiO/ITO bioelectrode increases linearly with scan rate (inset: Figure 
5.1.7) indicating quasi-reversible diffusion controlled behaviour. It can be seen that anodic potential shifts 
towards positive side and the cathodic peak potential (inset: Fig. 4.6) shifts in the reverse direction. The 
values of the slope, intercept and correlation coefficient are given by Eq. (5.1.1-5.1.2). 
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The surface concentration (  
 ) of ChEt-ChOx/NR-NiO/ITO bioelectrode has been estimated using the 
following Eq. 5.1.3 
                                    
       
     
  
      
                                                                  Eq. 5.1.3 
where ip is the anodic peak current, n is the number of electrons transferred (1), F is the Faraday constant 
(96485.34 C mol
-1
), R is the gas constant (8.314 Jmol
-1
 K
-1
), A is the area of electrode surface (cm
2
),   
  is 
the surface concentration of the ionic species in the film (mol/cm
2
), Ep is the peak potential and   
  is the 
formal potential.            and  
  (rate constant) corresponds to the slope and intercept of ln(ip) versus 
      
   curve at different scan rates. The value of surface concentration for ChEt-ChOx/NR-NiO/ITO 
bioelectrode has been found to be as 5.6 × 10
−7
 mol/cm
2
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1.7 CV of ChEt-ChOx/NR-NiO/ITO bioelectrode as a function of scan rate [30-110 (mV/s)
-1/2
 in 
ascending order in PBS solution containing 5 mM [Fe(CN)6]
3−/4-
. 
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5.3.7 Effect of flow rate 
Figure 5.1.8 shows the plot between diffusivity of [Fe(CN)6]
3-/4- 
ions for the NR-NiO/ITO electrode and 
flow rate [10-70 µl/min] using CV in PBS (50mM, pH 7.0, 0.9% NaCl) at a scan rate of 30 mV/s. It has 
been found that the flow rate influences the diffusion of charge carriers (electrons) towards the electrode. 
The anodic current is found to increase with increasing flow rate of PBS buffer which is controlled by 
application of a positive pressure (syringe pump) [inset: Figure 5.1.8].  The diffusion coefficient (or 
diffusivity) of the electrolyte ions for each CV response at different flow rate has been estimated using 
Randles-Sevcik equation. It has been observed that diffusivity of the redox species increases at higher 
buffer flow rate due to improved mass transport resulting from increasing fluid velocity [263]. However, 
Collier et al. have demonstrated that response time decreases with increasing flow rate of buffer solution 
and have shown that the response time is inversely proportional to the flow rate [264] Thus, 
electrochemical studies have been carried out the at optimized flow rate of 10 μL/min.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1.8 Diffusivity of NR-NiO/ITO electrode at different flow rates using syringe pump [inset: CV 
response of NR-NiO/ITO electrode at different flow rates (10-70 μL/min)]. 
 
5.3.8 Electrochemical response studies 
The CV response of ChEt-ChOx/NR-NiO/ITO bioelectrode has been conducted with successive addition 
of cholesterol oleate at the inlet of the microchannel at a scan rate of 30 mV/s with optimum flow rate (10 
µL/min) condition [inset: Figure 5.1.9]. It has been observed that the anodic peak current increases with 
increased concentration of cholesterol oleate (cholesterol esters) varying from 25 to 400 mg/dL [Figure 
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5.1.9]. In the proposed biochemical reaction, cholesterol esters (e.g. cholesterol oleate) are hydrolyzed via 
cholesterol esterase (ChEt) into cholesterol (or 3β-hydroxysteroids) and fatty acid. Again utilizing flavin-
adenine-dinucleotide (FAD), ChOx catalyses the oxidation and isomerization of 3β-hydroxysteroids 
having trans double bond Δ5-Δ6 of steroid ring corresponding to Δ4-3-ketosteroid and hydrogen peroxide 
(H2O2).
35
 The H2O2 produce electrons via re-oxidation at 0.45 V. Thus during cholesterol detection, the 
NiO nanorods directly accept electrons from the reduced ChOx molecules in presence of [Fe(CN)6]
3−/4−
 as 
mediator (Schematic S1, supplementary data). This integrated microfluidic sensor exhibits detection in 
the range, 0.65 mM to 10.3 mM with excellent sensitivity of 120 μA/mgdL-1/cm2 compared to that of 
other microfluidic devices as shown in Table 5.1.1. The detection limit is found to be 0.64 mM and the 
value of the enzyme–substrate kinetics parameter (Michaelis–Menten constant, Km) has been estimated 
using the Lineweaver–Burke plot [inset: Fig. 4.9(i)] revealing affinity of enzyme for desired analyte. It 
has been observed that the wide detection range of this biosensor for cholesterol is obtained compared to 
that using carbon nanotubes and gold nanowires based microflsuidic devices (Table 5.1.1). The 
Lineweaver–Burke equation [Eq. 5.1.4] is given by the following as 
                                              
 
   
 
 
    
 
  
   
     
                                                                     Eq. 5.1.4                                                 
where Iss is the steady-state current after addition of the substrate, C is the bulk concentration of the 
substrate, and Imax is the maximum current measured under saturated substrate conditions. It may be noted 
that Km is dependent both on matrix and the method of immobilization of enzymes that may in turn bring 
about conformational changes resulting in different values of Km. Besides this, the value of Km for the 
bound enzyme can be lower or higher than that of purified enzyme. The obtained value of Km for the 
ChEt-ChOx/NR-NiO/ITO bioelectrode (0.16 mM) is lower than the reported value [Table 5.1.1]. The 
lower Km value indicates high affinity for cholesterol to ChOx and ChEt onto NR-NiO/ITO surface for 
faster biochemical reaction. This microfluidic sensor achieves 95% of the steady-state current in less than 
5s indicating fast electron exchange between the ChEt-ChOx and NR-NiO/ITO electrode.   
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Figure 5.1.9 Calibration curve for this microfluidic biosensor between peak current and different 
concentration of cholesterol oleate (25-400 mg/dl) (inset: CV response of ChEt-ChOx/NR-NiO/ITO 
bioelectrode as a function of cholesterol oleate concentration. 
 
5.3.9 Effect of interferents, stability and reproducibility 
The effect of potential interferents such as ascorbic acid (AA), uric acid (UA), glucose (G), lactic acid 
(LA) and urea present in the blood samples at normal concentrations has been investigated on the 
response of ChEt-ChOx/NR-NiO/ITO bioelectrode using CV at the same flow rate [Figure 5.2.1(i)]. The 
change in the oxidation current has been measured in PBS containing equal amount (1:1) of cholesterol 
oleate (200 mg/dL) and interferent using the following Eq. 5.1.5 
                                                                                                                                     Eq. 5.1.5 
where Ichol  and IInt  are the changes in the current corresponding to the cholesterol oleate and the mixture 
of cholesterol oleate with desired interferents. As illustrated [Figure 5.2.1(ii)] the effects are negligible 
except in the case of uric acid.  The storage stability of ChEt-ChOx/NR-NiO/ITO bioelectrode has been 
determined by measuring changes in the current response at regular intervals of 7 days for about 90 days 
[Figure 5.2.1(ii)].  This ChEt-ChOx/NR-NiO/ITO bioelectrode is stored at 4 
o
C when not in use. It has 
been found that bioelectrode exhibits 95% response after about 90 days.  
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Figure 5.2.0 (i) Studies using different interferents for the ChEt-ChOx/NR-NiO/ITO bioelectrode. Current 
response is plotted as a function of different analytes. (ii) Stability studies of the ChEt-ChOx/NR-
NiO/ITO bioelectrode as a function of days. 
 
Table 5.1.1 Sensing characteristics of cholesterol biosensor along with those reported in literature 
Working 
electrode  
Microfluidics 
used  
Detection 
range (mM)  
Lower 
Detection 
limit (mM)  
Sensitivity  Km 
Value 
(mM)  
Ref.  
CNT  Yes  1.25 -10.0  0.25  0.0512 nA/mM  ……..  241 
Au wire  Yes  1.293 -6.4  0.1  ……….  ……..  242 
Gold 
nanoparticles  
No  Up to 2.1  0.060  0.13μA/mM  2.94  243  
ZnO  No  Upto 7.7  0.012  1.53 nA/mM  0.22  244  
Aligned Au 
nanowires  
Yes  0.01–0.060  ...........  0.85 μA/mM  17.1  245 
Anatase-TiO2  Yes  0.64-10.3  0.64  94.65µA/mM  0.14  265 (Prsent 
work) 
NiO nanorods  Yes  0.64-10.3  0.64 120 µA/mM  0.16  Present Work  
 
 
5.4 Potential merits and demerits of this microfluidic biosensor 
The proposed microfluidic system for total cholesterol detection is an efficient technique. The NiO 
nanorods integrated with the microfluidic system offer higher sensitivity and a low detection limits. The 
high isoelectric point of NiO can result in better stability and selectivity. Thus, this system provides 
improved biosensing characteristics as shown in Table 5.1.1. The higher sensitivity of this proposed 
microfluidic system can be attributed to the inherent properties of NiO nanorods on transducer surface 
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that enhance electron transfer kinetics. In addition, Ni(OH)2 has uniform film forming ability, resulting in 
crack-free and better film formation and is easy to be integrated with microfluidic system. It is known that 
the direct functionalization of NiO with biomolecules is better due to positive surface potential which 
provides higher diffusion efficiency and better electrostatic interaction resulting in increased adsorption 
on sensor surface. However, this biosensing system offers higher Km (enzyme kinetics) value as compared 
to that of previously described anatase TiO2 integrated microfluidic system. 
5.5 Conclusions  
A microfluidic-based nano biosensor chip using nickel oxide nanorods functionalized with ChEt and 
ChOx has been presented for the detection of total cholesterol. These NiO nanorods have been 
successfully integrated with the microenvironment module to perform bioanalyte analysis as well as very 
precise and accurate detection. The laminar flow regime due to low Reynold number (0.82) at flow rate 
condition (10 μL/min) through microchannel influences diffusivity towards the electrode via nanorods 
and enzymes active sites. The flow rate is an important parameter in this microfluidic system.  The NiO 
nanorods integrated with the miniaturized microfluidic device offer improved sensitivity for total 
cholesterol detection. Studies show no significant change in redox current of this microfluidics sensor on 
introducing interferents along with the analyte. Thus, a miniaturized and low cost sensor with improved 
biosensing parameters has been developed using this proposed microfluidic chip.  
It is concluded that the NiO is a good nanostructured material suitable for the integration with 
microfluidic system as well as attachment of biomolecules. Thus, I have selected the NiO as a better 
candidate to form a composite material for this application. I have used carbon nanotubes for forming 
nanocomposite with NiO nanoparticles. Details of carbon nanotubes and NiO composite formation and 
integration with microfluidic assembly and detection are the topics of discussion for the next chapter.  
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CHAPTER 6 
Microfluidic biochip based on CNT-NiO  
nanocomposite cholesterol estimation 
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6.1. Introduction 
This Chapter describes the results of studies relating to fabrication of a novel microfluidic nanobiochip 
based on a composite comprising of nickel oxide (NiO) nanoparticles and carbon nanotubes (CNTs). This 
microfluidic chip is utilized for detection of cholesterol and low density lipoproteins (LDL). 
A nanocomposite is a multiphase material that incorporates nanosized particles into a matrix of 
standard material [266]. Recently, nanocomposites materials have gained much interest in various fields 
including biosensors, super-capacitors, battery, gas sensors and biomedical devices [267]. In particular, 
the characteristics of nanocomposites and the intrinsic benefits of microfluidics, including their laminar 
flow, low consumption of costly reagents and power, portability, minimal need for handling biohazardous 
materials, fast response time, multiplexing, and parallelization, are advantageous for the fabrication of a 
biochip [30, 268-270]. In this context, 1D structures, such as nanotubes, nanowires, and nanocomposites, 
composed of carbon materials can play an important role in medicinal chemistry and diagnostics, 
including the development of biochips for in vitro and in vivo investigations [270-272]. Carbon nanotubes 
(CNTs), allotropes of carbon originating from the fullerene family play an important role towards the 
development of biochips because of their high carrier mobility and tensile strength, as well as their high 
aspect ratio, which leads to quantum electron transport [271]. In addition, CNTs are non-reactive (like 
graphite) except at the nanotube caps located at ends (the tips when they are not cut), where the dangling 
bonds and edge-plane-like sites are open to reactions [273]. The CNTs are known to produce changes in 
energy bands close to the Fermi level [274].
 
The preferred electronic properties and high electrochemical 
reactivity of the enzymatic products suggest that fast electron transfer reactions occur when CNTs are 
used as electrodes in an electrochemical biochip [274].  
Lin et al. have developed a microfluidic electrochemical sensor for on-site, non-invasive 
monitoring of Lead and Chlorophenols [275]. Wisitsoraat et al. have developed an electrochemical 
biochip for cholesterol detection that has a sensitivity of 0.0512 nA/mg/dl, which is based on the direct 
growth of CNTs on glass [241]. However, CNTs are known to agglomerate via Van der Waals 
interactions, resulting in poor film-forming ability. To overcome this problem, nanostructured metal 
oxides (NMOx) may be used to control the agglomeration of CNTs [276]. The covalent binding (or 
sidewall functionalization) of biomolecules (e.g., proteins, enzymes, and nucleic acids) to carboxyl-
functionalized CNTs via diimide-activated amidation may provide improved stability and reproducibility 
[277]. In such a case, the large surface area of the CNTs and the presence of abundant functional groups 
may offer a suitable platform for biofunctionalization [278]. Additionally, CNTs may facilitate 
continuous conducting pathways to transport the charge carriers, leading to a higher sensitivity [279].
 
154 
 
Shim et al. have used functionalized CNT for biomolecular recognition in a streptavidin/biotin approach 
to investigate the adsorption of proteins on the sidewalls of carbon nanotubes [277]. 
A biosensor based on nanostructured nickel oxide (NiO) has recently been explored to detect 
biomolecules such as DNA, antibody-antigen interactions, glucose, and cholesterol [219]. However, NiO-
based biosensors have limited applications due to the inherently poor electrical conductivity of nNiO 
[280]. It has been shown that the non-covalent immobilization of enzymes onto NiO-based biochip results 
in poor stability of the desired biomolecules [172]. To improve the characteristics of a biosensing device, 
NiO can be integrated with CNT [281]. Zhang et al. have used CNT-NMOx to develop solar cells and gas 
sensors [282].
 
Chen et al. have reported the fabrication of a non-enzymatic electrochemical glucose sensor 
based on a MnO2/CNT matrix [283].
 
Zhu et al. have utilized CNTs with ZnO nanoparticles for ultrafast, 
nonlinear optical switching [203].  
The sp
2
 hybridization and electronic properties of NiO coupled with the specific recognition 
properties of immobilized CNTs could lead to a miniaturized biochip [278]. Additionally, the toxicity 
effect of these synthesized CNT, NiO and CNT-NiO using A549 cell line, has been investigated. CNTs 
have been widely used for developing various nanomaterial based sensors but the toxicity associated with 
it had remained a cause of concern in biological applications or where the fabricated material may 
potentially come in direct contact with body fluids [284]. It has been found that these nanomaterials show 
a good performance for bio-application including in situ monitoring of biomolecules, especially for 
implantable devices without inducing remarkable deleterious effects. Thus, a systematic investigation 
relating to toxicity of the hybrid nanomaterials is required to understand the cells activities in order to 
develop the cell-based biosensors, LOC or implantable biosensor devices. The results presented here 
indicate that CNT-NiO nanocomposite-based microfluidic sensors as fabricated in the current study 
would be a better and safer choice for field applications. 
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 Part I: CNT-NiO nanocomposite-based biochip for total cholesterol 
estimation 
 
In this study, I discuss the fabrication of a novel CNT-NiO nanocomposite-based biochip for total 
cholesterol estimation. The biochip is immobilized with a bienzyme, composed of cholesterol esterase 
(ChEt) and cholesterol oxidase (ChOx), and integrated with PDMS microchannels. Unlike the 
conventional methods, this procedure results in bienzyme functionalization through carboxylation and 
amidation of the CNT-NiO nanocomposite that serves as the sensing interface.  
6.2 Experimental  
6.2.1 Cell proliferation studies 
         The effect of CNT, NiO nanoparticles or CNT-NiO nanocomposite on human cell line is studied 
using Methyl Thiazol Tetrazolium (MTT) assay and bright field microscopy. The lung epithelial cancer 
cell line A549 is used as a test cell line. The A549 cells were procured from NCCS, Pune, India. The cells 
are maintained in complete growth medium (RPMI -1640+10% FBS) at 37
o
C under humidified 5% CO2 
environment. For the assay, cells are plated at 5×10
3 
cell/well in 96-well tissue-culture plate and are 
allowed to attach for about 24 hours. Next day, the medium on the plated cells is replaced with fresh 
growth medium supplemented with CNTs, NiO or CNT-NiO nanocomposite. The nanoparticles of NiO, 
CNTs (1mg/ml) or their composite made of NiO and CNTs in the ratio 49:1 ratio were dispersed in de-
ionized water by continuous sonication. These nanoparticles suspensions were kept at room temperature 
for 1 h to allow the undispersed material to settle down. Prior to the addition of dispersed nanoparticles to 
the growth medium, the nanoparticles are again dispersed by sonication using sonicator bath at room 
temperature (10 min at 40 W). The dispersed nanoparticles are added to the cell growth medium at 
various concentrations of 50, 25, 12.5 and 6.25 µg/ml.  
After incubating for 24 hours, the medium on cells are replaced with RPMI-1640 medium 
containing MTT. The cells are further incubated for 1-2 hours at 37
o
C to allow reduction of MTT dye to 
formazan crystals. The cells are also observed under an inverted microscope prior to MTT addition and 
about 1-2 h later before solubilisation of cells with dimethyl sulfoxide (DMSO). The cells are solubilized 
in 100 μl of DMSO, followed by absorbance measurement at 540 nm. The absorbance value gives a 
measure of cell proliferation. The relative proliferation is calculated with respect to cells not exposed to 
any kind of nanoparticles. In each experiment, every treatment group is replicated in three independent 
wells. Each experiment is repeated three times, and the average proliferation was calculated.  
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6.2.2 Fabrication of microfluidic biochip platform 
The CNTs (90%) are synthesized by catalytic CVD as discussed in Chapter 3. I have discussed the 
synthesis of CNT-NiO nanocomposite and modified microelectrode fabrication in the Material and 
Method Section: 3.3.8 (Chapter 3). A mixture of ChEt (1 mg/ml) and ChOx (1 mg/ml) in a 1:1 ratio is 
spread onto the CNT-NiO/ITO microelectrode via physical absorption [Figure 6.1.1]; the electrode is then 
kept in a humid chamber for 4 h at 4°C. The carboxyl-terminated CNTs and the NiO nanoparticles are 
respectively, negatively and positively charged resulting in increased electrostatic interactions. However, 
the carboxylic groups can undergo an amidation reaction with the amino acids of proteins. One approach 
to covalently bind proteins or enzymes utilizes the diimide-activated amidation of carboxylic acid 
functionalized carbon nanotubes. The COOH terminal group is activated using EDC (0.4 M) as the 
coupling agent and NHS (0.1 M) as the activator. The formation of strong covalent (C-N) amide bonds 
between the COOH groups of the CNTs and the NH2 groups of the bienzyme [Figure 6.1.1] is confirmed 
via XPS studies. It is possible that the nNiO molecules with a high isoelectric point (an IEP of 10.0) 
interact with the bienzyme directly through electrostatic interactions due to their low IEP (5.5).  
A PDMS microchannel slab is sealed temporarily with the ITO glass substrate containing the 
modified CNT-NiO and ChEt-ChOx electrodes [Figure 6.1.1]. The photograph of the fabricated 
microfluidic nanobiochip for cholesterol detection is shown in Figure 6.1.1(a). Figure 6.1.1 (b) shows the 
enlarged view of optical microscopic image of this microfluidic nanobiochip. The PDMS surface provides 
an adhesive layer that plays an important role, making the bonding with the glass substrate irreversible 
through weak Van der Waal’s forces. The bare ITO acts as the counter electrode (CE), and the ChEt-
ChOx/CNT-NiO/ITO bioelectrode is used as a sensor for total cholesterol detection. The glass substrate 
contained three electrodes and PDMS microchannels are embedded onto the same biochip. 
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Figure 6.1.1 The schematic of the microfluidic biochip used for total cholesterol detection (the ordered 
arrangement of this microsystem is assumed). 
 
Figure 6.1.2(a) The photograph of the microfluidic biochip for cholesterol detection and (b) An enlarged 
view of the microfluidic channel. 
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3 Results and discussions 
6.3.1 XRD studies 
To confirm the formation of the nanocomposite (CNT-NiO) on the microfluidic electrode, X-ray 
diffraction (XRD), Raman spectroscopy, X-ray photoelectron spectroscopy (XPS), and zeta potential and 
electrochemical studies were performed. The XRD studies of the NiO-modified CNT [Figure 6.1.3(i)] 
revealed the purity and crystallinity of the synthesized NiO nanoparticles with the face-centered cubic 
(fcc) configuration (a) (4.1 Å) and space group Fm3m (225) (JCPDS Card No. 78-0423). Figure 6.1.3(i) 
reveals a peak at 26° (2θ value) due to the (002) plane (JCPDS Card No. 75-1261) of the CNTs. However, 
the peak intensity of the CNTs is lower compared to the other peaks due to the presence of defects. The 
other peaks observed in the diffraction pattern are attributed to the (111), (200), (220), (311), and (222) 
planes of the cubic NiO. The peak intensity observed for the (200) plane at 2θ (43.3°) is higher than that 
of the (111) plane, indicating that the growth is mainly dominated by the (200) facet. The d200 value of 
0.20 nm corresponds to the hkl (200) plane.  
6.3.2 Raman studies  
The Raman studies [Figure 6.1.3(ii)] show several bands at 532 nm (the excitation wavelength). The 
vibrational band of NiO (spectra (a)), arising due to one phonon (1P) sampling at 494 cm
-1
, corresponds 
to transverse optical (TO) mode. The two-phonon (2P) peak observed at approximately 746 cm
-1
 is 
assigned to the 2TO and 2LO (longitudinal optical) modes (at approximately 1027 cm
-1
). The band 
observed at approximately 713 cm
-1
 exhibits lower intensity at room temperature (298 K), indicating the 
presence of NiO. In spectra (b), two sharp intense peaks attributed to G (graphite) and D (disorder) bands 
of CNT at 1342 cm
-1
 and 1580 cm
-1
, respectively, can be observed. The 2D band is found at 2695 cm
-1
 
(the second order of the D band). A small feature near 1617 cm
-1
 can be assigned to the G2 or D band.  
The peaks pertaining to the G+D band (approximately 2942 cm
-1
), as well as a small peak approximately 
at 2450 cm
-1
, can also be observed. The tangential G band (approximately 1580 cm
-1
), derived from the 
graphite-like in-plane mode, splits into two distinct bands attributed to G1 (1577 cm
-1
). The G2 (1610 cm
-
1
) peak arises due to changes in the curvature of the inner and outer cylinders of CNTs. 
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Figure 6.1.3(i) The X-ray diffraction pattern of CNT-NiO and (ii) the Raman spectroscopy spectra of (a) 
NiO nanoparticles and (b) CNT-NiO.  
 
  
6.3.3 XPS studies  
Figure 6.1.4(i) shows an XPS wide-scan spectrum obtained for the CNT-NiO/ITO (subfigure a) and 
ChEt-ChOx/CNT-NiO/ITO (sub-figure b) electrodes. The peaks found at 284.6 and 530.6 eV are 
attributed to the C1s and O1s of the COOH-functionalized CNTs. In spectrum (b), the characteristic peak 
observed at 399 eV is attributed to the presence of N1s in the bienzyme (ChEt-ChOx). The additional 
peaks found at 66.0, 112.6, 777.6, 870.6, and 1009.0 eV are assigned to Ni 3p
3
, Ni 3S, Ni-Auger, Ni 2p
3
, 
and Ni 2P
1
, respectively. The Ni 2S peak is due to the incorporation of NiO nanoparticles onto the CNTs. 
The relative atomic concentrations (%) of carbon, nitrogen, oxygen, and nickel are summarized in Table 
6.1.1. The atomic concentration of nitrogen in the ChEt-ChOx/CNT-NiO/ITO bioelectrode was found to 
be 9.93%. This result indicates that the CNT-NiO/ITO surface facilitates the covalent functionalization of 
ChEt-ChOx via EDC-NHS chemistry. The XPS spectra of the carbon 1s region of the deposited CNT-
NiO electrode [Figure 6.1.4 (ii)] is deconvoluted into characteristic peaks using the Shirley-type baseline 
and Lorentzian-Doniac-Sunsic curves, with a Gaussian profile. The peak found at 284.1 eV is graphitic 
(sp
2
), the peak at 285.2 eV is due to a defect (sp
3
), the peak at 286.3 eV is attributed to a hydroxyl group, 
the peak at 287.3 eV is assigned to a carbonyl group and the peak found at 288.2 eV is attributed to the 
carboxyl group (-O-C=O).  
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Figure 6.1.4 (i) The wide-scan X-ray photoelectron spectra (XPS) of various films. (ii) The XPS spectra 
of the C1s region of the CNT-NiO film after deconvolution; (iii) the C1s region of the ChEt-ChOx/CNT-
NiO/ITO film; and (iv) the N1s core-level spectra of the ChEt-ChOx/CNT-NiO/ITO film. 
 
 
In the ChEt-ChOx/CNT-NiO/ITO electrode [Figure 6.1.4(iii)], the binding energy peaks 
corresponding to functional groups are the same as those clearly visible in the spectra of the CNT-
NiO/ITO electrode. The observed lower intensities of the ChEt-ChOx electrode, as well as the slight shift 
in its binding energy positions [Figure 6.1.4(iii)] compared with those of the CNT-NiO/ITO electrode 
[Figure 6.1.4(ii)], may perhaps be attributed to the covalent attachment of the bienzyme molecules to the 
film surface. In particular, the percentage of COOH groups decreased to 2.7% from the CNT-NiO/ITO 
film’s value of 13%, indicating that most of the COOH functional groups have been used in bienzyme 
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attachment (ChEt-ChOx). The deconvoluted peak observed at approximately 282 eV in both the spectra 
may be due to the adsorption of NiO to the CNTs in the sample. In Figure 6.1.4(iv), the typical binding 
energy peak observed at 398.2 eV is due to the core-level electron of N1s. The peak found at 400.3 eV for 
the ChEt-ChOx/CNT-NiO bioelectrode corresponds to the amide nitrogen (CO-NH) present in the 
bienzyme molecules, whereas the peak observed at 401.7 eV, attributed to the ≡N species, confirms 
covalent functionalization. 
Table 6.1.1 The atomic concentration (%) of the elements C, Ni, O, and N present in the CNT-NiO/ITO 
and ChEt-ChOx/CNT-NiO/ITO films obtained from XPS analysis. 
 
6.3.4 Zeta potential measurements 
The value of the average surface potential of colloidal NiO nanoparticles is estimated to be +22.7 mV 
using zeta potential measurements. This value reveals that the NiO nanoparticles are positively charged 
[Figure 6.1.5(a)]. The average surface potential of the CNTs is measured to be -6.7 mV, indicating the 
presence of negatively charged groups on the sidewalls of the carbon nanotubes [Fig. 5.1.5(b)]. The 
positively charged NiO provides strong electrostatic interactions that link it to the negatively charged 
CNTs. 
 
 
 
 
 
 
 
Elements/atomic 
concentration (%) 
C Ni O N 
nNiO-MWCNT/ITO 12.52 33.72 53.76  
ChEt-ChOx/nNiO-
MWCNT/ITO 
59.11 3.88 27.08 9.93 
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Figure 6.1.5(a) Zeta potential studies of dispersed NiO nanoparticles in water solution 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1.5(b) Zeta potential studies of dispersed CNTs in water solution 
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Figure: 6.1.6 CNT-NiO composite has reduced toxicity compared to CNTs alone. The A549 cells plated 
at 5 × 10
3 
cells per well in 96 well tissue culture plate were exposed to growth medium containing  
indicated concentrations of nanoparticles for 24 hrs. The cells were treated with MTT for 1 hr and then 
relative reduction of MTT to formazan by cells was calculated. The relative reduction of MTT is 
presented as % proliferation with respect to cells not exposed to any nanoparticles (Ctrl). The error bars 
represent ± average deviation (AVEDEV).  
6.3.5 Cytotoxicity studies 
The MTT assay reveals that nanoparticles of NiO and CNT-NiO nanocomposite had much reduced 
negative influence on the well being of A549 cells. Consequently the ability of cells to reduce MTT to 
formazan at all the concentrations has been investigated in comparision with CNTs [Figure 6.1.6]. The 
relative proliferation %  is estimated with respect to growth of the control cells (Ctrl) that are not exposed 
to any nanoparticle. Though, the MTT assay [Figure 6.1.6] does not show much difference among the 
cells exposed to CNT, NiO or NiO-CNT composite upto 12.5 µg/ml concentration, further increase in the 
concentration showed incremental detrimental effect in case of CNT while others appear to have very 
little effect. The toxicity of CNT is more evident from the pattern of formazon crystal formation in CNT 
exposed cells as compared to NiO or CNT-NiO composite exposed cells. The CNT exposed cells 
progressively shows more diffuse formazon crystal formation and appearance of extracellular debris with 
increase in CNT concentration while NiO and NiO-CNT composite exposed cells are relatively 
unaffected in the concentration range studied [Figure 6.1.7].  
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Figure 6.1.7 CNTs exposure significantly attenuates the ability of A549 cells to reduce MTT dye to 
formazan compared to NiO nanoparticles or CNT-NiO composite. A549 cells incubated with indicate 
concentration of CNTs, NiO nanoparticles or NiO-CNT composite for 24 hours and incubated in the 
presence of 1 mg/ml MTT for 1h. The cells are imaged using Nikon eclipse microscope at 100x 
magnification  
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6.3.6 Morphological studies analysis 
The SEM studies [Figure 6.1.8] have been carried out for morphological observations at an accelerating 
voltage of 20 kV. The SEM image [Figure 6.1.8(i)] shows COOH-functionalized CNTs that are randomly 
oriented on the ITO substrate. The in situ incorporated CNTs along with deposited NiO nanoparticles are 
shown in Figure 6.1.8(ii). The NiO nanoparticles appear to be attached to the CNT, which are not 
agglomerated, indicating that the presence of NiO nanoparticles prevented their agglomeration. Figure 
6.1.8(iii) shows the SEM image of NiO nanoparticles.  
The TEM image shows spherical NiO nanoparticles with an average size <70 nm [Figure 
6.1.9(i)]. The high-resolution image of the individual CNTs show outer and inner diameters of 34 and 12 
nm, respectively. The selected area electron diffraction (SAED) pattern shows that graphitic (002) and 
(004) reflections are present in the CNTs [the inset in [Figure 6.1.9 (ii)].  
 
 
 
 
 
 
 
Figure 6.1.8 (i) SEM studies of COOH functionalized CNTs, (ii) CNT-NiO film on ITO coated glass 
substrate and (iii) SEM image of NiO nanoparticles. 
 
 
 
 
 
 
 
 
 
(ii) 
(i) (ii) (iii) 
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Figure 6.1.9 The HR-TEM analysis of (i) the NiO nanoparticles, (ii) an individual CNTs (inset: the SAED 
pattern of the CNTs), (iii) the CNTs modified with NiO nanoparticles, and (iv) an atomic-scale image of a 
CNT-NiO (inset: lattice fringes of the CNTs). 
 
Figure 6.1.9(iii) shows that the well-dispersed COOH-functionalized tubular-shaped CNTs are 
entangled with NiO nanoparticles and randomly oriented. It appears that some of the NiO nanoparticles 
are aggregated on the CNTs surfaces. These CNTs are multi-walled in structure. A few NiO nanoparticles 
can be observed inside the carbon nanotubes [Figure 6.1.9(iii)]. The length range of the CNTs is several 
tens of micrometers, and they have an external diameter of approximately 20-80 nm. From the atomic-
scale image of the CNT-NiO [Figure 6.1.9(iv)], it can be concluded that this nanocomposite is crystalline 
in nature, with an interlayer spacing of 3.41 Å (d002 for CNTs, shown in the subfigure inset, iv). The 
(i) (ii) 
(iii) (iv) 
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lattice fringe spacing of the NiO nanocrystal is estimated to be 2.0 Å, which agrees with the results of the 
XRD studies. These results clearly reveal a successful and predictable formation of the CNT-NiO 
composite that can be used to fabricate the desired biochip. 
6.3.7 Electrochemical properties  
The electrochemical behaviour of the biochip, both before and after undergoing surface modification by 
the bienzyme (ChEt-ChOx), is investigated using CV in PBS, pH 7.0 containing ferro/ferri cyanide (as a 
mediator) at a scan rate of 30 mV/s [Figure 6.2.1(i)]. The CV of the NiO/ITO electrode exhibits well-
defined oxidation/reduction peaks in the -0.8 V to +0.9 V potential range, with a peak-to-peak separation 
(ΔE) of 0.115 V (a). After incorporation of NiO nanoparticles into the CNTs (1.0 %) (b), the 
electrochemical current increases to 28.0 μA because CNTs are more conductive than the NiO/ITO 
electrode alone (23.0 μA). The large number of edge plane sites along the surface of the tubes, as well as 
the presence of defects in the CNT, result in enhanced electrochemical behavior. In addition, the outer 
and inner surfaces of the carbon nanotubes are accessible to the electrolyte solution containing redox 
species ions and acts as pathways for the transport of electrons toward the electrode, resulting in an 
enhanced faradic current. In case of the CNT-NiO (2.0%) electrode (c), the peak current increases to 31.2 
μA. This increase is due to the presence of a large number of defect sites in the CNTs, leading to 
enhanced heterogeneous electron transfer. The resulting current can be controlled by varying the CNTs 
concentration (2.0%) in the nNiO matrix. Furthermore, a redox current of 14.0 μA is obtained for the 
CNT-NiO/ITO electrode after bienzyme functionalization (d), which is lower than that of the CNT-
NiO/ITO electrode; the bienzyme has insulating properties that block the transport of electrons toward the 
electrode. The magnitudes of the cathodic and anodic peaks increases linearly with the square root of the 
scan rate (30 to 100 mV s
−1
), indicating a diffusion-controlled or quasi-reversible process and favourable 
electron transfer kinetics [Figure 6.2.2]. The values of the slope, intercept, and correlation coefficient of 
the ChEt-ChOx/CNT-NiO/ITO bioelectrode can be estimated using Eq. (6.1.1)-(6.1.4). 
         μ        μ   
                                                                         Eq.  6.1.1 
           μ        μ   
                                                                    Eq.  6.1.2 
                  
                                                                                      Eq. 6.1.3 
                  
                                                                                    Eq. 6.1.4 
The anodic peak potential (Epa) varied linearly with the natural logarithm of the scan rate (ln ν) and 
followed Eq. (6.1.5).  
                                                 ν                                                                                  Eq. 6.1.5 
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The surface concentration of the ChEt-ChOx/CNT-NiO/ITO bioelectrode was estimated using Laviron’s 
theory Eq. (6.1.6), and the slope is given by Eq. (6.1.7): 
                                                                                                                                           Eq. 6.1.6 
                                                        
                                                                                   Eq. 6.1.7 
where   is the transfer coefficient, n is the number of electrons transferred (1 in this case), F is the 
Faraday constant (96485.34 C/mol), I* is the surface concentration of the ChEt-ChOx/ CNT-NiO/ITO 
bioelectrode, ν is the scan rate (mV s−1), R is the gas constant (8.314 J mol−1 K−1), and T is the absolute 
temperature (298 K). The ip/ν value can be calculated from the slope of the ip versus ν plot. The total 
surface concentration of the ChEt-ChOx/CNT-NiO/ITO bioelectrode is found to be 11.07×10
−6
 mol/cm
2
, 
indicating a high coverage of ChEt-ChOx on the CNT-NiO/ITO surface.  
The flow rate is optimized for the ChEt-ChOx/CNT-NiO microfluidics biochip using the 
chronoamperometric technique [inset: Figure 6.2.1(ii and iii)]. The chronoamperometric current response 
of the CNT-NiO/ITO (ii) and ChEt-ChOx/CNT-NiO/ITO (iii) electrodes is obtained as a function of the 
flow rate (0.01-10 µL/min) and the corresponding current versus time, and the plots are shown in inset: 
Figure 6.2.1(ii and iii respectively). The chronoamperometric current increases for the CNT-NiO/ITO 
electrode with an increasing flow rate of the buffer solution. The maximum current is 0.1 µL/min, after 
which it reaches saturation (ii). This pattern is perhaps due to diffusivity of the redox species, which 
increases with a higher buffer flow rate because of the improved mass transport. At a flow rate of 0.1 
µL/min, the response time of the microfluidics electrode is 2 s, after which, the amperometric current 
becomes saturated [inset: Figure 6.2.1(ii)].  
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Figure 6.2.1(i) CV of different electrodes in PBS solution (50 mM, pH 7.0, 0.9% NaCl) containing 5 mM 
[Fe(CN)6]
3−/4−
, (ii) the chronoamperometric (current-time) response of CNT-NiO/ITO electrode as a 
function of flow rate [0.01-5 µL/min], inset: current vs flow plot, (iii) the chronoamperometric response 
of ChEt-ChOx/CNT-NiO/ITO electrode as a function of flow rate [0.01-20 µL/min], inset: current vs 
flow plot and (iv) EIS spectra of electrodes. 
After its ChEt-ChOx functionalization, the CNT-NiO/ITO electrode (iii) shows a high initial 
current decrease as the flow rate is increased [inset: Figure 6.2.1(iii)]. This response may be attributed to 
the retention time of the biocatalytic reaction. As the flow rate increases, the retention time becomes 
shorter, resulting in decreased response current. It appears that the cholesterol molecules move away from 
the biochip-sensing surface prior to the completion of the biochemical reaction. The diffusion time 
becomes maximum (approximately 3 s) at a flow rate of 1.0 µL/min, so the chronoamperometric 
measurements are carried out at this optimum flow rate. These results indicate that the fluid flow through 
the rectangular microchannel is laminar due to the low Reynolds number (0.082). 
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EIS studies have been carried out by applying a small-amplitude sinusoidal AC signal (with a 
bias voltage of 0.35 V) as a function of the frequency (0.01 to 10
5
 Hz) [Figure 6.2.1(iv)] using a 
frequency response analyzer (FRA). The electrical impedance (Z) is the ratio of the incremental change in 
voltage, V(t), to the resulting change in current, I(t), and Z is given by Eq. (6.1.8).  
                                          
    
    
 
 
 
 
           
              
                                                                      Eq. 6.1.8 
where, V0 and I0 are respectively, the maximum voltage and current signals, f is the frequency, t is the 
time,   is the phase shift between the voltage-time and current-time function, and Y is the complex 
admittance. The impedance is described either by the modulus     and the phase shift   or by its real (Z′) 
and imaginary (Z″). The most frequently used equivalent circuit for modeling the EIS experimental data 
is the Randles circuit [inset: Figure 6.2.1(iv)] which contains the electrolyte (RS) in series with a double-
layer capacitance (Cdl), charge-transfer resistance (RCT), and Warburg impedance (Zw). The Nyquist plot 
includes a semicircle region lying on the real axis, which is followed by a straight line. The linear portion 
(ψ =  /4), observed in the low-frequency range, implies a mass-transfer limited process; the semicircle 
portion, observed in the high-frequency range, implies a charge-transfer-limited process. The imaginary 
component decreases to zero at a high frequency because it offers no impedance. As the frequency drops, 
the capacitance (Cdl) offers higher impedance and the current flows primarily through the RCT and RS 
segments. The RCT value of the CNT-NiO/ITO electrode is 1.9 kΩ (shown in curve b), which is lower 
than the value of the NiO/ITO electrode (19 kΩ; curve b). 
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Figure 6.2.2 CV studies ChEt-ChOx/CNT-NiO/ITO bioelectrode as a function of scan rate [30-100 
(mV/s)], inset: (i) anodic and cathodic peak current vs square root of scan rate and (ii) anodic and 
cathodic peak current vs square root of scan rate. 
This result is due to the presence of the CNTs that causes enhanced catalytic activity and 
favorable electron-transfer kinetics; improved kinetics leads to a greater diffusion of the redox species 
ions from the bulk solution to the electrode surface. The RCT value of the ChEt-ChOx/CNT-NiO/ITO 
bioelectrode increases to 3.9 kΩ (curve c), a value greater than that of the CNT-NiO/ITO (curve b) 
electrode, implying that the bienzyme absorbed onto the CNT-NiO surface provides steric hindrance to 
the diffusion of electrons through the electrode-electrolyte interface. 
6.3.8 Chronoamperometric response studies 
The chronoamperometric response of the biochip (ChEt-ChOx/CNT-NiO/ITO) has been measured 
[Figure 6.2.3(i)] as a function of the cholesterol oleate concentration (0.25-12.93 mM). During this 
chronoamperometric measurement, the solutions containing various concentrations of cholesterol oleate 
in PBS are injected through an inlet of the microchannel at regular intervals. The sensing potential is 
maintained at -0.4 V during the measurements, when the specific oxidative reaction of the bienzyme 
ChEt-ChOx was dominant. The chronoamperometric current of the microfluidics biochip increases 
linearly in the range of 0.25-12.93 mM, after which, it gets saturated [inset: Figure 6.2.3(i), curve a]. First, 
esterified cholesterol is converted into fatty acids and cholesterol in the presence of ChEt. ChOx 
molecules containing flavin-adenine-dinucleotide (FAD) sites react with the cholesterol to produce 
cholesterol-4-ene-3-one and H2O2 via catalytic conversion. The produced H2O2 further oxidized to H2O 
(i) 
(ii) 
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and oxygen by losing two electrons. These generated electrons (not mediated electrons) are responsible 
for the enhanced chronoamperometric current, and the current is directly proportional to the concentration 
of the injected esterified cholesterol. The enzymatic reactions used for total cholesterol detection are 
given by  
                                                                                                   Eq. 6.1.9         
                                                                                       Eq. 6.2.1 
 A control experiment is conducted using the CNT-NiO/ITO electrode without bienzyme 
functionalization under similar conditions [inset: Figure 6.2.3(i), curve b]. No significant change in the 
current response of the CNT-NiO/ITO electrode has been observed with increasing concentrations of 
esterified cholesterol. These results reveal that the CNT-NiO/ITO electrode surface did not react with the 
esterified cholesterol molecules, and therefore, the electrochemical  
current remained unchanged. 
In the clinical sample analysis, the response of the biochip (ChEt-ChOx/CNT-NiO/ITO) has been 
carried out in presence of clinical samples with varying cholesterol concentration. Various cholesterol 
concentrations are 149, 166, 193, and 230 mg/dl are obtained from a clinical diagnostics laboratory at 
New Delhi (India). In comparison to the standard cholesterol concentration, it has been observed that the 
ChEt-ChOx/CNT-NiO/ITO bioelectrode shows minute difference of 0.64-6.77 % during cholesterol 
detection presence in serum sample [Figure 6.2.3 (iii)]. Thus, these results indicate that this novel 
biosensor has potential to detect cholesterol directly in human serum sample. 
Table 6.1.2 shows characteristics of the fabricated microfluidics biosensor along with those 
reported in the literature. It can be seen that the CNT-NiO composite-based microfluidic biodevice 
exhibits a much higher sensitivity (2.2×10
3
 µA/mM/cm
2
), lower response time (2 s), lower   
   
  (0.22 
mM), and more extended linearity (0.25-12.93 mM) than other total cholesterol sensors reported in the 
literature [285,288-285]. The observed low   
   
 value, obtained using the Lineweaver-Burk plot 
(1/concentration vs. 1/current) and the best linear fit (Table 6.1.2) indicates that ChEt-ChOx has a high 
affinity for cholesterol oleate and is properly functionalized onto the CNT-NiO surface. The 20-fold 
higher sensitivity, 2.2×10
3
 µA/mM/cm
2
, may be due to the integration of the high-aspect-ratio 
microfluidics device with the CNT-NiO matrix, as well as an improved biofunctionalization of the 
bienzyme. The composite material (CNT-NiO) results in enhanced electrochemical properties, and the 
micro-dimensions of the fabricated electrode perhaps cause improved electron diffusion. Additionally, the 
CNTs provide a channel for electron conduction with long electron mean free paths towards the electrode 
and thus have the capability to support very large current densities. The detection limit of this 
nanobiochip is found to be a cholesterol concentration of 0.03×10
-3 
M, which corresponds to a 
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physiological range of 2.07-6.2 mM in human blood. The comparatively higher detection limit of the 
ChEt-ChOx/CNT-NiO/ITO microfluidic total cholesterol sensor may be caused by either insufficient 
electrical conductivity of the nNiO or the morphological changes arising as a result of interactions 
between the bienzyme (ChEt-ChOx) and the CNT-NiO nanocomposite surface [285]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2.3 (i) The chronoamperometric response of the ChEt-ChOx/CNT-NiO/ITO-based biochip as a 
function of the cholesterol oleate concentration (0.25-12.93 mM) in a PBS solution containing 5 mM of 
[Fe(CN)6]
3−/4−
. The experiment is controlled using a syringe pump attached to the inlet of the microsystem 
(inset: the response current as a function of the cholesterol concentration obtained for both (a) ChEt-
ChOx/CNT-NiO/ITO and (b) CNT-NiO/ITO electrodes). (ii) A calibration plot showing the logarithm of 
the cholesterol concentration (mM) and the amperometric current of the biochip during sensing. (iii) 
Serum (real) sample analysis.  
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Table 6.1.2 The sensing characteristics of the ChEt-ChOx/CNT-NiO/ITO based biochip designed for total 
cholesterol estimation. 
 
6.3.9 Reproducibility studies 
The ChEt-ChOx/CNT-NiO/ITO based biochip shows good reproducibility for cholesterol concentrations 
of 2.59 and 5.18 mM [Figure 6.2.4(i)] as is evidenced by the low standard deviations (RSD) found 
(4.19% and 2.13%, n=5), indicating good precision. The ChEt-ChOx/CNT-NiO/ITO bioelectrode also 
shows good repeatability, as evidenced by its low RSD of 1.12% (n = 15) for a cholesterol concentration 
of 2.50 mM. No significant decrease in the current is observed after 12 uses. In further procedures, the 
bioelectrode showed slight decreases in its current response possibility due to the denaturation of the 
biomolecules [Figure 6.2.4(ii)].  
6.4.0 Selectivity and stability studies 
The selectivity of the ChEt-ChOx/CNT-NiO/ITO bioelectrode is demonstrated using lactic acid (LA), 
glucose (G), ascorbic acid (AA), uric acid (UA), and other interferents in a buffer solution. The present 
bioelectrode is highly specific to total cholesterol (5.18 mM) and shows a negligible change in its 
response current in the presence of other analytes (interferents) [Figure 6.2.4(iii)]. The shelf life of this 
biochip is determined by measuring the change in the current response at regular 5-day intervals for 
approximately 3 months; the chip exhibited a 93.7% response after approximately 40 days. The ChEt-
ChOx/CNT-NiO/ITO bioelectrode is stored at 4°C when not in use. This integrated microfluidics 
Electrode 
materials 
Microfluidic 
used 
Detection 
limit (M) 
Sensitivity 
(/mM/ cm
2
) 
Detection 
range 
Km Value 
(mM) 
Stability 
(days) 
Ref. 
CNT Yes 0.25×10
-3
 0.0512 nA 1.25 -10.0mM …… ……. [241] 
Anatase-TiO2 Yes 0.64×10
-3
 0.094 mA 0.64-10.3 mM 0.14 mM 35 Present 
work 
nNiO Yes 0.64×10
-3
 0.12  mA 0.64-10.3 mM 0.16 mM 60 Present 
work 
ZnO No 37 ×10
-9
 23.7 µA 1.0 to 500.0 nM 4.7 mM 50 [286] 
Pt nanoparticles No 0.2 ×10
-6
 2.07 µA Upto 4.0 µM 5 mM 3 [287] 
Polyelectrolyte-
MWCNT 
No 0.2 ×10
-3
 0.559 µA Upto 6.0 mM 7.17 mM ….. [288] 
Chitosan/silica-
MWCNT 
No 1 ×10
-6
 1.55 µA 4.0 µM-0.7mM 0.24 mM 50 [285] 
CNT-NiO Yes 0.03×10
-3
 2.2 mA 0.25-12.93 mM 0.22 mM 40 Present 
Work 
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nanobiochip reached 92% of its steady-state current in less than 2 s, indicating that a fast electron 
exchange is occurring between the active sites of the bienzyme and the CNT-NiO/ITO electrode.  
 
 
Figure 6.2.4(i) Reproducibility studies of the ChEt-ChOx/CNT-NiO/ITO microfluidics bioelectrodes 
under similar conditions. (ii) Stability studies of the ChOx-ChEt/CNT-NiO/ITO bioelectrode and (iii) 
selectivity studies of the ChOx-ChEt/CNT-NiO/ITO-based biochip. 
 
6.5 Conclusions  
In summary, the miniaturized microfluidics-integrated biochip based on a CNT-NiO composite allows for 
the rapid detection of biomolecules at a low cost. The NiO serves as a support for the dispersion of CNT 
and helps exfoliate smaller bundles or individual nanotubes. The covalent functionalization through 
reactions of desired chemical groups onto the  -conjugated skeleton of this CNT-NiO composite matrix 
offers considerable advantages for the development of a nanobiochip to detect molecules such as 
cholesterol. In particular, the COOH groups on the CNT provide simple biofunctionalization and a higher 
loading capacity of biomolecules on the microfluidic transducer surface. The 9.3% of the carboxyl groups 
present on the CNT-NiO surface are used to covalently bind with the bienzyme. The synergistic 
electrocatalytic activity of the CNT provides straight conducting pathways for carriers such as electrons 
and ions, resulting in a higher sensitivity than NiO-based biochips. This bienzyme functionalized and 
integrated microfluidic biochip is highly sensitive to cholesterol oxidation and is both highly reproducible 
and stable, allowing it to be utilized for total cholesterol monitoring. This   microfluidic platform exhibits 
improved detection limits and faster response times. This highly efficient composite microfluidics biochip 
could be used to monitor low-density lipoproteins molecules based on antigen-antibody reaction. Details 
have been discussed in the next part. 
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Part II: CNT-NiO nanocomposite  
based impedimetric-Lab on a chip for LDL  detection 
         
  In this part, an impedimetric-Lab on a chip (iLOC) immunosensor for the label free detection of blood 
low density lipoprotein (LDL) using the proposed CNT-NiO nanocomposite. In this iLOC, the 
immunoelectrode has been fabricated using anti-apolipoprotein B 100 (AAB) functionalized carbon 
nanotubes-nickel oxide (CNT-NiO) patterned onto ITO substrate.  
6.6 Biosensing platform 
In previous Section, I have discussed the fabrication of patterned microelectrode based on CNT-NiO 
nanocomposite. The AAB solution (10 μl) is spread onto the CNT-NiO/ITO microelectrode surface via 
physical absorption followed by EDC-NHS chemistry and kept for 4 h in humid chamber (4
o
C). The 
carboxylic groups can further undergo an amidation reaction with the amino acids of the proteins. One 
approach for covalent binding of proteins or enzymes utilizes the diimide-activated amidation of 
carboxylic acid functionalized carbon nanotubes. The COOH terminal has been activated using EDC 
(0.4M) as the coupling agent and NHS (0.1M) as activator. The strong covalent (C-N) bond formed 
between –COOH group of CNT and –NH2 group of enzymes that has been confirmed via XPS studies. 
Finally, the BSA solution has been used for blocking the nonspecific site of antibody functionalized 
surface. Hence, the prepared BSA-AAB/CNT-NiO/ITO immunosensor is kept at 4 °C when not in use. 
6.7 Results and discussions 
6.7.1 FT-IR studies 
The FT-IR spectrum of various electrodes is shown in the Figure 6.2.5. The absorption peak at 503cm
-1 
(curve a) in the finger print region corresponds to Ni-O vibration band (a). The characteristic absorption 
seen at 2839 cm
-1
 and 2917 cm
-1
 are attributed to CH stretching of COOH-CNTs. The band seen at 1562.5 
cm
-1
 arises due to the C=C stretching that forms the framework of the CNT sidewall. The bands observed 
in the range of 2500-3000 cm
-1
 wave number results from the carboxylic acid O-H stretching. The 
absorption bands seen at ~1000–2500 cm−1 are assigned to the O–C=O symmetric and asymmetric 
stretching vibrations and the C–O stretching vibration indicating CO2 absorption on CNT-NiO film. After 
immobilization of BSA-AAB onto CNT-NiO/ITO electrode surface (curve b), the peak found at 850 cm
-1 
is assigned to the aromatic C-H bending. The peak at 1040 cm
-1
 is due to C-OH stretching vibration. The 
band seen at 3300 cm
-1
 is attributed to the OH stretching on film surface. The bands seen at 1248 cm
-1
 and 
1650 cm
-1
 are due to amide III and amide I of BSA-AAB proteins molecules.  
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Figure 6.2.5 FT-IR spectra of (a) CNT-NiO/ITO film and (b) BSA-AAB/CNT-NiO/ITO film. 
6.7.2 UV-Vis studies 
The results of UV-Visible spectroscopic studies of NiO nanoparticles (i), CNTs (ii) and CNT-NiO (iii) 
carried out in water are shown in the Figure 6.2.6 (A). The strong absorption peak seen at 330 nm (curve 
i) corresponds to intra-3d transition of Ni
++
 in the cubic structure of NiO. The blue shift of the absorption 
edge compared to bulk NiO reveals the quantum size effect that might occur at the time of particle 
growth. Figure 6.2.6(B) shows the extrapolation for the determination of direct band gap, where ( hν)2 
plots versus energy from the intercept with the x-axis using the following Tauc Eq. Eq. 6.2.2 
                                     ν      ν                                                                           Eq. 6.2.2 
where   is absorbance, h is Plank’s constant and k is a constant. The direct band gap (  ) of synthesized 
nanostuctured NiO is found to be 3.29 eV [Figure 6.2.6B (a)]. In addition to the fundamental absorption 
of NiO, it has been found   that the band edge (broadened line; shown by dotted mark) shows an 
absorption which fall slightly below the conduction band of NiO that is arising due to exciton (electron-
hole pair) that interacts with impurities.
 
The energy of photon involved in exciton absorption is given by 
 ν        , where     is the exciton binding energy (0.01 eV). The absorption peak at 266 nm arises 
from a  - * transition due to an unshared pair of electrons of the -C=O bond in the carbonyl group (-
COO) terminated CNT [Figure 6.2.6B, curve b)]. The band gap of synthesis COOH functionalized CNTs 
is found to be 2.1 eV [Figure 6.2.6B, curve b)]. In case of CNT-NiO the absorption peak found at 307 nm 
which is red shifted compared to that of CNTs results from incorporation of NiO onto CNTs [Figure 
6.2.6A, curve c)]. The energy gap of synthesized NiO has been tuned to 3.17eV due to incorporation of 
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CNTs and exhibits higher conductivity. This shifting of energy band of NiO indicates the presence of 
CNT-NiO composite. 
 
 
 
 
 
 
 
 
 
Figure 6.2.6(A) UV-Visible studies and (B) ( hν)2 versus energy plots of various films 
 
6.7.3 Chronocoulometric studies 
 In order to measure the electrode surface areas, diffusion coefficients and charges with respect to time 
and the mechanisms and rate constants for chemical reactions coupled to electron transfer reactions, the 
chronocoulogram (CC) have been carried out for various electrodes at same step potential of waveform 
(2V) as shown in  Figure 6.2.7(i). Typical CC plots (charge-time) for both (a) CNT-NiO/ITO electrode 
and (b) BSA-AAB/CNT-NiO/ITO bioelectrode are shown in Figure 6.2.7(i) and indicates charge-time 
dependence for linear diffusion control. It has been observed that the BSA-AAB/CNT-NiO 
immunoelectrode shows less charges value at each time compared to that of CNT-NiO/ITO electrode. 
The analysis of the chronocoulometric data is based on the Anson equation (Eq. 6.2.3) which defines the 
charge-time dependence for linear diffusion control: 
                                                 Q = 2nFACD
1/2 1/2t1/2                                                                                         Eq. 6.2.3 
where, Q represents the charge (coulombs). A plot of Q vs. t ½ is referred as the Anson plot Fig. 5.2.3(ii), 
where the slope (a) can be determined by the following Eq.6.2.3 and 6.2.4 
                                                  a = 2nAFCD
1/2/ 1/2                                                         Eq. 6.2.4 
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n and A represent respectively, the number of electrons transferred and the real electrochemical surface 
area of the electrode (cm
2
). F is the Faraday’s constant (96,485 coulombs/mole). 
 The concentration of the mediator is denoted by C and the diffusion coefficient of the mediator 
(cm
2
/sec) and time (sec) are denoted by D and t, respectively. Therefore, the real electrochemical surface 
area of the electrode (Aec) can be calculated from the slope in Eq.6.2.4, provided the other four parameters 
(n, F, C and D) are known. 
                                                         A = a/(2nFCD
1/2/ 1/2)                                                 Eq. 6.2.5 
The calculation of the diffusion coefficient (D) of the mediator for the (a) CNT-NiO/ITO 
electrode and (b) BSA-AAB/CNT-NiO/ITO bioelectrode are found to be respectively, 6.29 ×10
-9
 cm
2
/s 
and 2.82 ×10
-9
 cm
2
/s. The electrochemical active surface area (Aec) are found to as 1.9 ×10
-2
 cm
2
 and 
2.0×10
-2
 cm
2
 for the (a) CNT-NiO/ITO electrode and (b) BSA-AAB/CNT-NiO/ITO bioelectrode, 
respectively.  
Figure 6.2.8(i) shows potential-dependent chronocoulometric responses recorded for the BSA-
AAB/CNT-NiO/ITO bioelectrode at different potential (1.0-5.0 V). It has been seen that that the charge-
time responses increases with increasing potential. Again, I have recorded CC curves at different flow 
rates (0.01-15 µL/min) and are shown in Figure 6.2.8(ii).  The Q vs. t
1/2 
plot for different flow rates 
[Figure 6.2.8(iii)] and slope of chronocoulometric curves vs. flow rates are shown inset [Figure 6.2.8(iii)].  
At flow rate 1.0 µL/min, the slope value is found to decease and after that the slope value of bioelectrode 
increases to saturated value.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2.7(i) CC plots (charge-time) for CNT-NiO/ITO (a) electrode and BSA-AAB/CNT-NiO/ITO (b) 
bioelectrode, and (ii) charge (Q) vs. t
½
 plot of CNT-NiO/ITO (a) electrode and BSA-AAB/CNT-NiO/ITO 
(b) bioelectrode. 
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Figure 6.2.8(i) Potential-dependent chronocoulometric responses for the BSA-AAB/CNT-NiO/ITO 
bioelectrode at different potential (1.0-5.0 V), (ii) chronocoulometric responses at different flow rate 
(0.01-15 µL/min) and (iii) Q vs. t
1/2 
plot for different flow rates (inset: slope; Q/ t
1/2 
vs flow
 
rate plot). 
 
 
6.7.4 Electrochemical impedance properties of iLOC 
In order to investigate the antigen-antibody interaction, the impedance analysis can employ by applying a 
small amplitude sinusoidal AC signal as function of frequency 0.01–105 Hz at fixed bias potential. The 
impedance can be measure by the real part (Z′) and the imaginary part (Z″) of the Nyquist plot. A typical 
shape of Nyquist plot includes a semicircle region lying on the real axis followed by a straight line. The 
linear part observed in the low frequency range implies a mass-transfer limited process, where the 
semicircle portion observed in high frequency range, implies a charge-transfer limited process. The 
imaginary component, at high frequency falls to zero because it offers no impedance. As the frequency 
drops, the capacitance Cdl offers high impedance and hence current flows mostly through Rct and Rs. The 
double layer capacitance or constant phase element (CPE) can be calculated from the frequency at the 
maximum of the semicircle (ω = 2f = 1/RctCdl). The charge-transfer resistance (Rct) and the double layer 
capacitance (Cdl) are the most important electrical parameters in the analyses of the change in impedance 
signal for antibody-antigen interaction. The parameter of interest here is Rct, which can be extracted from 
the fitted circuit model. Figure 6.2.9(a) shows the Rct value of the CNT-NiO/ITO (i) is 2.4 kΩ. This is due 
to the fact that CNT-NiO act as mediators for electron transfer and reduces the electron tunnelling 
distance from the redox probe [Fe(CN)6]
3-/4-
 in bulk solution to the electrode resulting in decreased Rct. 
The CPE value of CNT-NiO/ITO is found to be higher (10.0 µF) compared to that of the bioelectrode 
(4.6µF) arising due to the AAB-BSA incorporation onto CNT-NiO/ITO surface that enhances the 
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dielectric thickness. After BSA-AAB immobilization onto CNT-NiO/ITO surface, the Rct value increases 
to 11.2 kΩ (ii). This is attributed to the antibody and CNT-NiO interaction that impedes the ions transfer 
from bulk solution to the electrode. Antibody and BSA act as insulating materials, which covalently bind 
with CNT-NiO/ITO resulting in blocking the charge transfer through the diffusion layer. 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2.9(a) EIS spectra of CNT-NiO/ITO electrode (i) and BSA-AAB/CNT-NiO/ITO bioelectrode 
(ii), (b) EIS spectra of BSA-AAB/CNT-NiO/ITO bioelectrode as a function of potential (V), (c) plot 
between charge transfer resistance (Rct) and potential (V) and (d) EIS responses of BSA-AAB/CNT-
NiO/ITO bioelectrode as function of LDL concentration.  
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The bioelectrode is characterized by analyzing the following important parameters such as 
heterogeneous electron transfer rate constant (k0) and time constant (τ) for redox probe containing redox 
species. These parameters provide the information relating to the interfacial interactions of biomolecules 
as well as for explaining the mechanisms of chemical processes occurring at the electrode/solution 
interfaces. The corresponding k0 of the modified electrodes has been calculated by using Eq. 3.3.5 and 
Eq. 3.3.7 (Chapter 3). The k0 value of the BSA-AAB/CNT-NiO/ITO bioelectrode is 23.0×10
-8
/s, which is 
higher than that for CNT-NiO/ITO electrode (1.4×10
-8
/s), indicating a faster electron exchange between 
the redox probe and electrode. The BSA-AAB immobilization on CNT-NiO/ITO shows a sluggish 
electron charge transfer rate constant resulting in the generation of low capacitance at the electrode 
surface. The high value of time constant (τ) for the BSA-AAB/CNT-NiO/ITO is estimated as 5.15×10-2 
due to the slow diffusion of [Fe(CN)6]
3−/4−
 ions at the electrode enzyme layer/solution interface compared 
to that of the CNT-NiO/ITO (2.4 ×10
-2
) electrode. The surface coverage (θ), is calculated using the Eq. 
4.1.9 (Chapter 4). The value of θ is estimated to be 0.8, indicating more than 80% surface coverage of the 
CNT-NiO/ITO electrode by BSA-AAB molecules. Figure 6.2.9(b) shows EIS spectra of iLOC as a 
function of potential (0.01 – 0.5 V). It has been seen that there are two semicircles appears in low 
frequency region as shown in equivalent circuit model. The Rct values of semicircles in low frequency 
region of the iLOC has been found to increase linearly with increased potential [Figure 6.2.9(c)]. This 
reveals facile electron transfer kinetics wherein resistance controls the electron transfer kinetics of the 
redox probe at the electrode. It suggests that the resistance represented in the semicircle of the Nyquist 
plot depends on the bias voltage. The electric double layer or constant phase element (Cdl) has been found 
to decrease with increasing potential. Thus, the Rct values are found to increase at higher potential 
indicating that the charge transfer at low frequency is dependent to the polarization potential, thus the 
high potential of 0.5V has been chosen for biosensing. 
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Figure 6.3.1(a) Linear sensor calibration plot of iLOC, (b) EIS spectra of iLOC without BSA-AAB for 
control experiment, (c) sensing and control experiment plots as a function of LDL concentration and (d) 
1/Rct and 1/concentration plot for association constant. 
 
6.7.5 Impedimetric response of iLOC 
The impedimetric response for the iLOC (BSA-AAB/CNT-NiO/ITO bioelectrode) measured as a function 
of lipid (LDL) concentration [5-120 mg/dl] in PBS containing [Fe(CN)6]
3-/4-
 with incubation time of about 
5 minutes [Figure 6.2.9(d)]. The changes in the Rct value or dielectric/blocking properties of the BSA-
AAB/CNT-NiO/ITO bioelectrode arise from antigen-antibody interaction at electrode/electrolyte 
interface.  
The magnitude of charge transfer resistance (Rct) value increases linearly for the iLOC on 
addition of LDL concentration [Figure 6.3.1(a)]. The increased Rct value indicates that presence of the 
insulating layer of LDL molecules onto BSA-AAB/CNT-NiO/ITO bioelectrode surface inhibits 
penetration of the redox species towards the electrode, resulting in higher diameter of EIS spectra. The 
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negative charges carried by the LDL phospholipids coating perhaps block the electron transfer of the 
[Fe(CN)6]
3-/4-
 redox couple resulting in higher impedance. The bioelectrode when treated with the 0.2 M 
glycine solution of pH 2.4 for about two minutes results in 95 % of the regenerated bioelectrode. The plot 
between Rct value and LDL concentration (5-120 mg/dl) yields,                              
   
                 . The impedimetric sensitivity of this iLOC is obtained to be as high as 5.3 k /mg/dl 
with regression coefficient (r
2
) as 0.94. It has been found that the impedimetric iLOC exhibits improved 
characteristics such as low detection limit of 0.63 mg/dl using 3σb/m criteria, where m is slope of the 
calibration graph and σb is standard deviation. 
A control experiment is carried out using the CNT-NiO/ITO electrode without BSA-AAB 
functionalization under similar conditions. EIS spectra of each concentration are shown in the Figure 
6.3.1(b and c)]. I have observed a slight change in the impedance value of the CNT-NiO/ITO electrode 
with increasing concentration of LDL [Figure 6.3.1(b and c)]. These results reveal that the CNT-NiO/ITO 
electrode surface does not interact with the LDL molecules, and therefore, the electrochemical impedance 
remain unchanged. The association and dissociation constant of this iLOC are estimated as 8.13 M
-1
s
-1
 
and 0.12 s
-1
, respectively, indicating that LDL molecules have higher affinity towards this iLOC [Figure 
6.3.1(d)]. 
 
6.7.6 Stability and selectivity studies 
Stability of this proposed biochip has been evaluated for 100 days. This chip shows an excellent stability 
upto 60 days with 95% response of Rct value, after which the response is decreased to 78 %. The BSA-
AAB/CNT-NiO immunoelectrode is stored at 3°C when not in use. The reproducibility of the working 
electrodes that are produced under same conditions has been observed. The changes in impedance (Rct) 
values for electrodes used in the chip are negligible as indicated by the relative standard deviation (RSD) 
of 3.44 %. In order to determine the selectivity of the iLOC for LDL (90 mg/dl) detection, I have 
performed EIS studies by incorporating the other analytes including triglyceride (150 mg/dl), free 
cholesterol (150 mg/dl), and total cholesterol (150 mg/dl) and all mixed together. In this study, a low 
RSD value (4.3 %) has been observed which indicates a negligible interference with other analytes. Thus, 
this proposed biochip shows excellent selectivity and stability.  
6.7.7  Potential merits of this fabricated microfluidic platform 
The CNT-NiO nanocomposite can be easily integrated with microfluidic transducer through 
functionalization of biomolecules such as enzyme, antibodies. Sensitivity and other biosensing parameters 
are improved due to this CNT-NiO nanocomposite and low aspect ratio of microfluidic device. This 
CNT-NiO nanocomposite can be used for enzymatic analysis as well as antibody-antigen kinetics 
185 
 
analysis. The amperometric detection of the nanocomposite based electrode offers highly sensitivity to 
impedance in microchannel solution. The selectivity and stability of biofunctionalized electrode is found 
to be higher. A label free immunosensor for LDL monitoring indicates that this platform is suitable for the 
detection of antibody-antigen interaction.    
6.8 Conclusions 
In summary, an iLOC based on anti-apoliprotein B 100 functionalized CNT-NiO has been described.  
This iLOC has been used to evaluate antigen-antibody binding kinetics as well as blood LDL detection 
via EIS technique. The observed higher value of association  and dissociation rate constants with this 
iLOC indicates strong binding affinity between AAB functionalized CNT-NiO nanocomposite and LDL 
molecules. The BSA-AAB/CNT-NiO immunoelectrode is found to be highly selective for LDL and 
exhibits detection range of 5-120 mg/dl within the physiological range of LDL in blood/serum in human 
body. The CNT-NiO composite provides a biocompatible and favourable environment due to high 
surface-to-volume ratio resulting in enhanced loading capacity of AAB. Low cost, low reagent/power 
consumption and high specificity are the main advantages of this proposed iLOC. This BSA-AAB/CNT-
NiO immunoelectrode shows higher sensitivity as 5.3 k /mg/dl and faster response. The application of 
CNT-NiO composite not only improves the electrochemical properties but also result in enhanced loading 
capacity of antibodies. This CNT-NiO nanocomposite shows less toxicity effect with human cells 
compared to that of only using CNT. The high sensitivity combined with specificity of LDL-AAB 
binding, towards LDL detection using CNT-NiO is a promising platform that can be used to detect other 
lipids such as  VLDL, triglyceride etc. The impedimetric measurements have been carried out by 
introducing three electrode systems in microchannels. The impedance depends on the charge transfer 
property of solution as well as the electrode assembly. This chapter demonstrated the amperometric 
detection of enzymatic microfluidic biosensor for cholesterol as well as impedance detection of LDL via 
antigen-antibody interaction.  
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CHAPTER 7 
Summary of the work and future prospects  
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7.1 Summary of the work 
Microfluidic devices are capable of, detecting and analyzing small sample volumes, and provide 
automated sample preparation and reduced processing times at the consumption of lowest amounts of 
expensive reagents. These advantages promote the integration of microfluidic biosensors for POC 
diagnostic applications. Several intrinsic characteristics of microfluidic devices such as laminar flow, 
minimal handling of hazardous materials, and multiplexed and parallel sample detection, portability and 
versatility can be in-built in a POC testing system. This work reported here is an effort to explore the 
feasibility of microfluidic chips in detecting concentration of specific analyte rapidly, accurately and at a 
low cost in a desired test sample.  
In this thesis, I have demonstrated the design and fabrication of the microfluidic biosensor 
systems using soft lithographic technique for free cholesterol, total cholesterol and LDL detection via 
electrochemical techniques. In these microfluidic biochips, the ITO electrodes have been utilized as 
supporting material for integration of nanomaterials as well as for immobilization of biomolecules. The 
chemical etching, which is a low cost technique, was employed for fabrication of ITO. The fabricated 
ITO electrodes on glass substrate were easily coupled with PDMS microchannels through the reversible 
sealing. In addition, the physical adsorption method for modification of ITO electrode shows an excellent 
absorption of nanomaterials which facilitate the immobilization of biomolecules. A systematic protocol 
was tested and followed for modification of ITO microelectrodes using nanomaterials to improve the 
biosensor characteristics. The model enzymes such as cholesterol oxidase and cholesterol esterase were 
used in these biochips for accurate identification of cholesterol. In these microfluidic biosensors, the 
binding kinetics of biomolecular interactions has revealed the association and dissociation rates of 
enzymes interaction with cholesterol molecules. The surface modification of enzymes on these 
microfluidic transducers via covalent interaction (EDC/NHS coupling chemistry) improved the detection 
parameters like detection limit, sensitivity, stability etc. of the biosensors. In addition to enzymatic 
analysis, these microfluidic biochips served as provide an ideal platform for applications such as detection 
of LDL molecules via antigen-antibody interaction and study their binding kinetics.   
The fabricated microfluidic biosensor platforms offered numerous advantages compared to other 
traditional methods such as ultracentrification, electrophoresis, NMR etc. These proposed devices are 
capable of high-throughput analysis and massive parallelization due to compactness. Excellent 
reproducibility, high selectivity, accuracy, reliability, ease of use, portability, small size and cost 
effectiveness are main advantages of these microfluidic devices for detection of cholesterol and LDL 
molecules. Additionally, these microfluidic devices have been observed as safer platforms, which can 
precisely control and manipulate the various body fluids such as blood serum and other chemical fluids 
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(like buffer solution). The results from these microfluidic biosensors indicate a promising technological 
innovation for the next generation of analytical miniaturized systems towards POC diagnostics. 
Selection of materials is very important in designing microfluidic devices. I have focused on 
PDMS-based microchannels to control the biological fluids in the fabricated microfluidic devices. PDMS 
offer good mechanical and optical properties, flexibility, transparency and rapid prototyping compared to 
silicon and glass. The PDMS behaves like an elastic solid material that maintains its molded structure. 
PDMS can reduce time and complexity for fabrication of microfluidic devices, which are compatible with 
aqueous media and biological samples prepared in aqueous solutions. In addition, it can be molded at low 
temperature and thus, researchers working in benchtop can construct devices easily and rapidly. PDMS is 
an ideal and robust material for fabrication of microfluidic biochips and its channels, reservoirs, holes etc. 
can make easy for alignment and reversible/irreversible sealing with ITO microelectrode. 
The size of the electrode in electrochemical microfluidic biochip is one of the key design issues. 
The size of electrode may affect the mass transport of ions to and from the electrode surface in the bulk 
solution, which in turn may influence the electrochemical response. The planer diffusion of ions occurs in 
the case of macro-electrodes in a conventional biosensor. The micro-dimensions of the electrode in a 
microfluidic device is known to facilitate spherical or radial diffusion arising due to the diffusion from 
different directions of the surrounding bulk solution towards the electrode resulting in improved mass 
transfer towards the electrode. In addition, the microelectrode provides small capacitive-charging 
currents, reduced ohmic drop of potential (iR) and steady-state diffusion currents leading to improved 
biosensor sensitivity. Some of the other important parameters such as detection time and limit also can be 
improved to better numbers in a microfluidics device.  
In this thesis, the synthesis of various type metal oxides (anatase TiO2 and NiO) and their 
composite with chitosan and carbon nanotubes for fabrication of microfluidic biochips have also been 
described. These synthesized nanomaterials were integrated with the fabricated microfluidic systems in 
order to improve the biosensor efficacy and efficient loading of biomolecules such as cholesterol oxidase, 
cholesterol esterase and anti-apolipoproteins. The large surface-to-volume ratio, excellent catalytic  
properties, non-toxicity, biocompatiblity, high chemical and thermal stability, negligible swelling in both 
aqueous and non-aqueous solvents, and high electron transfer communication are the potential merits of 
these nanomaterials to be integrated with microfluidic biosensors. In particular, these nanomaterials act as 
mediators that accelerate generated electrons from active site of proteins to the electrodes during 
electrochemical detection. These nanomaterials provide a friendly environment for loading of enzymes or 
antibodies without any loss of their biological activities. Incorporation of these nanomaterials in these 
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microfluidic chips have enhanced the electrochemical current, leading to higher sensitivity and lower 
detection limits. This thesis presented a new microfluidic biosensor chip platform using nanostructured 
materials that can be used for the detection of clinically important analytes such as free cholesterol, 
esterfied cholesterol and LDL molecules. 
The results relating to the fabrication of nanostructured anatase-TiO2 nanoparticle-based 
microfluidic platform for free cholesterol estimation were described in Chapter 3.  The sol- gel 
synthesized monodisperse TiO2 nanoparticles uniformly absorb the cholesterol oxidase molecules in the 
microfluidic transducer surface. The use of crystalline nanostructured ant-TiO2 improved the charge 
transfer properties in this microfluidic device resulting in enhanced sensitivity towards free cholesterol 
detection. The response of this microfluidic biosensor depends on flow rate of the buffer solution, which 
influences response time and diffusivity through the diffusion layer.  Good reproducibility, high 
selectivity and low Km value of the proposed biosensor were observed. This miniaturized microfluidic 
biosensor requires minimal instrumentation and can be readily integrated with micro-electronics in a chip-
based format.  
 In the next chapter, we explored the possibility of using TiO2 composite with CH. In order to improve 
the biosensor efficacy, the TiO2 nanoparticles have been modified with chitosan molecules. The 
mesoporous structure of TiO2-CH nanocomposite and available functional groups such as the amino, 
hydroxyl etc. enhanced adsorption capacity and created a hydrophilic environment for loading enzyme 
molecules on transducer surface. This TiO2-CH nanocomposite in this microfluidic device contained 
~80% of mesoporosity of total pore volume of 0.2961cc/g. The integration of the mesoporous antTiO2-
CH with this microfluidic device improved the biosensor characteristics due to excellent electrochemical 
properties for total cholesterol detection. An XPS study of the microfluidic biosensor was used to 
quantify the used functional groups before and after enzyme immobilization. The results reported from 
this study have shown that the sensitivity of mesoporous TiO2-CH based microfluidic device is several-
folds higher, indicating that the combination of impedimetric detection with biopolymer-nanostructured 
microelectrode provides a technology that is more sensitive towards esterified cholesterol. This 
microfluidic biosensor showed a lower detection limit of 0.2 mg/dl in a wide range (2-500 mg/dl) of 
cholesterol detection. Additionally, the Km value of this microfluidic biosensor was found to be lower, 
indicating a strong affinity of CH-TiO2 based microfluidic bioelectrode to the cholesterol. 
     In the next experiment, I have explored NiO nanorods as another candidate for microfluidic 
bioelectrode modification. Utilization of nickel oxide nanorods to the microfluidic biosensor for total 
cholesterol detection facilitated the direct enzyme immobilization on transducer surface due to its high 
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isoelectric point.  The nanorod shape geometries and well-defined crystal surfaces of NiO in the 
microfluidic device enhanced the electrons transfer from bulk solution to electrode. Nanostructured NiO 
acted as good acceptors of electrons generated during re-oxidation of cholesterol oxidase that transfer to 
electrode via Ni
+2
/Ni
+3
 redox couple resulting in increased sensitivity compared to using TiO2 
nanoparticles in microfluidic system. It was observed that this NiO based microfluidic device shows 
excellent sensitivity and high adsorption ability of biomolecules on transducer surface. Thus, it can be 
concluded that the NiO is a good candidate for the integration with microfluidic system as well as 
attachment of biomolecules for cholesterol detection.  
In addition to these modifications, CNTs were used to form CNT-NiO nanocomposite and were 
integrated with microfluidic device for detection of cholesterol and LDL. The smart CNT-NiO 
nanocomposite matrix with microfluidic assembly showed better biosensing characteristics compared to 
using single component such as TiO2 and NiO nanoparticles. In this microfluidic biosensor, the toxicity 
effect of the CNT-NiO composite was found to be lesser compared to CNTs and NiO nanoparticles. The 
application of CNT-NiO composite in this device improved the electrochemical properties as well as 
loading capacity of antibody/enzyme. Surface immobilization of cholesterol oxidase and cholesterol 
esterase was carried out on CNT-NiO composite via covalent interaction for estimation of total 
cholesterol molecules.  In this strategy, a 20-fold of sensitivity (2.2 mA/mM/cm
2
) enhancement for 
cholesterol monitoring was observed. The low detection limit (0.03 mM) and fast detection time (2 s) are 
quite remarkable for detection of cholesterol molecules using this microfluidic biosensor. This may be 
due to the available functional groups of CNTs utilized in this microfluidic biosensor. In this same 
microfluidic biosensor, we carried out an anti-apolipoprotein immobilization in place of cholesterol 
oxidase and esterase to covert this to an immunosensor for the detection of LDL molecules. The results 
relating to the detection of LDL molecules using this microfluidic biosensor showed good selectivity, 
stability, reproducibility and can detect LDL molecules within its physiological range. Higher values of 
association  and dissociation constants indicated strong binding affinity between AAB functionalized 
CNT-NiO nanocomposite and LDL molecules. Sensitivity and othered biosensing characteristics were 
improved due to the covalently bind AAB molecules to CNT-NiO nanocomposite on microfluidic 
transducer. The label free detection of LDL molecules in this microfluidic device offered higher 
selectivity and stability. The CNT-NiO composite based microfluidic device facilitated detection of 
cholesterol as well as LDL molecules in an efficient manner.  
 Thus to be conclusive, the main focus of this thesis was to develop POC microfluidic platforms for 
detection of biomolecules. Efforts have been made to critically evaluate biosensing parameters and 
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optimize of detection cholesterol and LDL via electrochemical techniques. Starting from the 
microfabrication, synthesis and characterization of nanoparticles, their immobilization etc. this thesis has 
explained every step in the development of a novel microfluidic platform with nanostructured materials. 
For fabrication of cholesterol microfluidic biosensor, we used various immobilization matrices such as 
TiO2, NiO, CNT-NiO and CH-TiO2 to increased stability, reusability, ordered arrangement and high 
reproducibility. They facilitated the immobilization of biomolecules without denaturation and provided 
fast electron transfer between biomolecules and electrode surface. The functional properties of 
biomolecules and nanostructured materials were easily manipulated to make them compatible for 
immobilization of biomolecules with better orientation. 
 These demonstrated microfluidic systems can address the problems like miniaturization, cost 
effectiveness, compactness, reagent/power consumption, detection time and sensitivity to be greater 
extent. Additionally, the simplicity and basic fundamentals of electrochemistry can improve our device 
fabrication in fluidic-format. These proposed biochips could positively create a new direction in future 
medical health-care diagnostics.  
7. 2 Future prospects 
The basic design of a microfluidic biosensor needs microstructures to control fluidic operations as well as 
the bioelectrode. The bioelectrode should be attached with biological receptor coupled to an electronic 
transducer that converts a biological event into a measurable signal. The problems can arise due to limited 
functional stability of immobilized biomolecules and electrical interference of signal transduction. To 
overcome these problems, the selection of a suitable matrix for immobilization of desired biomolecules 
can play an important role. The fabricated microfluidic devices for detection of cholesterol are greatly 
benefitted from the use of nanoparticles, particularly from the use of CNTs. Efforts are still in progress to 
utilize graphene oxide sheets as detectors in lab-on-a-chip devices.  
Using a syringe pump may be a limitation for fluidic manipulation towards the point-of-care 
diagnostics. The disadvantages include large dead volumes and significant flow hysteresis.  To obviate 
this problem, the passive mixing elements that exploit liquid movement in the geometries of the 
microchannels to induce fluid mixing can be proposed. Passive mixers are generally reliable, low cost, 
can be easily fabricated and integrated onto POC diagnostic devices. The typical driving forces for 
propelling fluids in passive microfluidic devices are dependent on chemical gradients, osmotic pressure, 
and capillary forces etc. Thus, these microfluidic devices offer portability, reduced cost, minute dead 
volumes and low power consumption.  However, a major limitation relates to the flow rates of these 
devices that can only be presently varied to a limited degree. 
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The PDMS behaves like an elastic solid material that maintains its molded structure. It offers low 
cost, flexibility, and rapid prototyping. PDMS has poor chemical compatibility with many organic 
solvents as it tends to swell upon contact, making it mainly suitable for aqueous applications. PDMS 
adsorbs small molecules and it can be deformed under pressure of pneumatic valves. It can become a 
significant issue for high pressure operation as it leads to a large alteration of channel geometry. Though, 
PDMS has gained widespread acceptance in the field, glass and silicon certainly still have increased 
utility in microfluidics device fabrication. The permanent modification of PDMS surface using various 
chemical treatments has been investigated. In Chapter 2 (Section 2.3), I have described relating to the 
modification of PDMS surface via chemical treatment over some period. Researchers are trying to find a 
solution using self assembled monolayer (SAM) onto PDMS surface to reduce swelling and obtain 
improved stability. PDMS can be modified by conversion of chemical bonding from Si-CH3 
(hydrophobic) to Si-OH (hydrophilic) which can reduce the use of syringe pump in the proposed 
microfluidic system to develop a hand-held compact device.  
It is proposed to detect multi-analytes such as LDL, cholesterol and triglycerides, using same 
microfluidic detection system with minor modifications. In this proposed microfluidic system, fabrication 
of a suitable electrode array and selective deposition of biofunctionalized nanomaterials is proposed to 
detect desired analytes. Advances in microfluidic technologies have provided an exciting opportunity to 
integrate photonics and microfluidics at micron-size scales to leverage the combined advantages resulting 
in a totally new area of research termed as ‘optofluidics’. Non-contact label-free measurements and 
microscopic optical imaging based on microfluidics have attracted the attention of researchers in this field 
as most effective ways for fast, real-time and high sensitivity detection of biomolecules. Optofluidic 
elements that can manipulate light inside a microchannel have also been demonstrated. Principles of 
optical microscopic imaging coupled with fluorescence tags and SPR-based detection have been explored 
and demonstrated as effective biosensing platforms for detection and quantification of various 
biomolecules. In SPR measurements, resonance angle is very sensitive to the change in refractive index 
and SPR shift in millidegrees (m°), due to the change in refractive index, is used as the response to 
quantify the binding of macromolecules at the sensor surface. SPR patterned Au electrode on glass can be 
used to functionalize biomolecules and PDMS microchannel will be used to control biological fluids for 
desired analyte on this SPR electrode. The SPR signal can be recorded as a typical sensogram.  
Microfluidics systems have been adapted for imaging intracellular events like cell division, 
migration etc. The nanotechnology developments and a wide variety of nanoparticulate imaging contrast 
agents have significantly contributed to the development of nanoparticles based biosensors both in vitro 
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as well as in vivo levels. Thus, using a microscope in combination with optofluidic channels is likely to 
create new possibilities towards POC diagnostics for human health care.  
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